"Name","Gene.s.","Protein.change","Condition.s.","Clinical.significance..Last.reviewed.","Review.status","Accession","GRCh37Chromosome","GRCh37Location","GRCh38Chromosome","GRCh38Location","VariationID","AlleleID.s.","dbSNP.ID","Canonical.SPDI"
"0","0","0","0","0","0","0","0","0","0","0",0,"0","0","0"
"NM_002506.2(NGF):c.661C>T (p.Arg221Trp)","NGF|NGF-AS1","R211W, R221W","Congenital sensory neuropathy with selective loss of small myelinated fibers","Pathogenic(Last reviewed: Feb 1, 2011)","no assertion criteria provided","VCV000014045","1","115828756","1","115286135",14045,"29084","rs11466112","NC_000001.11:115286134:G:A"
"NM_005373.2(MPL):c.823C>A (p.Pro275Thr)","MPL","P275T","Congenital amegakaryocytic thrombocytopenia","Pathogenic(Last reviewed: Jan 1, 2001)","no assertion criteria provided","VCV000014161","1","43805767","1","43340096",14161,"29200","rs28928908","NC_000001.11:43340095:C:A"
"NM_170707.4(LMNA):c.664C>T (p.His222Tyr)","LMNA","H222Y, H141Y, H110Y","Emery-Dreifuss muscular dystrophy 3, autosomal recessive|Emery-Dreifuss muscular dystrophy 2, autosomal dominant|not provided","Pathogenic(Last reviewed: Jan 17, 2013)","no assertion criteria provided","VCV000014492","1","156104620","1","156134829",14492,"29531","rs28928901","NC_000001.11:156134828:C:T"
"NM_170707.4(LMNA):c.254T>G (p.Leu85Arg)","LMNA","L85R","not provided|Dilated cardiomyopathy 1A","Pathogenic(Last reviewed: Dec 2, 1999)","no assertion criteria provided","VCV000014480","1","156084963","1","156115172",14480,"29519","rs28933090","NC_000001.11:156115171:T:G"
"NM_170707.4(LMNA):c.1445G>A (p.Arg482Gln)","LMNA","R482Q, R370Q, R401Q","Hutchinson-Gilford syndrome|Heart-hand syndrome, Slovenian type|Mandibuloacral dysplasia with type A lipodystrophy|Charcot-Marie-Tooth disease type 2B1|Dilated cardiomyopathy 1A|Emery-Dreifuss muscular dystrophy 3, autosomal recessive|Congenital muscular dystrophy, LMNA-related|Familial partial lipodystrophy 2|Lethal tight skin contracture syndrome|Emery-Dreifuss muscular dystrophy 2, autosomal dominant|Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome|Laminopathy|Monogenic diabetes|not provided|Cardiomyopathy|Emery-Dreifuss muscular dystrophy 3, autosomal recessive|Charcot-Marie-Tooth disease, type 2|Familial partial lipodystrophy 2","Conflicting interpretations of pathogenicity(Last reviewed: Aug 21, 2020)","criteria provided, conflicting interpretations","VCV000014486","1","156106776","1","156136985",14486,"29525","rs11575937","NC_000001.11:156136984:G:A"
"NM_170707.4(LMNA):c.1445G>T (p.Arg482Leu)","LMNA","R482L, R370L, R401L","Lethal tight skin contracture syndrome|Emery-Dreifuss muscular dystrophy|Emery-Dreifuss muscular dystrophy 2, autosomal dominant|Congenital muscular dystrophy, LMNA-related|Hutchinson-Gilford syndrome|Charcot-Marie-Tooth disease type 2B1|Mandibuloacral dysplasia with type A lipodystrophy|Familial partial lipodystrophy 2|Dilated cardiomyopathy 1A|not provided|Lipoatrophy with Diabetes, Hepatic Steatosis, Hypertrophic Cardiomyopathy, and Leukomelanodermic Papules","Uncertain significance(Last reviewed: Jan 9, 2019)","criteria provided, single submitter","VCV000014490","1","156106776","1","156136985",14490,"29529","rs11575937","NC_000001.11:156136984:G:T"
"NM_000702.4(ATP1A2):c.2291T>C (p.Leu764Pro)","ATP1A2","L764P","Familial hemiplegic migraine|Familial hemiplegic migraine type 2","Pathogenic(Last reviewed: Apr 22, 2021)","no assertion criteria provided","VCV000012917","1","160105635","1","160135845",12917,"27956","rs28933398","NC_000001.11:160135844:T:C"
"NM_000702.4(ATP1A2):c.2659T>C (p.Trp887Arg)","ATP1A2","W887R","Familial hemiplegic migraine|Familial hemiplegic migraine type 2","Pathogenic(Last reviewed: Apr 22, 2021)","no assertion criteria provided","VCV000012918","1","160106455","1","160136665",12918,"27957","rs28933399","NC_000001.11:160136664:T:C"
"NM_000702.4(ATP1A2):c.2192T>C (p.Met731Thr)","ATP1A2","M731T","Familial hemiplegic migraine type 2","Pathogenic(Last reviewed: Jan 13, 2012)","no assertion criteria provided","VCV000012919","1","160105300","1","160135510",12919,"27958","rs28933400","NC_000001.11:160135509:T:C"
"NM_000488.3(SERPINC1):c.166C>T (p.Arg56Cys)","SERPINC1","R56C, R8C","Antithrombin III deficiency|not provided","Likely pathogenic(Last reviewed: Oct 7, 2016)","criteria provided, single submitter","VCV000018022","1","173883933","1","173914795",18022,"33061","rs28929469","NC_000001.11:173914794:G:A"
"NM_001007792.1(NTRK1):c.1702C>T (p.His568Tyr)","NTRK1","H598Y, H568Y, H604Y","not specified|not provided|Hereditary insensitivity to pain with anhidrosis|Familial medullary thyroid carcinoma","Benign/Likely benign(Last reviewed: Jul 1, 2021)","criteria provided, multiple submitters, no conflicts","VCV000037077","1","156848918","1","156879126",37077,"38397","rs6336","NC_000001.11:156879125:C:T"
"NM_006894.5(FMO3):c.472G>A (p.Glu158Lys)","FMO3","","Trimethylaminuria|not specified","Benign(Last reviewed: Mar 6, 2018)","criteria provided, multiple submitters, no conflicts","VCV000038394","1","171076966","1","171107825",38394,"38476","rs2266782","NC_000001.11:171107824:G:A"
"NM_000157.4(GBA):c.680A>G (p.Asn227Ser)","GBA|LOC106627981","N227S, N140S, N178S","Gaucher disease type 3C|Gaucher disease type III|Gaucher disease type I|Gaucher disease type II|not provided|Gaucher disease|Gaucher disease type I|Gaucher disease type III","Pathogenic/Likely pathogenic(Last reviewed: Jul 26, 2020)","criteria provided, multiple submitters, no conflicts","VCV000004314","1","155208006","1","155238215",4314,"19353","rs364897","NC_000001.11:155238214:T:C"
"NM_000157.3(GBA):c.1448T>C","GBA|LOC106627981","L483P, L396P, L434P","not provided|Gaucher disease type 3C|Gaucher disease type III|Gaucher disease type I|Gaucher disease type II|Parkinson disease, late-onset|Gaucher disease|Dementia, Lewy body, susceptibility to|Hereditary late onset Parkinson disease|Gaucher disease, perinatal lethal|Gaucher disease type I|Gaucher disease type II|Gaucher disease type III|Thoracolumbar scoliosis|Resting tremor|Parkinsonism|Hypomimic face|Movement disorder","Pathogenic, risk factor(Last reviewed: Jun 1, 2021)","criteria provided, multiple submitters, no conflicts","VCV000004288","1","155205043","1","155235252",4288,"19327","rs421016","NC_000001.11:155235251:A:G"
"NM_000157.4(GBA):c.259C>T (p.Arg87Trp)","GBA|LOC106627981","R87W","Gaucher disease|Gaucher disease type I|not provided","Pathogenic(Last reviewed: Feb 13, 2020)","criteria provided, multiple submitters, no conflicts","VCV000004321","1","155209725","1","155239934",4321,"19360","rs1141814","NC_000001.11:155239933:G:A"
"NM_004700.4(KCNQ4):c.853G>A (p.Gly285Ser)","KCNQ4","G285S","Autosomal dominant nonsyndromic deafness 2A|Rare genetic deafness|Nonsyndromic hearing loss and deafness","Pathogenic(Last reviewed: Sep 11, 2018)","reviewed by expert panel","VCV000006241","1","41285565","1","40819893",6241,"21280","rs28937588","NC_000001.11:40819892:G:A"
"NM_004700.4(KCNQ4):c.853G>T (p.Gly285Cys)","KCNQ4","G285C","Autosomal dominant nonsyndromic deafness 2A","Pathogenic(Last reviewed: Feb 17, 2011)","no assertion criteria provided","VCV000006244","1","41285565","1","40819893",6244,"21283","rs28937588","NC_000001.11:40819892:G:T"
"NM_024009.3(GJB3):c.101T>C (p.Leu34Pro)","GJB3","L34P","Erythrokeratodermia variabilis et progressiva 1","Pathogenic(Last reviewed: May 15, 2002)","no assertion criteria provided","VCV000006491","1","35250464","1","34784863",6491,"21530","rs28937583","NC_000001.11:34784862:T:C"
"NM_000130.4(F5):c.1601G>A (p.Arg534Gln)","F5","","not specified|Thrombophilia due to factor V Leiden|Factor V deficiency|Ischemic stroke, susceptibility to|Budd-Chiari syndrome, susceptibility to|Pregnancy loss, recurrent, susceptibility to, 1|Thrombophilia due to factor V Leiden|Factor V deficiency","Pathogenic, risk factor(Last reviewed: Feb 22, 2021)","criteria provided, multiple submitters, no conflicts","VCV000000642","1","169519049","1","169549811",642,"15681","rs6025","NC_000001.11:169549810:C:T"
"NM_001008216.2(GALE):c.937C>A (p.Leu313Met)","GALE","L313M","UDPglucose-4-epimerase deficiency","Pathogenic(Last reviewed: Jan 1, 1998)","no assertion criteria provided","VCV000003680","1","24122692","1","23796202",3680,"18719","rs3180383","NC_000001.11:23796201:G:T"
"NM_001122764.3(PPOX):c.767C>G (p.Pro256Arg)","PPOX","P256R, P120R, P223R, P94R","not provided|Variegate porphyria|Variegate porphyria, homozygous","Conflicting interpretations of pathogenicity(Last reviewed: Dec 5, 2020)","criteria provided, conflicting interpretations","VCV000008704","1","161138933","1","161169143",8704,"23743","rs12735723","NC_000001.11:161169142:C:G"
"NM_005263.5(GFI1):c.1208A>G (p.Lys403Arg)","GFI1","K403R","Neutropenia, nonimmune chronic idiopathic, of adults|Severe congenital neutropenia 2, autosomal dominant","Likely benign(Last reviewed: May 28, 2019)","criteria provided, single submitter","VCV000008740","1","92941647","1","92476090",8740,"23779","rs28936382","NC_000001.11:92476089:T:C"
"NM_000098.3(CPT2):c.149C>A (p.Pro50His)","CPT2","P50H","Carnitine palmitoyltransferase II deficiency|not provided|Carnitine palmitoyltransferase II deficiency, infantile|Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced|Gastrointestinal dysmotility|Inappropriate sinus tachycardia|Chronic pain|Dysautonomia|Sinus tachycardia|Arthritis|Pancytopenia|Polyarticular arthritis|Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced|Carnitine palmitoyltransferase II deficiency, infantile|Carnitine palmitoyltransferase II deficiency, lethal neonatal|Encephalopathy, acute, infection-induced, 4, susceptibility to","Pathogenic(Last reviewed: Sep 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000008954","1","53662764","1","53197092",8954,"23993","rs28936375","NC_000001.11:53197091:C:A"
"NM_000098.3(CPT2):c.1883A>C (p.Tyr628Ser)","CPT2","Y628S, Y605S","Carnitine palmitoyltransferase II deficiency|Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced|Carnitine palmitoyltransferase II deficiency, infantile","Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)","criteria provided, multiple submitters, no conflicts","VCV000008956","1","53679173","1","53213501",8956,"23995","rs28936673","NC_000001.11:53213500:A:C"
"NM_000098.3(CPT2):c.520G>A (p.Glu174Lys)","CPT2","E174K","Carnitine palmitoyltransferase II deficiency|Carnitine palmitoyltransferase II deficiency, infantile","Pathogenic/Likely pathogenic(Last reviewed: Oct 19, 2020)","criteria provided, multiple submitters, no conflicts","VCV000008957","1","53675866","1","53210194",8957,"23996","rs28936674","NC_000001.11:53210193:G:A"
"NM_000642.3(AGL):c.4459C>T (p.Arg1487Ter)","AGL","R1487*, R1471*","Glycogen storage disease type III|Glycogen storage disease","Conflicting interpretations of pathogenicity(Last reviewed: Oct 1, 2020)","criteria provided, conflicting interpretations","VCV000456508","1","100382265","1","99916709",456508,"448519","rs12118058","NC_000001.11:99916708:C:T"
"NM_174936.3(PCSK9):c.158C>G (p.Ala53Gly)","PCSK9","A53G","Familial hypercholesterolemia|Familial hypercholesterolemia 1|Familial hypercholesterolemia 3|not specified|Hypobetalipoproteinemia","Uncertain significance(Last reviewed: Jul 20, 2020)","criteria provided, multiple submitters, no conflicts","VCV000440708","1","55505668","1","55039995",440708,"434137","rs11583680","NC_000001.11:55039994:C:G"
"NM_001244753.2(FCGR3B):c.316A>G (p.Ile106Val)","FCGR3B","I106V, I105V, I89V","not specified","Benign(Last reviewed: Mar 28, 2016)","criteria provided, single submitter","VCV000402858","1","161599571","1","161629781",402858,"389362","rs2290834","NC_000001.11:161629780:T:C"
"NM_002016.1(FLG):c.3551C>A (p.Ser1184Ter)","FLG","S1184*","not provided","Pathogenic(Last reviewed: Jul 15, 2015)","criteria provided, single submitter","VCV000419209","1","152283811","1","152311335",419209,"404917","rs3120649","NC_000001.11:152311334:G:T"
"NM_018116.3(MSTO1):c.971C>T (p.Thr324Ile)","MSTO1","T324I, T146I, T147I, T143I, T269I","Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome|Inborn genetic diseases","Conflicting interpretations of pathogenicity(Last reviewed: Apr 23, 2021)","criteria provided, conflicting interpretations","VCV000438833","1","155582639","1","155612848",438833,"432466","rs622288","NC_000001.11:155612847:C:T"
"NM_015602.3(TOR1AIP1):c.961C>T (p.Arg321Ter)","TOR1AIP1","R321*, R322*","Muscular dystrophy, limb-girdle, type 2y","Likely pathogenic(Last reviewed: Jun 20, 2019)","criteria provided, single submitter","VCV000804380","1","179883186","1","179914051",804380,"792713","rs11581962","NC_000001.11:179914050:C:T"
"NM_000098.3(CPT2):c.520G>T (p.Glu174Ter)","CPT2","E174*","Carnitine palmitoyltransferase II deficiency, infantile","Likely pathogenic(Last reviewed: Jan 26, 2017)","criteria provided, single submitter","VCV000550520","1","53675866","1","53210194",550520,"541317","rs28936674","NC_000001.11:53210193:G:T"
"NM_000143.3(FH):c.1302C>T (p.Cys434=)","FH","","none provided|Hereditary leiomyomatosis and renal cell cancer|Fumarase deficiency|Multiple Cutaneous and Uterine Leiomyomas|not provided|Hereditary cancer-predisposing syndrome|not specified","Benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000137372","1","241663825","1","241500525",137372,"141075","rs2070080","NC_000001.11:241500524:G:A"
"NM_006516.3(SLC2A1):c.1372C>A (p.Arg458=)","SLC2A1","","History of neurodevelopmental disorder|GLUT1 deficiency syndrome 1|GLUT1 deficiency syndrome 1, autosomal recessive|not specified|Dystonia 9","Benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000139167","1","43392819","1","42927148",139167,"142870","rs13306758","NC_000001.11:42927147:G:T"
"NM_000069.3(CACNA1S):c.2748C>G (p.His916Gln)","CACNA1S","H916Q","Hypokalemic periodic paralysis 1","Pathogenic(Last reviewed: Jul 31, 2014)","no assertion criteria provided","VCV000143198","1","201035071","1","201065943",143198,"152916","rs2297902","NC_000001.11:201065942:G:C"
"NM_000157.4(GBA):c.475C>T (p.Arg159Trp)","GBA|LOC106627981","R159W, R110W, R72W","Gaucher disease|not provided","Pathogenic(Last reviewed: Dec 3, 2019)","criteria provided, multiple submitters, no conflicts","VCV000065570","1","155208421","1","155238630",65570,"76478","rs439898","NC_000001.11:155238629:G:A"
"NM_006516.3(SLC2A1):c.1372C>T (p.Arg458Trp)","SLC2A1","R458W","Dystonia 9|GLUT1 deficiency syndrome 2|Epilepsy, idiopathic generalized, susceptibility to, 12|Stomatin-deficient cryohydrocytosis with neurologic defects|GLUT1 deficiency syndrome 1|not provided|Epilepsy, idiopathic generalized, susceptibility to, 12|GLUT1 deficiency syndrome 1, autosomal recessive","Pathogenic/Likely pathogenic(Last reviewed: Nov 9, 2018)","criteria provided, multiple submitters, no conflicts","VCV000096708","1","43392819","1","42927148",96708,"102597","rs13306758","NC_000001.11:42927147:G:A"
"NM_000350.3(ABCA4):c.1411G>A (p.Glu471Lys)","ABCA4","E471K","not provided|Retinal dystrophy|ABCA4-Related Disorders|Inborn genetic diseases|Stargardt disease","Conflicting interpretations of pathogenicity(Last reviewed: Nov 17, 2020)","criteria provided, conflicting interpretations","VCV000099052","1","94543389","1","94077833",99052,"104942","rs1800548","NC_000001.11:94077832:C:T"
"NM_000350.3(ABCA4):c.4685T>C (p.Ile1562Thr)","ABCA4","I1562T","Stargardt disease|Cone-rod dystrophy 3|Retinal dystrophy|not provided|Cone-Rod Dystrophy, Recessive|Retinitis Pigmentosa, Recessive|Cone-rod dystrophy|ABCA4-Related Disorders|Stargardt disease 1","Conflicting interpretations of pathogenicity(Last reviewed: Oct 8, 2020)","criteria provided, conflicting interpretations","VCV000099311","1","94487490","1","94021934",99311,"105200","rs1762111","NC_000001.11:94021933:A:G"
"NM_000157.4(GBA):c.1448T>G (p.Leu483Arg)","GBA|LOC106627981","L483R, L434R, L396R","not provided|Gaucher disease type II|Gaucher disease type III|Gaucher disease type I|Gaucher disease type II|Gaucher disease type 3C|Gaucher disease type I|Gaucher disease","Pathogenic/Likely pathogenic(Last reviewed: Aug 14, 2020)","criteria provided, multiple submitters, no conflicts","VCV000093449","1","155205043","1","155235252",93449,"99356","rs421016","NC_000001.11:155235251:A:C"
"NM_000157.4(GBA):c.1483G>C (p.Ala495Pro)","GBA|LOC106627981","A495P, A408P, A446P","not specified","Benign(Last reviewed: Jul 24, 2012)","criteria provided, single submitter","VCV000093450","1","155205008","1","155235217",93450,"38384","rs368060","NC_000001.11:155235216:C:G"
"NM_000157.4(GBA):c.1497G>C (p.Val499=)","GBA|LOC106627981","","not specified","Benign/Likely benign(Last reviewed: Jul 21, 2017)","criteria provided, multiple submitters, no conflicts","VCV000093451","1","155204994","1","155235203",93451,"38385","rs1135675","NC_000001.11:155235202:C:G"
"NM_000157.4(GBA):c.681T>G (p.Asn227Lys)","GBA|LOC106627981","N227K, N140K, N178K","Gaucher disease type II|Gaucher disease type I|Gaucher disease type 3C|Gaucher disease type III|not provided|Gaucher disease","Pathogenic(Last reviewed: May 26, 2017)","criteria provided, multiple submitters, no conflicts","VCV000093458","1","155208005","1","155238214",93458,"99363","rs381418","NC_000001.11:155238213:A:C"
"NM_000069.3(CACNA1S):c.2748C>T (p.His916=)","CACNA1S","","Hypokalemic periodic paralysis 1|Malignant hyperthermia, susceptibility to, 5|not specified|Hypokalemic periodic paralysis 1|not provided","Benign(Last reviewed: Dec 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000254822","1","201035071","1","201065943",254822,"249618","rs2297902","NC_000001.11:201065942:G:A"
"NM_000350.3(ABCA4):c.3377T>C (p.Leu1126Pro)","ABCA4","L1126P","Stargardt disease 1","Likely pathogenic(Last reviewed: Jan 1, 2016)","criteria provided, single submitter","VCV000236101","1","94506910","1","94041354",236101,"237679","rs1047376","NC_000001.11:94041353:A:G"
"NM_170707.4(LMNA):c.254T>A (p.Leu85His)","LMNA","L85H","Charcot-Marie-Tooth disease, type 2","Uncertain significance(Last reviewed: Dec 16, 2015)","criteria provided, single submitter","VCV000242004","1","156084963","1","156115172",242004,"238146","rs28933090","NC_000001.11:156115171:T:A"
"NM_000570.4(FCGR3B):c.316A= (p.Ile106=)","FCGR3B","","","no interpretation for the single variant","no interpretation for the single variant","VCV000242687","1","161599571","1","161629781",242687,"45585","rs2290834","NC_000001.11:161629780:T:T"
"NM_015074.3(KIF1B):c.3260A>G (p.Tyr1087Cys)","KIF1B","Y1087C, Y1133C","Charcot-Marie-Tooth disease, type 2A1|Charcot-Marie-Tooth disease, type 2|Neuroblastoma|Charcot-Marie-Tooth disease","Benign(Last reviewed: Nov 27, 2020)","criteria provided, multiple submitters, no conflicts","VCV000291567","1","10397567","1","10337509",291567,"275799","rs2297881","NC_000001.11:10337508:A:G"
"NM_000143.3(FH):c.1302C>A (p.Cys434Ter)","FH","C434*","not provided","Likely pathogenic(Last reviewed: Nov 17, 2016)","criteria provided, single submitter","VCV000373513","1","241663825","1","241500525",373513,"359342","rs2070080","NC_000001.11:241500524:G:T"
"NM_014625.3(NPHS2):c.586C>T (p.Arg196Ter)","NPHS2","R196*","Idiopathic nephrotic syndrome|not provided","Pathogenic/Likely pathogenic(Last reviewed: Oct 25, 2019)","criteria provided, multiple submitters, no conflicts","VCV000188892","1","179526314","1","179557179",188892,"186604","rs12568913","NC_000001.11:179557178:G:A"
"NM_000130.5(F5):c.1601= (p.Arg534=)","F5","","Factor V deficiency|not provided|hormonal contraceptives for systemic use response - Toxicity/ADR","drug response(Last reviewed: Nov 28, 2017)","reviewed by expert panel","VCV000226007","1","169519049","1","169549811",226007,"227743","rs6025","NC_000001.11:169549810:C:C"
"NM_020975.6(RET):c.2944C>T (p.Arg982Cys)","RET","R982C, R728C","not specified|Hereditary cancer-predisposing syndrome|not provided|Malignant tumor of breast|Multiple endocrine neoplasia, type 2|Hirschsprung disease|Familial medullary thyroid carcinoma|Renal hypodysplasia/aplasia 1|Hirschsprung disease 1|Pheochromocytoma|Multiple endocrine neoplasia, type 2b|Multiple endocrine neoplasia|Multiple endocrine neoplasia, type 2a","Conflicting interpretations of pathogenicity(Last reviewed: Dec 7, 2020)","criteria provided, conflicting interpretations","VCV000013938","10","43620335","10","43124887",13938,"28977","rs17158558","NC_000010.11:43124886:C:T"
"NM_001378373.1(MBL2):c.161G>A (p.Gly54Asp)","MBL2","","Mannose-binding protein deficiency","Pathogenic(Last reviewed: Oct 1, 2004)","no assertion criteria provided","VCV000014350","10","54531235","10","52771475",14350,"29389","rs1800450","NC_000010.11:52771474:C:T"
"NM_001378373.1(MBL2):c.154C>T (p.Arg52Cys)","MBL2","","Mannose-binding protein deficiency|Cystic fibrosis","Pathogenic(Last reviewed: Dec 11, 2018)","criteria provided, single submitter","VCV000014352","10","54531242","10","52771482",14352,"29391","rs5030737","NC_000010.11:52771481:G:A"
"NM_001083116.3(PRF1):c.673C>T (p.Arg225Trp)","PRF1","R225W","Familial hemophagocytic lymphohistiocytosis 2","Pathogenic(Last reviewed: Apr 27, 2017)","criteria provided, single submitter","VCV000013711","10","72358804","10","70599048",13711,"28750","rs28933973","NC_000010.11:70599047:G:A"
"NM_000043.6(FAS):c.779A>T (p.Asp260Val)","FAS","D244V, D260V, D239V","Autoimmune lymphoproliferative syndrome, type 1a","Pathogenic(Last reviewed: Nov 1, 1998)","no assertion criteria provided","VCV000016504","10","90773978","10","89014221",16504,"31543","rs28929498","NC_000010.11:89014220:A:T"
"CYP2C19*4A/*30","CYP2C19","R73C","Voriconazole response|Sertraline response|Citalopram response|Escitalopram response","drug response","practice guideline","VCV000634307","10","96534863","10","94775106",634307,"622283","rs145328984","NC_000010.11:94775105:C:T"
"CYP2C19*4A/*11","CYP2C19","R150H","Citalopram response|Voriconazole response|Sertraline response|Escitalopram response","drug response","practice guideline","VCV000634361","10","96535264","10","94775507",634361,"622288","rs58973490","NC_000010.11:94775506:G:A"
"CYP2C19*4A/*13","CYP2C19","R410C","Voriconazole response|Escitalopram response|Citalopram response|Sertraline response","drug response","practice guideline","VCV000634362","10","96609752","10","94849995",634362,"622294","rs17879685","NC_000010.11:94849994:C:T"
"CYP2C19*4A/*15","CYP2C19","I19L","Citalopram response|Voriconazole response|Escitalopram response|Sertraline response","drug response","practice guideline","VCV000634363","10","96522517","10","94762760",634363,"622281","rs17882687","NC_000010.11:94762759:A:C"
"CYP2C19*4A/*22","CYP2C19","R186P","Escitalopram response|Voriconazole response|Citalopram response|Sertraline response","drug response","practice guideline","VCV000634017","10","96540331","10","94780574",634017,"622289","rs140278421","NC_000010.11:94780573:G:C"
"CYP2C19*4A/*35","CYP2C19","","Voriconazole response|Escitalopram response|Citalopram response|Sertraline response","drug response","practice guideline","VCV000634019","10","96535124","10","94775367",634019,"622287","rs12769205","NC_000010.11:94775366:A:G"
"CYP2C19*4A/*12","CYP2C19","","Citalopram response|Escitalopram response|Sertraline response|Voriconazole response","drug response","practice guideline","VCV000634158","10","96612671","10","94852914",634158,"622297","rs55640102","NC_000010.11:94852913:A:C"
"CYP2C19*4A/*14","CYP2C19","L17P","Citalopram response|Escitalopram response|Voriconazole response|Sertraline response","drug response","practice guideline","VCV000634159","10","96522512","10","94762755",634159,"622280","rs55752064","NC_000010.11:94762754:T:C"
"CYP2C19*4A/*32","CYP2C19","H99R","Escitalopram response|Sertraline response|Voriconazole response|Citalopram response","drug response","practice guideline","VCV000634162","10","96534942","10","94775185",634162,"622286","rs1288601658","NC_000010.11:94775184:A:G"
"CYP2C19*4A/*10","CYP2C19","P227L","Voriconazole response|Sertraline response|Escitalopram response|Citalopram response","drug response","practice guideline","VCV000633981","10","96541615","10","94781858",633981,"47951","rs6413438","NC_000010.11:94781857:C:T"
"CYP2C19*4A/*16","CYP2C19","R442C","Voriconazole response|Escitalopram response|Citalopram response|Sertraline response","drug response","practice guideline","VCV000633982","10","96612522","10","94852765",633982,"622295","rs192154563","NC_000010.11:94852764:C:T"
"NM_000392.5(ABCC2):c.2901C>A (p.Tyr967Ter)","ABCC2","Y967*","not provided","Pathogenic(Last reviewed: May 19, 2015)","criteria provided, single submitter","VCV000195649","10","101591385","10","99831628",195649,"192810","rs17222547","NC_000010.11:99831627:C:A"
"NM_000315.4(PTH):c.247C>T (p.Arg83Ter)","PTH","R83*, R115*","Primary hyperparathyroidism","Pathogenic(Last reviewed: Sep 11, 2008)","no assertion criteria provided","VCV000013759","11","13514053","11","13492506",13759,"28798","rs6256","NC_000011.10:13492505:G:A"
"NM_000518.4(HBB):c.20A>C (p.Glu7Ala)","LOC106099062|LOC107133510|HBB","E7A","HEMOGLOBIN G (MAKASSAR)","other(Last reviewed: Dec 12, 2017)","no assertion criteria provided","VCV000015175","11","5248232","11","5227002",15175,"30214","rs334","NC_000011.10:5227001:T:G"
"NM_000518.5(HBB):c.20A>T (p.Glu7Val)","HBB|LOC106099062|LOC107133510","E7V","HEMOGLOBIN S|Hemoglobin E|Fetal hemoglobin quantitative trait locus 1|not provided|none provided|Anemia|Hb SS disease|Sickle cell disease and related diseases|Malaria, resistance to|Fetal hemoglobin quantitative trait locus 1|Hb SS disease|Erythrocytosis 6, familial|Methemoglobinemia, beta-globin type|Susceptibility to malaria|alpha Thalassemia|Heinz body anemia|Beta-thalassemia, dominant inclusion body type|beta Thalassemia|beta Thalassemia|Inborn genetic diseases|Fetal hemoglobin quantitative trait locus 1|Hb SS disease|Susceptibility to malaria|Heinz body anemia|Beta-thalassemia, dominant inclusion body type|beta Thalassemia","Conflicting interpretations of pathogenicity(Last reviewed: Jun 30, 2021)","criteria provided, conflicting interpretations","VCV000015333","11","5248232","11","5227002",15333,"30372","rs334","NC_000011.10:5227001:T:A"
"NM_000518.5(HBB):c.93G>T (p.Arg31Ser)","LOC106099062|LOC107133510|HBB","R31S","Heinz body anemia|not specified|not provided","Uncertain significance(Last reviewed: Nov 11, 2019)","criteria provided, multiple submitters, no conflicts","VCV000015368","11","5248029","11","5226799",15368,"30407","rs1135071","NC_000011.10:5226798:C:A"
"NM_000518.5(HBB):c.118C>T (p.Gln40Ter)","HBB|LOC106099062|LOC107133510","Q40*","not provided|none provided|Hb SS disease|Fetal hemoglobin quantitative trait locus 1|Hb SS disease|Erythrocytosis 6, familial|Methemoglobinemia, beta-globin type|Susceptibility to malaria|alpha Thalassemia|Heinz body anemia|Beta-thalassemia, dominant inclusion body type|beta Thalassemia|beta Thalassemia|beta^0^ Thalassemia|alpha Thalassemia","Pathogenic(Last reviewed: Oct 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000015402","11","5248004","11","5226774",15402,"30441","rs11549407","NC_000011.10:5226773:G:A"
"NM_000260.4(MYO7A):c.635G>A (p.Arg212His)","MYO7A","R212H, R201H","Deafness, autosomal recessive 2|Usher syndrome type 1|Rare genetic deafness|not provided|Usher syndrome, type 1B|Retinal dystrophy","Pathogenic/Likely pathogenic(Last reviewed: Jun 16, 2019)","criteria provided, multiple submitters, no conflicts","VCV000011850","11","76867950","11","77156904",11850,"26889","rs28934610","NC_000011.10:77156903:G:A"
"NM_000448.2(RAG1):c.2164G>A (p.Glu722Lys)","RAG1","E722K","Severe combined immunodeficiency, B cell-negative","Pathogenic(Last reviewed: Oct 4, 1996)","no assertion criteria provided","VCV000013139","11","36597018","11","36575468",13139,"28178","rs28933392","NC_000011.10:36575467:G:A"
"NM_000207.3(INS):c.266G>A (p.Arg89His)","INS|INS-IGF2","R89H","not provided|Hyperproinsulinemia","Pathogenic(Last reviewed: Jan 1, 2020)","criteria provided, single submitter","VCV000013380","11","2181149","11","2159919",13380,"28419","rs28933985","NC_000011.10:2159918:C:T"
"NM_000207.3(INS):c.266G>T (p.Arg89Leu)","INS-IGF2|INS","R89L","Hyperproinsulinemia","Pathogenic(Last reviewed: Jun 1, 1992)","no assertion criteria provided","VCV000013382","11","2181149","11","2159919",13382,"28421","rs28933985","NC_000011.10:2159918:C:A"
"NM_000207.3(INS):c.266G>C (p.Arg89Pro)","INS|INS-IGF2","R89P","Hyperproinsulinemia","Pathogenic(Last reviewed: May 1, 1997)","no assertion criteria provided","VCV000013383","11","2181149","11","2159919",13383,"28422","rs28933985","NC_000011.10:2159918:C:G"
"NM_005343.4(HRAS):c.181C>A (p.Gln61Lys)","HRAS|LRRC56","Q61K","not provided|Noonan syndrome 3|Lip and oral cavity carcinoma|Spermatocytic seminoma|Breast neoplasm|Thyroid cancer, nonmedullary, 2","Pathogenic/Likely pathogenic(Last reviewed: Aug 16, 2018)","criteria provided, multiple submitters, no conflicts","VCV000012601","11","533875","11","533875",12601,"27640","rs28933406","NC_000011.10:533874:G:T"
"NM_000256.3(MYBPC3):c.2992C>G (p.Gln998Glu)","MYBPC3","Q998E","Primary familial hypertrophic cardiomyopathy|Primary dilated cardiomyopathy|Cardiovascular phenotype|not provided|Cardiomyopathy|Left ventricular noncompaction 10|Primary dilated cardiomyopathy|Cardiomyopathy|Hypertrophic cardiomyopathy|none provided|Familial hypertrophic cardiomyopathy 4|not specified","Benign/Likely benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000036610","11","47355475","11","47333924",36610,"45272","rs11570112","NC_000011.10:47333923:G:C"
"NM_000480.3(AMPD3):c.1744C>T (p.Arg582Cys)","AMPD3","R573C, R582C, R580C, R414C","Erythrocyte AMP deaminase deficiency","Pathogenic(Last reviewed: Apr 27, 2017)","criteria provided, single submitter","VCV000018270","11","10521792","11","10500245",18270,"33309","rs3741040","NC_000011.10:10500244:C:T"
"NM_000352.6(ABCC8):c.674T>C (p.Leu225Pro)","ABCC8","L225P","Permanent neonatal diabetes mellitus","Pathogenic(Last reviewed: Jul 5, 2011)","no assertion criteria provided","VCV000021170","11","17483278","11","17461731",21170,"34022","rs1048095","NC_000011.10:17461730:A:G"
"NM_000260.4(MYO7A):c.47T>C (p.Leu16Ser)","MYO7A","L16S, L5S","Usher syndrome type 1|Usher syndrome, type 1B|Deafness, autosomal dominant 11|Deafness, autosomal recessive 2|not provided|none provided|not specified","Benign(Last reviewed: Jul 1, 2021)","criteria provided, multiple submitters, no conflicts","VCV000043258","11","76853783","11","77142737",43258,"52428","rs1052030","NC_000011.10:77142736:T:C"
"NM_003476.5(CSRP3):c.336G>A (p.Ala112=)","CSRP3","R56Q","Familial hypertrophic cardiomyopathy 12|Cardiovascular phenotype|Cardiomyopathy|Primary dilated cardiomyopathy|none provided|Dilated cardiomyopathy 1M|Familial hypertrophic cardiomyopathy 12|not specified|not provided","Benign(Last reviewed: Dec 3, 2020)","criteria provided, multiple submitters, no conflicts","VCV000044696","11","19207841","11","19186294",44696,"53863","rs13451","NC_000011.10:19186293:C:T"
"NM_001567.4(INPPL1):c.2415+1G>A","INPPL1","","Opsismodysplasia","Pathogenic(Last reviewed: Jan 10, 2013)","no assertion criteria provided","VCV000039476","11","71945660","11","72234616",39476,"48075","rs655423","NC_000011.10:72234615:G:A"
"NM_000244.3(MEN1):c.76G>A (p.Glu26Lys)","MEN1","E26K","not provided|Multiple endocrine neoplasia, type 1|Parathyroid adenoma, somatic","Conflicting interpretations of pathogenicity(Last reviewed: Mar 29, 2019)","criteria provided, conflicting interpretations","VCV000016689","11","64577506","11","64810034",16689,"31728","rs28931612","NC_000011.10:64810033:C:T"
"NM_000482.4(APOA4):c.1140G>T (p.Gln380His)","APOA4","Q360H, Q380H","APOLIPOPROTEIN A-IV POLYMORPHISM, APOA4*1/APOA4*2","Pathogenic(Last reviewed: May 1, 1992)","no assertion criteria provided","VCV000017905","11","116691634","11","116820918",17905,"32944","rs5110","NC_000011.10:116820917:C:A"
"NM_000039.2(APOA1):c.589C>T (p.Arg197Cys)","APOA1","R197C, R88C","APOLIPOPROTEIN A-I (MILANO)","Pathogenic(Last reviewed: Nov 5, 2003)","no assertion criteria provided","VCV000017909","11","116706739","11","116836023",17909,"32948","rs28931573","NC_000011.10:116836022:G:A"
"NM_000039.2(APOA1):c.101G>T (p.Arg34Leu)","APOA1|APOA1-AS","R34L","not provided|APOLIPOPROTEIN A-I (BALTIMORE)","Uncertain significance(Last reviewed: Aug 5, 2020)","criteria provided, single submitter","VCV000017920","11","116707816","11","116837100",17920,"32959","rs28929476","NC_000011.10:116837099:C:A"
"NM_000039.2(APOA1):c.341T>C (p.Leu114Pro)","APOA1|APOA1-AS","L90P, L114P, L5P","Amyloidosis, cardiac and cutaneous","Pathogenic(Last reviewed: Jan 1, 1999)","no assertion criteria provided","VCV000017931","11","116706987","11","116836271",17931,"32970","rs28931575","NC_000011.10:116836270:A:G"
"NM_018389.4(SLC35C1):c.923C>G (p.Thr308Arg)","SLC35C1","T308R, T295R","Leukocyte adhesion deficiency type II","Pathogenic(Last reviewed: Jun 15, 2002)","no assertion criteria provided","VCV000004740","11","45832714","11","45811163",4740,"19779","rs28937886","NC_000011.10:45811162:C:G"
"NM_001814.6(CTSC):c.1235A>G (p.Tyr412Cys)","CTSC","Y412C","Periodontitis, aggressive, 1","Pathogenic(Last reviewed: Mar 1, 2004)","no assertion criteria provided","VCV000007300","11","88027331","11","88294163",7300,"22339","rs28937571","NC_000011.10:88294162:T:C"
"NM_003356.4(UCP3):c.304G>A (p.Val102Ile)","UCP3","V102I","UCP3 POLYMORPHISM G/A|Obesity, severe, and type II diabetes","Conflicting interpretations of pathogenicity(Last reviewed: Oct 1, 1998)","no assertion criteria provided","VCV000007576","11","73717247","11","74006202",7576,"22615","rs2229707","NC_000011.10:74006201:C:T"
"NM_003356.4(UCP3):c.208C>T (p.Arg70Trp)","UCP3","R70W","Obesity, severe, and type II diabetes","Pathogenic(Last reviewed: Sep 2, 2008)","no assertion criteria provided","VCV000007579","11","73717343","11","74006298",7579,"22618","rs17848368","NC_000011.10:74006297:G:A"
"NM_002716.5(PPP2R1B):c.269G>A (p.Gly90Asp)","PPP2R1B","G90D","Lung carcinoma","Pathogenic(Last reviewed: Apr 1, 2002)","no assertion criteria provided","VCV000006621","11","111635566","11","111764842",6621,"21660","rs1805076","NC_000011.10:111764841:C:T"
"NM_181798.1(KCNQ1):c.641C>T (p.Ala214Val)","KCNQ1","A341V, A214V","Cardiovascular phenotype|Long QT syndrome 1|not provided|Long QT syndrome","Pathogenic(Last reviewed: Oct 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000003121","11","2604765","11","2583535",3121,"18160","rs12720459","NC_000011.10:2583534:C:T"
"NM_000051.3(ATM):c.2250G>A (p.Lys750=)","ATM","","Malignant tumor of breast|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Ataxia-telangiectasia syndrome|not provided|Familial cancer of breast|Ataxia-telangiectasia syndrome","Pathogenic/Likely pathogenic(Last reviewed: May 1, 2021)","criteria provided, multiple submitters, no conflicts","VCV000003044","11","108127067","11","108256340",3044,"18083","rs1137887","NC_000011.10:108256339:G:A"
"NM_181798.1(KCNQ1):c.641C>A (p.Ala214Glu)","KCNQ1","A341E, A214E","not provided|none provided|Long QT syndrome|Cardiovascular phenotype|Long QT syndrome 1/2, digenic|Congenital long QT syndrome|Long QT syndrome 1","Pathogenic(Last reviewed: Oct 5, 2020)","criteria provided, multiple submitters, no conflicts","VCV000003120","11","2604765","11","2583535",3120,"18159","rs12720459","NC_000011.10:2583534:C:A"
"NM_181798.1(KCNQ1):c.651G>A (p.Ala217=)","KCNQ1","","Cardiovascular phenotype|Long QT syndrome 1|not provided|Long QT syndrome|Long QT syndrome 2","Pathogenic(Last reviewed: Oct 23, 2020)","criteria provided, multiple submitters, no conflicts","VCV000003135","11","2604775","11","2583545",3135,"18174","rs1800171","NC_000011.10:2583544:G:A"
"NM_000372.5(TYR):c.1205G>A (p.Arg402Gln)","TYR","R402Q","not provided|Oculocutaneous albinism type 1B|Skin/hair/eye pigmentation, variation in, 3|Cutaneous malignant melanoma 8|Skin/hair/eye pigmentation 3, blue/green eyes|Tyrosinase-negative oculocutaneous albinism|Autosomal recessive ocular albinism|Albinism|Foveal hypoplasia|Abnormality of metabolism/homeostasis|Choroidal neovascularization|Slow decrease in visual acuity|Elevated hepatic transaminases|Oculocutaneous albinism type 1, temperature sensitive|not specified|Malignant tumor of breast|Oculocutaneous albinism","Conflicting interpretations of pathogenicity, other(Last reviewed: Nov 26, 2020)","criteria provided, conflicting interpretations","VCV000003779","11","89017961","11","89284793",3779,"18818","rs1126809","NC_000011.10:89284792:G:A"
"NM_001876.4(CPT1A):c.2126G>A (p.Gly709Glu)","CPT1A","G709E","Carnitine palmitoyltransferase 1A deficiency","Pathogenic(Last reviewed: Mar 7, 2013)","no assertion criteria provided","VCV000009069","11","68527709","11","68760241",9069,"24108","rs28936374","NC_000011.10:68760240:C:T"
"NM_000352.6(ABCC8):c.4477C>T (p.Arg1493Trp)","ABCC8","R1494W, R1493W, R1515W, R1492W","Hyperinsulinemic hypoglycemia, familial, 1|not provided","Pathogenic/Likely pathogenic(Last reviewed: Oct 13, 2020)","criteria provided, multiple submitters, no conflicts","VCV000009096","11","17415881","11","17394334",9096,"24135","rs28936371","NC_000011.10:17394333:G:A"
"NM_005343.4(HRAS):c.181C>G (p.Gln61Glu)","HRAS|LRRC56","Q61E","Neoplasm of the large intestine|Transitional cell carcinoma of the bladder|Lung adenocarcinoma|Chronic lymphocytic leukemia|Hepatocellular carcinoma|Squamous cell lung carcinoma|Malignant neoplasm of body of uterus|Neoplasm of the thyroid gland|Malignant melanoma of skin|Adenocarcinoma of stomach|Acute myeloid leukemia|Pancreatic adenocarcinoma|Multiple myeloma","Likely pathogenic(Last reviewed: May 31, 2016)","no assertion criteria provided","VCV000376444","11","533875","11","533875",376444,"363323","rs28933406","NC_000011.10:533874:G:C"
"NM_000256.3(MYBPC3):c.208G>T (p.Glu70Ter)","MYBPC3","E70*","not provided","Likely pathogenic(Last reviewed: Nov 5, 2015)","criteria provided, single submitter","VCV000429923","11","47372874","11","47351323",429923,"421860","rs11570045","NC_000011.10:47351322:C:A"
"NM_000518.5(HBB):c.93G>C (p.Arg31Ser)","HBB|LOC106099062|LOC107133510","R31S","beta Thalassemia","Pathogenic(Last reviewed: Nov 25, 2019)","no assertion criteria provided","VCV000869321","11","5248029","11","5226799",869321,"857494","","NC_000011.10:5226798:C:G"
"NM_000518.5(HBB):c.118C>A (p.Gln40Lys)","HBB|LOC106099062|LOC107133510","Q40K","not specified","Uncertain significance(Last reviewed: Oct 8, 2018)","criteria provided, single submitter","VCV000811501","11","5248004","11","5226774",811501,"799653","rs11549407","NC_000011.10:5226773:G:T"
"NM_007103.4(NDUFV1):c.1312C>A (p.Leu438Met)","NDUFV1","L438M, L429M","Mitochondrial complex 1 deficiency, nuclear type 4","Likely pathogenic(Last reviewed: Sep 26, 2019)","no assertion criteria provided","VCV000800963","11","67379846","11","67612375",800963,"788853","rs1127511","NC_000011.10:67612374:C:A"
"NM_181798.1(KCNQ1):c.651G>T (p.Ala217=)","KCNQ1","","Long QT syndrome","Likely pathogenic(Last reviewed: Nov 11, 2015)","no assertion criteria provided","VCV000560649","11","2604775","11","2583545",560649,"551716","rs1800171","NC_000011.10:2583544:G:T"
"NM_000260.4(MYO7A):c.47T>A (p.Leu16Ter)","MYO7A","L16*, L5*","not provided|Usher syndrome type 1|Deafness, autosomal recessive 2","Pathogenic/Likely pathogenic(Last reviewed: Sep 26, 2019)","criteria provided, multiple submitters, no conflicts","VCV000549974","11","76853783","11","77142737",549974,"546385","rs1052030","NC_000011.10:77142736:T:A"
"NM_000256.3(MYBPC3):c.2992C>T (p.Gln998Ter)","MYBPC3","Q998*","not provided|Hypertrophic cardiomyopathy","Pathogenic(Last reviewed: Feb 19, 2020)","criteria provided, multiple submitters, no conflicts","VCV000180993","11","47355475","11","47333924",180993,"179222","rs11570112","NC_000011.10:47333923:G:A"
"NM_000256.3(MYBPC3):c.1147C>G (p.Leu383Val)","MYBPC3","L383V","Familial hypertrophic cardiomyopathy 4|Hypertrophic cardiomyopathy|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Nov 8, 2019)","criteria provided, conflicting interpretations","VCV000181062","11","47365119","11","47343568",181062,"179338","rs11570077","NC_000011.10:47343567:G:C"
"NM_001173990.3(TMEM216):c.253C>T (p.Arg85Ter)","TMEM216","R24*, R85*","Joubert syndrome 2|Joubert syndrome|TMEM216-Related Disorders|Meckel syndrome, type 2|not provided|Meckel syndrome, type 2|Joubert syndrome 2","Pathogenic/Likely pathogenic(Last reviewed: Oct 9, 2020)","criteria provided, multiple submitters, no conflicts","VCV000056384","11","61165269","11","61397797",56384,"71023","rs11230683","NC_000011.10:61397796:C:T"
"NM_004588.5(SCN2B):c.82C>T (p.Arg28Trp)","SCN2B","R28W","not provided|Atrial fibrillation, familial, 14","Uncertain significance(Last reviewed: Feb 6, 2017)","criteria provided, single submitter","VCV000060769","11","118039455","11","118168740",60769,"75311","rs17121819","NC_000011.10:118168739:G:A"
"NM_181798.1(KCNQ1):c.641C>G (p.Ala214Gly)","KCNQ1","A341G, A214G","Congenital long QT syndrome|not provided","Pathogenic(Last reviewed: May 30, 2013)","criteria provided, single submitter","VCV000067005","11","2604765","11","2583535",67005,"77901","rs12720459","NC_000011.10:2583534:C:G"
"NM_181798.1(KCNQ1):c.651G>C (p.Ala217=)","KCNQ1","","not provided","Pathogenic(Last reviewed: Jul 26, 2013)","criteria provided, single submitter","VCV000052939","11","2604775","11","2583545",52939,"67607","rs1800171","NC_000011.10:2583544:G:C"
"NM_000518.5(HBB):c.*132+101G>C","HBB|LOC107133510|LOC110006319","","not provided|not specified|beta Thalassemia","Benign(Last reviewed: Nov 25, 2020)","criteria provided, multiple submitters, no conflicts","VCV000256341","11","5246595","11","5225365",256341,"254202","rs12788013","NC_000011.10:5225364:C:G"
"NM_000315.4(PTH):c.247C>A (p.Arg83=)","PTH","","not specified|Familial isolated hypoparathyroidism","Benign(Last reviewed: Mar 6, 2018)","criteria provided, multiple submitters, no conflicts","VCV000255817","11","13514053","11","13492506",255817,"254060","rs6256","NC_000011.10:13492505:G:T"
"NM_001173990.3(TMEM216):c.253C>A (p.Arg85=)","TMEM216","","Meckel syndrome, type 2|not specified|Joubert syndrome 2|Joubert syndrome|not provided","Benign/Likely benign(Last reviewed: May 4, 2021)","criteria provided, multiple submitters, no conflicts","VCV000282947","11","61165269","11","61397797",282947,"267184","rs11230683","NC_000011.10:61397796:C:A"
"NM_000510.3(FSHB):c.298T>C (p.Cys100Arg)","FSHB|ARL14EP-DT","C100R","Hypogonadotropic hypogonadism 24 without anosmia","Pathogenic(Last reviewed: Nov 25, 2010)","no assertion criteria provided","VCV000189329","11","30255255","11","30233708",189329,"187217","rs5030777","NC_000011.10:30233707:T:C"
"NM_000217.3(KCNA1):c.731C>A (p.Pro244His)","KCNA1","P244H","Myokymia 1","Pathogenic(Last reviewed: Oct 1, 2000)","no assertion criteria provided","VCV000013490","12","5021275","12","4912109",13490,"28529","rs28933382","NC_000012.12:4912108:C:A"
"NM_000545.6(HNF1A):c.1720G>A (p.Gly574Ser)","HNF1A","G574S","not specified|not provided|Maturity-onset diabetes of the young, type 3","Benign(Last reviewed: Nov 30, 2020)","criteria provided, multiple submitters, no conflicts","VCV000014939","12","121437382","12","120999579",14939,"29978","rs1169305","NC_000012.12:120999578:A:A"
"NM_001065.4(TNFRSF1A):c.362G>C (p.Arg121Pro)","TNFRSF1A","R92P, R121P, R13P","TNF receptor-associated periodic fever syndrome (TRAPS)","Pathogenic(Last reviewed: Jan 1, 2001)","no assertion criteria provided","VCV000012341","12","6442643","12","6333477",12341,"27380","rs4149584","NC_000012.12:6333476:C:G"
"NM_000431.4(MVK):c.1129G>A (p.Val377Ile)","MVK","V377I, V325I","Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever|Porokeratosis 3, disseminated superficial actinic type|not specified|not provided|Porokeratosis 3, disseminated superficial actinic type|Mevalonic aciduria|Hyperimmunoglobulin D with periodic fever|Hyperimmunoglobulin D with periodic fever|MVK-Related Disorders","Conflicting interpretations of pathogenicity(Last reviewed: Mar 30, 2021)","criteria provided, conflicting interpretations","VCV000011929","12","110034320","12","109596515",11929,"26968","rs28934897","NC_000012.12:109596514:G:A"
"NM_000545.8(HNF1A):c.1720A>G (p.Ser574Gly)","HNF1A","S581G, S574G","not provided|not specified|Maturity-onset diabetes of the young, type 3","Benign(Last reviewed: Dec 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000036810","12","121437382","12","120999579",36810,"45471","rs1169305","NC_000012.12:120999578:A:G"
"NM_004985.5(KRAS):c.183A>T (p.Gln61His)","KRAS","Q61H","Neoplasm of the large intestine|Acute myeloid leukemia|Hepatocellular carcinoma|Malignant melanoma of skin|Multiple myeloma|Chronic lymphocytic leukemia|Non-small cell lung cancer|Pancreatic adenocarcinoma|Squamous cell lung carcinoma|Transitional cell carcinoma of the bladder|Lung adenocarcinoma|Malignant neoplasm of body of uterus|Adenocarcinoma of stomach|Neoplasm of the thyroid gland","Pathogenic/Likely pathogenic(Last reviewed: May 31, 2016)","no assertion criteria provided","VCV000045117","12","25380275","12","25227341",45117,"54284","rs17851045","NC_000012.12:25227340:T:A"
"NM_000486.5(AQP2):c.170A>C (p.Gln57Pro)","AQP2","Q57P","not provided|Nephrogenic diabetes insipidus, autosomal","Pathogenic(Last reviewed: Feb 5, 2019)","criteria provided, single submitter","VCV000017842","12","50344783","12","49951000",17842,"32881","rs28931580","NC_000012.12:49950999:A:C"
"NM_020638.3(FGF23):c.535C>T (p.Arg179Trp)","FGF23","R179W","not provided|Autosomal dominant hypophosphatemic rickets","Likely pathogenic(Last reviewed: Nov 20, 2015)","criteria provided, single submitter","VCV000005026","12","4479730","12","4370564",5026,"20065","rs28937882","NC_000012.12:4370563:G:A"
"NM_000017.4(ACADS):c.511C>T (p.Arg171Trp)","ACADS","R171W","not provided|Deficiency of butyryl-CoA dehydrogenase","Conflicting interpretations of pathogenicity(Last reviewed: Aug 24, 2020)","criteria provided, conflicting interpretations","VCV000003830","12","121175678","12","120737875",3830,"18869","rs1800556","NC_000012.12:120737874:C:T"
"NM_000277.3(PAH):c.754C>T (p.Arg252Trp)","PAH","R252W","not provided|Phenylketonuria","Pathogenic(Last reviewed: Aug 13, 2018)","reviewed by expert panel","VCV000000584","12","103246681","12","102852903",584,"15623","rs5030847","NC_000012.12:102852902:G:A"
"NM_000277.3(PAH):c.727C>T (p.Arg243Ter)","PAH","R243*","not provided|Phenylketonuria","Pathogenic(Last reviewed: Aug 7, 2018)","reviewed by expert panel","VCV000000588","12","103246708","12","102852930",588,"15627","rs5030846","NC_000012.12:102852929:G:A"
"NM_000277.3(PAH):c.1066-11G>A","PAH","","Phenylketonuria|not provided","Pathogenic(Last reviewed: Oct 1, 2018)","reviewed by expert panel","VCV000000607","12","103237568","12","102843790",607,"15646","rs5030855","NC_000012.12:102843789:C:T"
"NM_000277.3(PAH):c.143T>C (p.Leu48Ser)","PAH","L48S","not provided|Phenylketonuria","Pathogenic(Last reviewed: Apr 8, 2019)","reviewed by expert panel","VCV000000608","12","103306594","12","102912816",608,"15647","rs5030841","NC_000012.12:102912815:A:G"
"NM_000277.3(PAH):c.1222C>T (p.Arg408Trp)","PAH","R408W","not provided|Phenylketonuria","Pathogenic(Last reviewed: Aug 6, 2018)","reviewed by expert panel","VCV000000577","12","103234271","12","102840493",577,"15616","rs5030858","NC_000012.12:102840492:G:A"
"NM_000785.4(CYP27B1):c.1144C>T (p.Pro382Ser)","CYP27B1","P382S","Vitamin D-dependent rickets type 1A","Pathogenic(Last reviewed: Mar 5, 1998)","no assertion criteria provided","VCV000001661","12","58157952","12","57764169",1661,"16700","rs28934607","NC_000012.12:57764168:G:A"
"NM_000020.2(ACVRL1):c.1120C>T (p.Arg374Trp)","ACVRL1","R374W","not provided|Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|Telangiectasia, hereditary hemorrhagic, type 2","Pathogenic/Likely pathogenic(Last reviewed: Oct 24, 2020)","criteria provided, multiple submitters, no conflicts","VCV000008249","12","52309891","12","51916107",8249,"23288","rs28936401","NC_000012.12:51916106:C:T"
"NM_000020.3(ACVRL1):c.1031G>A (p.Cys344Tyr)","ACVRL1","C344Y","Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia|not provided|Telangiectasia, hereditary hemorrhagic, type 2","Pathogenic(Last reviewed: Dec 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000008254","12","52309267","12","51915483",8254,"23293","rs28936688","NC_000012.12:51915482:G:A"
"NM_020297.3(ABCC9):c.3650G>A (p.Arg1217Lys)","ABCC9","R1217K","Hypertrichotic osteochondrodysplasia Cantu type","Likely pathogenic(Last reviewed: Dec 8, 2016)","criteria provided, single submitter","VCV000545440","12","21981911","12","21828977",545440,"535704","rs12298510","NC_000012.12:21828976:C:T"
"NM_002905.4(RDH5):c.208C>T (p.Arg70Trp)","RDH5|BLOC1S1-RDH5","R70W","not provided|Retinitis pigmentosa|Pigmentary retinal dystrophy","Conflicting interpretations of pathogenicity(Last reviewed: May 9, 2020)","criteria provided, conflicting interpretations","VCV000636196","12","56115176","12","55721392",636196,"623998","rs1058635","NC_000012.12:55721391:C:T"
"NM_002206.3(ITGA7):c.427C>T (p.Arg143Ter)","ITGA7","R143*, R46*, R30*","Muscular dystrophy, congenital, due to integrin alpha-7 deficiency","Pathogenic(Last reviewed: Jul 25, 2019)","criteria provided, multiple submitters, no conflicts","VCV000638329","12","56094926","12","55701142",638329,"626218","rs17854600","NC_000012.12:55701141:G:A"
"NM_000020.2(ACVRL1):c.1031G>T (p.Cys344Phe)","ACVRL1","C344F","Telangiectasia, hereditary hemorrhagic, type 2","Likely pathogenic(Last reviewed: Oct 16, 2018)","criteria provided, single submitter","VCV000658228","12","52309267","12","51915483",658228,"641250","rs28936688","NC_000012.12:51915482:G:T"
"NM_000618.5(IGF1):c.285C>A (p.Cys95Ter)","IGF1","C95*, C79*","Growth delay due to insulin-like growth factor type 1 deficiency","Likely pathogenic(Last reviewed: Apr 16, 2019)","no assertion criteria provided","VCV000829837","12","102813404","12","102419626",829837,"818294","rs3730193","NC_000012.12:102419625:G:T"
"NM_000618.5(IGF1):c.285C>T (p.Cys95=)","IGF1","","not provided|Growth delay due to insulin-like growth factor type 1 deficiency","Likely benign(Last reviewed: Dec 31, 2019)","criteria provided, multiple submitters, no conflicts","VCV000731380","12","102813404","12","102419626",731380,"738394","rs3730193","NC_000012.12:102419625:G:A"
"NM_002429.6(MMP19):c.13C>T (p.Gln5Ter)","MMP19","Q5*","not provided","Benign(Last reviewed: Dec 31, 2019)","criteria provided, single submitter","VCV000776900","12","56236602","12","55842818",776900,"702418","rs17844787","NC_000012.12:55842817:G:A"
"NM_000020.3(ACVRL1):c.1120C>A (p.Arg374=)","ACVRL1","","not provided","Uncertain significance(Last reviewed: Sep 1, 2018)","criteria provided, single submitter","VCV000806892","12","52309891","12","51916107",806892,"796796","rs28936401","NC_000012.12:51916106:C:A"
"NM_000552.4(VWF):c.1548T>A (p.Tyr516Ter)","VWF","Y516*","not provided","Pathogenic(Last reviewed: Mar 16, 2018)","criteria provided, single submitter","VCV000619930","12","6167196","12","6058030",619930,"611150","rs1800379","NC_000012.12:6058029:A:T"
"NM_000277.3(PAH):c.754C>G (p.Arg252Gly)","PAH","R252G","not provided|Phenylketonuria","Pathogenic(Last reviewed: Dec 8, 2018)","reviewed by expert panel","VCV000102823","12","103246681","12","102852903",102823,"108559","rs5030847","NC_000012.12:102852902:G:C"
"NM_004985.5(KRAS):c.183A>C (p.Gln61His)","KRAS","Q61H","Juvenile myelomonocytic leukemia|Acute myeloid leukemia|Non-small cell lung cancer|Neoplasm of the large intestine","Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2015)","no assertion criteria provided","VCV000177881","12","25380275","12","25227341",177881,"175854","rs17851045","NC_000012.12:25227340:T:G"
"NM_000277.3(PAH):c.735G>A (p.Val245=)","PAH","","not specified|not provided|Phenylketonuria","Benign(Last reviewed: Apr 24, 2018)","reviewed by expert panel","VCV000092748","12","103246700","12","102852922",92748,"98655","rs1042503","NC_000012.12:102852921:C:T"
"NM_000552.4(VWF):c.1548T>C (p.Tyr516=)","VWF","","not provided|not specified|none provided|von Willebrand disorder","Benign/Likely benign(Last reviewed: Aug 6, 2020)","criteria provided, multiple submitters, no conflicts","VCV000256655","12","6167196","12","6058030",256655,"254693","rs1800379","NC_000012.12:6058029:A:G"
"NM_001065.4(TNFRSF1A):c.362G>A (p.Arg121Gln)","TNFRSF1A","R121Q, R13Q","TNF receptor-associated periodic fever syndrome (TRAPS)|Multiple sclerosis, susceptibility to, 5|not specified|none provided|TNF receptor-associated periodic fever syndrome (TRAPS)|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Dec 2, 2020)","criteria provided, conflicting interpretations","VCV000217017","12","6442643","12","6333477",217017,"213624","rs4149584","NC_000012.12:6333476:C:T"
"NM_000059.4(BRCA2):c.7007G>A (p.Arg2336His)","BRCA2","R2336H","Breast and/or ovarian cancer|Hereditary breast and ovarian cancer syndrome|Breast-ovarian cancer, familial 2|not provided|Hereditary cancer-predisposing syndrome|Familial cancer of breast|Fanconi anemia, complementation group D1|not specified","Pathogenic(Last reviewed: Jun 18, 2019)","reviewed by expert panel","VCV000038077","13","32921033","13","32346896",38077,"46633","rs28897743","NC_000013.11:32346895:G:A"
"NM_000059.4(BRCA2):c.9117G>A (p.Pro3039=)","BRCA2","","Breast-ovarian cancer, familial 2|Malignant tumor of prostate|Medulloblastoma|Glioma susceptibility 3|Fanconi anemia, complementation group D1|Pancreatic cancer 2|Wilms tumor 1|Tracheoesophageal fistula|Familial cancer of breast|not provided|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Hereditary breast and ovarian cancer syndrome|Breast-ovarian cancer, familial 2|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial 2|Malignant tumor of prostate|Medulloblastoma|Glioma susceptibility 3|Fanconi anemia, complementation group D1|Pancreatic cancer 2|Wilms tumor 1|Familial cancer of breast|Breast-ovarian cancer, familial 1","Pathogenic(Last reviewed: Nov 6, 2020)","criteria provided, multiple submitters, no conflicts","VCV000038215","13","32954050","13","32379913",38215,"46771","rs28897756","NC_000013.11:32379912:G:A"
"NM_004004.6(GJB2):c.224G>A (p.Arg75Gln)","GJB2","R75Q","not provided|Autosomal recessive nonsyndromic deafness|Deafness, autosomal dominant 3a|Rare genetic deafness|Deafness, autosomal recessive 1A|Nonsyndromic hearing loss and deafness|Hereditary palmoplantar keratoderma|Palmoplantar keratoderma-deafness syndrome","Pathogenic(Last reviewed: Aug 21, 2020)","criteria provided, multiple submitters, no conflicts","VCV000017027","13","20763497","13","20189358",17027,"32066","rs28931593","NC_000013.11:20189357:C:T"
"NM_001110219.3(GJB6):c.263C>T (p.Ala88Val)","GJB6","A88V","Deafness, autosomal dominant 3b|Deafness, autosomal recessive 1b|Deafness, autosomal recessive 1A|Hidrotic ectodermal dysplasia syndrome|Hidrotic ectodermal dysplasia syndrome","Pathogenic(Last reviewed: Aug 10, 2018)","criteria provided, single submitter","VCV000005545","13","20797357","13","20223218",5545,"20584","rs28937872","NC_000013.11:20223217:G:A"
"NM_000059.3(BRCA2):c.8375T>G (p.Leu2792Arg)","BRCA2","L2792R","Hereditary cancer-predisposing syndrome|Hereditary breast and ovarian cancer syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Jan 24, 2020)","criteria provided, conflicting interpretations","VCV000481525","13","32944582","13","32370445",481525,"477236","rs28897751","NC_000013.11:32370444:T:G"
"NM_000059.3(BRCA2):c.9117G>C (p.Pro3039=)","BRCA2","","not specified","Uncertain significance(Last reviewed: Sep 11, 2017)","criteria provided, single submitter","VCV000632708","13","32954050","13","32379913",632708,"621449","rs28897756","NC_000013.11:32379912:G:C"
"NM_000059.3(BRCA2):c.2786T>C (p.Leu929Ser)","BRCA2","","not provided|Hereditary breast and ovarian cancer syndrome|Fanconi anemia, complementation group D1|not specified|Breast-ovarian cancer, familial 2|Hereditary cancer-predisposing syndrome|Malignant tumor of breast|none provided","Benign(Last reviewed: Aug 10, 2015)","reviewed by expert panel","VCV000051343","13","32911278","13","32337141",51343,"66011","rs2227943","NC_000013.11:32337140:T:C"
"NM_000059.4(BRCA2):c.7007G>C (p.Arg2336Pro)","BRCA2","R2336P","Malignant tumor of breast|Breast-ovarian cancer, familial 1|Familial cancer of breast|Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome|Fanconi anemia, complementation group D1|not provided|Hereditary breast and ovarian cancer syndrome|Breast-ovarian cancer, familial 2","Pathogenic(Last reviewed: Nov 11, 2020)","criteria provided, multiple submitters, no conflicts","VCV000052241","13","32921033","13","32346896",52241,"66909","rs28897743","NC_000013.11:32346895:G:C"
"NM_000059.4(BRCA2):c.7007G>T (p.Arg2336Leu)","BRCA2","R2336L","Hereditary cancer-predisposing syndrome|Hereditary breast and ovarian cancer syndrome|not provided|Breast-ovarian cancer, familial 2","Pathogenic/Likely pathogenic(Last reviewed: May 13, 2020)","criteria provided, multiple submitters, no conflicts","VCV000052242","13","32921033","13","32346896",52242,"66910","rs28897743","NC_000013.11:32346895:G:T"
"NM_000059.3(BRCA2):c.8375T>C (p.Leu2792Pro)","BRCA2","L2792P","Hereditary cancer-predisposing syndrome|Breast-ovarian cancer, familial 2|Hereditary breast and ovarian cancer syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Apr 20, 2020)","criteria provided, conflicting interpretations","VCV000052568","13","32944582","13","32370445",52568,"67236","rs28897751","NC_000013.11:32370444:T:C"
"NM_000059.4(BRCA2):c.9924C>G (p.Tyr3308Ter)","BRCA2","Y3308*","Breast-ovarian cancer, familial 2|not provided|Hereditary cancer-predisposing syndrome|Hereditary breast and ovarian cancer syndrome|Malignant tumor of breast|Breast and/or ovarian cancer","Pathogenic(Last reviewed: Apr 22, 2016)","reviewed by expert panel","VCV000052916","13","32972574","13","32398437",52916,"67584","rs4987049","NC_000013.11:32398436:C:G"
"NM_000059.3(BRCA2):c.9924C>T (p.Tyr3308=)","BRCA2","","Hereditary cancer-predisposing syndrome|Hereditary breast and ovarian cancer syndrome|Fanconi anemia, complementation group D1|not provided|not specified|Breast-ovarian cancer, familial 2","Benign(Last reviewed: Jun 29, 2017)","reviewed by expert panel","VCV000052917","13","32972574","13","32398437",52917,"67585","rs4987049","NC_000013.11:32398436:C:T"
"NM_001846.4(COL4A2):c.4987G>A (p.Gly1663Ser)","COL4A2","G1663S","Optic nerve hypoplasia|not provided|Porencephaly 2","Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)","criteria provided, conflicting interpretations","VCV000311195","13","111164386","13","110512039",311195,"327447","rs12877501","NC_000013.11:110512038:G:A"
"NM_000059.3(BRCA2):c.9924C>A (p.Tyr3308Ter)","BRCA2","Y3308*","Breast-ovarian cancer, familial 2|not provided","Pathogenic(Last reviewed: Oct 18, 2016)","reviewed by expert panel","VCV000267177","13","32972574","13","32398437",267177,"261561","rs4987049","NC_000013.11:32398436:C:A"
"NM_000059.3(BRCA2):c.9117G>T (p.Pro3039=)","BRCA2","","Hereditary breast and ovarian cancer syndrome|Breast-ovarian cancer, familial 2|not specified","Conflicting interpretations of pathogenicity(Last reviewed: Feb 27, 2021)","criteria provided, conflicting interpretations","VCV000267715","13","32954050","13","32379913",267715,"262852","rs28897756","NC_000013.11:32379912:G:T"
"NM_000257.4(MYH7):c.5533C>T (p.Arg1845Trp)","MYH7","R1845W","not provided|Hypertrophic cardiomyopathy|Cardiomyopathy|MYH7-related late-onset scapuloperoneal muscular dystrophy|Myosin storage myopathy","Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2021)","criteria provided, conflicting interpretations","VCV000014114","14","23884230","14","23415021",14114,"29153","rs28933098","NC_000014.9:23415020:G:A"
"NM_020529.2(NFKBIA):c.95G>T (p.Ser32Ile)","NFKBIA","S32I","Ectodermal dysplasia and immunodeficiency 2","Pathogenic(Last reviewed: Sep 6, 2004)","no assertion criteria provided","VCV000014003","14","35873756","14","35404550",14003,"29042","rs28933100","NC_000014.9:35404549:C:A"
"NM_000257.4(MYH7):c.1207C>T (p.Arg403Trp)","MYH7","R403W","not provided|Cardiomyopathy|Hypertrophic cardiomyopathy|Familial hypertrophic cardiomyopathy 1|Cardiovascular phenotype|MYH7-related late-onset scapuloperoneal muscular dystrophy|Congenital myopathy with fiber type disproportion|Myopathy, myosin storage, autosomal recessive|Familial hypertrophic cardiomyopathy 1|Myopathy, distal, 1|Dilated cardiomyopathy 1S|Myosin storage myopathy","Pathogenic(Last reviewed: Dec 15, 2016)","reviewed by expert panel","VCV000014102","14","23898488","14","23429279",14102,"29141","rs3218714","NC_000014.9:23429278:G:A"
"NM_006194.3(PAX9):c.271A>G (p.Lys91Glu)","PAX9","K91E","Partial congenital absence of teeth|Tooth agenesis, selective, 3","Uncertain significance(Last reviewed: Dec 5, 2016)","criteria provided, single submitter","VCV000013770","14","37132368","14","36663163",13770,"28809","rs28933373","NC_000014.9:36663162:A:G"
"NM_006194.3(PAX9):c.62T>C (p.Leu21Pro)","PAX9","L21P","Tooth agenesis, selective, 3","Pathogenic(Last reviewed: Aug 1, 2009)","no assertion criteria provided","VCV000013771","14","37132159","14","36662954",13771,"28810","rs28933970","NC_000014.9:36662953:T:C"
"NM_006194.3(PAX9):c.83G>C (p.Arg28Pro)","PAX9","R28P","Tooth agenesis, selective, 3","Pathogenic(Last reviewed: Feb 1, 2004)","no assertion criteria provided","VCV000013773","14","37132180","14","36662975",13773,"28812","rs28933971","NC_000014.9:36662974:G:C"
"NM_006194.3(PAX9):c.76C>T (p.Arg26Trp)","PAX9","R26W","Tooth agenesis, selective, 3","Pathogenic(Last reviewed: Aug 1, 2009)","no assertion criteria provided","VCV000013774","14","37132173","14","36662968",13774,"28813","rs28933972","NC_000014.9:36662967:C:T"
"NM_001127701.1(SERPINA1):c.194T>C (p.Leu65Pro)","SERPINA1","L65P","Alpha-1-antitrypsin deficiency|Chronic obstructive pulmonary disease|PI M(PROCIDA)|not provided|Alpha-1-antitrypsin deficiency","Pathogenic/Likely pathogenic(Last reviewed: Oct 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000017971","14","94849381","14","94383044",17971,"33010","rs28931569","NC_000014.9:94383043:A:G"
"NM_001127701.1(SERPINA1):c.187C>T (p.Arg63Cys)","SERPINA1","R63C","Alpha-1-antitrypsin deficiency|PI I|not provided","Pathogenic/Likely pathogenic(Last reviewed: Oct 26, 2020)","criteria provided, multiple submitters, no conflicts","VCV000017974","14","94849388","14","94383051",17974,"33013","rs28931570","NC_000014.9:94383050:G:A"
"NM_001127701.1(SERPINA1):c.415G>A (p.Gly139Ser)","SERPINA1","G139S","Alpha-1-antitrypsin deficiency|PI NULL(NEWPORT)|PI Q0(NEWPORT)|PI NULL(DEVON)|PI Q0(DEVON)","Pathogenic, other(Last reviewed: Jul 15, 2016)","no assertion criteria provided","VCV000017986","14","94849160","14","94382823",17986,"33025","rs11558261","NC_000014.9:94382822:C:T"
"NM_001127701.1(SERPINA1):c.347T>A (p.Ile116Asn)","SERPINA1","I116N","Alpha-1-antitrypsin deficiency|PI NULL(LUDWIGSHAFEN)|PI Q0(LUDWIGSHAFEN)","Pathogenic, other(Last reviewed: Jul 20, 2016)","no assertion criteria provided","VCV000017987","14","94849228","14","94382891",17987,"33026","rs28931572","NC_000014.9:94382890:A:T"
"NM_001085.5(SERPINA3):c.233T>C (p.Leu78Pro)","SERPINA3","L55P, L78P","ANTICHYMOTRYPSIN BOCHUM 1","Pathogenic(Last reviewed: Sep 1, 1993)","no assertion criteria provided","VCV000018049","14","95081011","14","94614674",18049,"33088","rs1800463","NC_000014.9:94614673:T:C"
"NM_000021.4(PSEN1):c.1229G>A (p.Cys410Tyr)","PSEN1","C410Y, C406Y","Frontotemporal dementia|Alzheimer disease, type 3|Acne inversa, familial, 3|Pick disease|not provided|Alzheimer disease, type 3","Pathogenic(Last reviewed: Nov 16, 2017)","criteria provided, single submitter","VCV000018127","14","73683933","14","73217225",18127,"33166","rs661","NC_000014.9:73217224:G:A"
"NM_000257.4(MYH7):c.2389G>A (p.Ala797Thr)","MYH7","A797T","Wolff-Parkinson-White pattern|Cardiovascular phenotype|Hypertrophic cardiomyopathy|Cardiomyopathy|Familial hypertrophic cardiomyopathy 1|Abnormality of cellular immune system|Immunodeficiency|Abnormality of T cell physiology|Severe combined immunodeficiency disease|Lymphopenia|Combined T and B cell immunodeficiency|not provided|Primary familial hypertrophic cardiomyopathy|Primary familial dilated cardiomyopathy|Myopathy, myosin storage, autosomal recessive|Myopathy, distal, 1|Familial hypertrophic cardiomyopathy 1|Myosin storage myopathy|MYH7-related late-onset scapuloperoneal muscular dystrophy|Dilated cardiomyopathy 1S|Congenital myopathy with fiber type disproportion","Pathogenic/Likely pathogenic(Last reviewed: Mar 4, 2021)","criteria provided, multiple submitters, no conflicts","VCV000042901","14","23894525","14","23425316",42901,"52071","rs3218716","NC_000014.9:23425315:C:T"
"NM_000257.4(MYH7):c.2334C>T (p.Asp778=)","MYH7","","Hypertrophic cardiomyopathy|not specified|Familial hypertrophic cardiomyopathy 1|Myopathy, distal, 1|not provided|Cardiovascular phenotype|Myosin storage myopathy|Dilated cardiomyopathy 1S|Cardiomyopathy","Conflicting interpretations of pathogenicity(Last reviewed: Dec 2, 2020)","criteria provided, conflicting interpretations","VCV000042894","14","23894580","14","23425371",42894,"52064","rs2069544","NC_000014.9:23425370:G:A"
"NM_001127701.1(SERPINA1):c.739C>T (p.Arg247Cys)","SERPINA1","R247C","not provided|Inborn genetic diseases|Alpha-1-antitrypsin deficiency|not specified|PI F","Conflicting interpretations of pathogenicity(Last reviewed: May 28, 2019)","criteria provided, conflicting interpretations","VCV000017961","14","94847386","14","94381049",17961,"33000","rs28929470","NC_000014.9:94381048:G:A"
"NM_001127701.1(SERPINA1):c.272G>A (p.Gly91Glu)","SERPINA1","G91E","Alpha-1-antitrypsin deficiency|PI M(MINERAL SPRINGS)","Pathogenic, other(Last reviewed: Jul 15, 2016)","no assertion criteria provided","VCV000017966","14","94849303","14","94382966",17966,"33005","rs28931568","NC_000014.9:94382965:C:T"
"NM_001127701.1(SERPINA1):c.1096G>A (p.Glu366Lys)","SERPINA1","E366K","Alpha-1-antitrypsin deficiency|Chronic obstructive pulmonary disease|FRAXE|Alpha-1-antitrypsin deficiency|Chronic obstructive pulmonary disease|PI Z|PI Z(AUGSBURG)|PI Z(TUN)|Inborn genetic diseases|not provided","Pathogenic, risk factor(Last reviewed: May 1, 2021)","criteria provided, multiple submitters, no conflicts","VCV000017967","14","94844947","14","94378610",17967,"33006","rs28929474","NC_000014.9:94378609:C:T"
"NM_020366.3(RPGRIP1):c.2480G>T (p.Arg827Leu)","RPGRIP1","R827L","not provided|Cone-rod dystrophy 13","Pathogenic(Last reviewed: May 2, 2013)","no assertion criteria provided","VCV000004986","14","21794102","14","21325943",4986,"20025","rs28937883","NC_000014.9:21325942:G:T"
"NM_000369.5(TSHR):c.1897G>C (p.Asp633His)","TSHR","D633H","THYROID CARCINOMA WITH THYROTOXICOSIS, SOMATIC","Pathogenic(Last reviewed: Mar 1, 1997)","no assertion criteria provided","VCV000006437","14","81610299","14","81143955",6437,"21476","rs28937584","NC_000014.9:81143954:G:C"
"NM_000257.4(MYH7):c.1207C>G (p.Arg403Gly)","MYH7","R403G","Hypertrophic cardiomyopathy","Likely pathogenic(Last reviewed: Jan 9, 2017)","criteria provided, single submitter","VCV000505562","14","23898488","14","23429279",505562,"497452","rs3218714","NC_000014.9:23429278:G:C"
"NM_020529.2(NFKBIA):c.95G>A (p.Ser32Asn)","NFKBIA","S32N","Ectodermal dysplasia and immunodeficiency 2","Pathogenic(Last reviewed: Nov 15, 2018)","no assertion criteria provided","VCV000590311","14","35873756","14","35404550",590311,"581252","rs28933100","NC_000014.9:35404549:C:T"
"NM_000257.4(MYH7):c.2334C>G (p.Asp778Glu)","MYH7","D778E","Cardiomyopathy|not provided|Hypertrophic cardiomyopathy","Pathogenic/Likely pathogenic(Last reviewed: Sep 2, 2019)","criteria provided, multiple submitters, no conflicts","VCV000265252","14","23894580","14","23425371",265252,"260053","rs2069544","NC_000014.9:23425370:G:C"
"NM_001126106.2(SLC7A7):c.475C>T (p.Arg159Cys)","SLC7A7","R159C","not provided|Lysinuric protein intolerance","Conflicting interpretations of pathogenicity(Last reviewed: Nov 23, 2020)","criteria provided, conflicting interpretations","VCV000203944","14","23282133","14","22812924",203944,"200280","rs11568437","NC_000014.9:22812923:G:A"
"NM_000257.4(MYH7):c.2334C>A (p.Asp778Glu)","MYH7","D778E","Cardiovascular phenotype|not provided|Hypertrophic cardiomyopathy","Pathogenic(Last reviewed: Dec 26, 2018)","criteria provided, multiple submitters, no conflicts","VCV000188615","14","23894580","14","23425371",188615,"186494","rs2069544","NC_000014.9:23425370:G:T"
"NM_000153.4(GALC):c.169G>A (p.Gly57Ser)","GALC","G57S","not provided|Galactosylceramide beta-galactosidase deficiency","Pathogenic(Last reviewed: Jun 6, 2017)","criteria provided, multiple submitters, no conflicts","VCV000193054","14","88459340","14","87992996",193054,"190219","rs11623","NC_000014.9:87992995:C:T"
"NM_000137.3(FAH):c.1021C>T (p.Arg341Trp)","FAH","R341W","not provided|Fumarylacetoacetase pseudodeficiency|Tyrosinemia type I","Benign/Likely benign, other(Last reviewed: May 18, 2021)","criteria provided, multiple submitters, no conflicts","VCV000011868","15","80472526","15","80180184",11868,"26907","rs11555096","NC_000015.10:80180183:C:T"
"NM_000326.5(RLBP1):c.700C>T (p.Arg234Trp)","RLBP1","R234W","Bothnia retinal dystrophy|RLBP1-Related Disorders|none provided|not provided|Retinitis pigmentosa|Retinitis punctata albescens","Pathogenic/Likely pathogenic(Last reviewed: Aug 25, 2020)","criteria provided, multiple submitters, no conflicts","VCV000013100","15","89754025","15","89210794",13100,"28139","rs28933990","NC_000015.10:89210793:G:A"
"NM_014249.4(NR2E3):c.932G>A (p.Arg311Gln)","NR2E3","R311Q","Retinal dystrophy|not provided|Retinitis pigmentosa|Autosomal recessive retinitis pigmentosa|Retinitis pigmentosa 37|Goldmann-Favre syndrome|NR2E3-Related Disorders|Enhanced S-cone syndrome|NR2E3-Related Disorders|Enhanced S-cone syndrome|Retinitis pigmentosa 37|Enhanced S-cone syndrome","Pathogenic/Likely pathogenic(Last reviewed: Apr 8, 2021)","criteria provided, multiple submitters, no conflicts","VCV000005532","15","72105913","15","71813573",5532,"20571","rs28937873","NC_000015.10:71813572:G:A"
"NM_000138.4(FBN1):c.3458G>A (p.Cys1153Tyr)","FBN1","C1153Y","Marfan syndrome|Familial thoracic aortic aneurysm and aortic dissection|Marfan syndrome","Pathogenic(Last reviewed: Jan 27, 2017)","criteria provided, single submitter","VCV000457194","15","48779514","15","48487317",457194,"465123","rs140599","NC_000015.10:48487316:C:T"
"NM_000138.4(FBN1):c.6158G>A (p.Cys2053Tyr)","FBN1","C2053Y","Marfan syndrome|Familial thoracic aortic aneurysm and aortic dissection","Pathogenic(Last reviewed: Jul 26, 2019)","criteria provided, single submitter","VCV000527145","15","48733923","15","48441726",527145,"529295","rs363805","NC_000015.10:48441725:C:T"
"NM_000138.4(FBN1):c.5826C>A (p.Cys1942Ter)","FBN1","C1942*","Weill-Marchesani syndrome|Acromicric dysplasia|Stiff skin syndrome|Familial thoracic aortic aneurysm and aortic dissection|Ectopia lentis, isolated, autosomal dominant|Marfan syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Apr 27, 2017)","criteria provided, conflicting interpretations","VCV000547334","15","48737664","15","48445467",547334,"538046","rs363806","NC_000015.10:48445466:G:T"
"NM_000138.4(FBN1):c.4022A>G (p.Asn1341Ser)","FBN1","N1341S","Marfan syndrome|Marfan syndrome|Familial thoracic aortic aneurysm and aortic dissection|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Dec 27, 2019)","criteria provided, conflicting interpretations","VCV000495603","15","48766790","15","48474593",495603,"487575","rs140638","NC_000015.10:48474592:T:C"
"NM_000138.4(FBN1):c.3963A>G (p.Thr1321=)","FBN1","","Marfan syndrome|Cardiovascular phenotype","Likely pathogenic(Last reviewed: Sep 17, 2015)","criteria provided, single submitter","VCV000520237","15","48773853","15","48481656",520237,"510594","rs140648","NC_000015.10:48481655:T:C"
"NM_000138.4(FBN1):c.306C>A (p.Cys102Ter)","FBN1","C102*","not provided","Likely pathogenic(Last reviewed: Aug 30, 2016)","criteria provided, single submitter","VCV000388980","15","48902965","15","48610768",388980,"374628","rs25388","NC_000015.10:48610767:G:T"
"NM_000138.5(FBN1):c.306C>T (p.Cys102=)","FBN1","","not specified|Marfan syndrome|Familial thoracic aortic aneurysm and aortic dissection|Acromicric dysplasia|none provided|Familial thoracic aortic aneurysm and aortic dissection|Connective tissue disease|Stiff skin syndrome|Ectopia lentis, isolated, autosomal dominant|Marfan syndrome|Cardiovascular phenotype|Weill-Marchesani syndrome|Geleophysic dysplasia","Benign/Likely benign(Last reviewed: Dec 6, 2020)","criteria provided, multiple submitters, no conflicts","VCV000137314","15","48902965","15","48610768",137314,"141017","rs25388","NC_000015.10:48610767:G:A"
"NM_002693.2(POLG):c.2481-7C>T","POLG","","Toe walking|none provided|POLG-Related Spectrum Disorders|Progressive sclerosing poliodystrophy|not provided|not specified","Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2021)","criteria provided, conflicting interpretations","VCV000138747","15","89865091","15","89321860",138747,"142450","rs2307448","NC_000015.10:89321859:G:A"
"NM_000138.5(FBN1):c.6509G>A (p.Cys2170Tyr)","FBN1","C2170Y","Marfan syndrome","Likely pathogenic(Last reviewed: Mar 15, 2018)","criteria provided, single submitter","VCV000163467","15","48726898","15","48434701",163467,"176125","rs363821","NC_000015.10:48434700:C:T"
"NM_014249.4(NR2E3):c.119-2A>C","NR2E3","","Cone-rod dystrophy|Enhanced S-cone syndrome|Retinitis pigmentosa 37|Goldmann-Favre syndrome|Retinitis pigmentosa 37|Enhanced S-cone syndrome|Retinitis pigmentosa|NR2E3-Related Disorders|Retinal dystrophy|not provided|not specified|Horizontal nystagmus|Visual impairment|Retinal dystrophy|Abnormality of color vision","Pathogenic/Likely pathogenic(Last reviewed: Jun 17, 2021)","criteria provided, multiple submitters, no conflicts","VCV000191059","15","72103821","15","71811481",191059,"188865","rs2723341","NC_000015.10:71811480:A:C"
"NM_002386.3(MC1R):c.880G>C (p.Asp294His)","MC1R","D294H","Skin/hair/eye pigmentation 2, red hair/fair skin|Cutaneous malignant melanoma 5|Skin and Hair Hypopigmentation|Melanoma|not provided|Tyrosinase-positive oculocutaneous albinism|not specified","Conflicting interpretations of pathogenicity, risk factor(Last reviewed: Dec 6, 2020)","criteria provided, conflicting interpretations","VCV000014307","16","89986546","16","89920138",14307,"29346","rs1805009","NC_000016.10:89920137:G:C"
"NM_002386.3(MC1R):c.478C>T (p.Arg160Trp)","MC1R","R160W","not specified|Cutaneous malignant melanoma 5|Increased analgesia from kappa-opioid receptor agonist, female-specific|OCULOCUTANEOUS ALBINISM, TYPE II, MODIFIER OF|Skin/hair/eye pigmentation 2, red hair/fair skin|Malignant tumor of breast|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)","criteria provided, conflicting interpretations","VCV000014310","16","89986144","16","89919736",14310,"29349","rs1805008","NC_000016.10:89919735:C:T"
"NM_003361.3(UMOD):c.307G>T (p.Gly103Cys)","UMOD","G103C, G136C","Familial juvenile hyperuricemic nephropathy type 1","Pathogenic(Last reviewed: Dec 1, 2002)","no assertion criteria provided","VCV000012257","16","20360316","16","20348994",12257,"27296","rs28934584","NC_000016.10:20348993:C:A"
"NM_000196.4(HSD11B2):c.623G>A (p.Arg208His)","HSD11B2","R208H","Apparent mineralocorticoid excess","Pathogenic(Last reviewed: Dec 1, 1997)","no assertion criteria provided","VCV000012096","16","67470004","16","67436101",12096,"27135","rs28934592","NC_000016.10:67436100:G:A"
"NM_000548.5(TSC2):c.1832G>A (p.Arg611Gln)","TSC2","R611Q, R411Q, R622Q, R574Q, R562Q","Hereditary cancer-predisposing syndrome|not provided|Tuberous sclerosis 2|Tuberous sclerosis syndrome|Lymphangiomyomatosis|Tuberous sclerosis 2|Focal cortical dysplasia type II|Lymphangiomyomatosis","Pathogenic(Last reviewed: Sep 29, 2020)","criteria provided, multiple submitters, no conflicts","VCV000012397","16","2120572","16","2070571",12397,"27436","rs28934872","NC_000016.10:2070570:G:A"
"NM_000558.3(HBA1):c.179G>T (p.Gly60Val)","HBA1|LOC106804613","G60V","HEMOGLOBIN TOTTORI","other(Last reviewed: Jul 20, 2016)","no assertion criteria provided","VCV000015827","16","227011","16","177012",15827,"30866","rs28928878","NC_000016.10:177011:G:T"
"NM_000558.3(HBA1):c.179G>A (p.Gly60Asp)","HBA1|LOC106804613","G60D","Hemoglobin H disease, nondeletional|HEMOGLOBIN ADANA|not provided","Pathogenic(Last reviewed: Mar 19, 2019)","criteria provided, multiple submitters, no conflicts","VCV000015849","16","227011","16","177012",15849,"30888","rs28928878","NC_000016.10:177011:G:A"
"NM_021615.5(CHST6):c.609C>A (p.Asp203Glu)","CHST6","D203E","Macular corneal dystrophy","Pathogenic(Last reviewed: Oct 1, 2000)","no assertion criteria provided","VCV000005072","16","75513118","16","75479220",5072,"20111","rs28937878","NC_000016.10:75479219:G:T"
"NM_021615.5(CHST6):c.521A>G (p.Lys174Arg)","CHST6","K174R","Macular corneal dystrophy","Pathogenic(Last reviewed: Apr 27, 2017)","criteria provided, single submitter","VCV000005071","16","75513206","16","75479308",5071,"20110","rs28937877","NC_000016.10:75479307:T:C"
"NM_021615.5(CHST6):c.599T>G (p.Leu200Arg)","CHST6","L200R","not provided|Macular corneal dystrophy|Macular corneal dystrophy, type II","Pathogenic(Last reviewed: Sep 1, 2019)","criteria provided, multiple submitters, no conflicts","VCV000005075","16","75513128","16","75479230",5075,"20114","rs28937879","NC_000016.10:75479229:A:C"
"NM_001138.2(AGRP):c.199G>A (p.Ala67Thr)","AGRP|ATP6V0D1-DT","A67T","Obesity, late-onset|Leanness, inherited","Pathogenic, association(Last reviewed: Aug 30, 2019)","no assertion criteria provided","VCV000007329","16","67516945","16","67483042",7329,"22368","rs5030980","NC_000016.10:67483041:C:T"
"NM_000243.3(MEFV):c.442G>C","MEFV","","Familial Mediterranean fever|Familial mediterranean fever, autosomal dominant|none provided|not provided|Familial Mediterranean fever|Familial mediterranean fever, autosomal dominant|not specified","Conflicting interpretations of pathogenicity(Last reviewed: Jun 21, 2021)","criteria provided, conflicting interpretations","VCV000002542","16","3304626","16","3254626",2542,"17581","rs3743930","NC_000016.10:3254625:C:G"
"NM_001126108.2(SLC12A3):c.1261T>C (p.Cys421Arg)","SLC12A3","C421R, C420R","not provided|Familial hypokalemia-hypomagnesemia","Pathogenic(Last reviewed: Jun 5, 2019)","criteria provided, single submitter","VCV000008585","16","56913065","16","56879153",8585,"23624","rs28936387","NC_000016.10:56879152:T:C"
"NM_001126108.2(SLC12A3):c.625C>T (p.Arg209Trp)","SLC12A3","R209W, R208W","not provided|Familial hypokalemia-hypomagnesemia","Pathogenic(Last reviewed: Jun 6, 2020)","criteria provided, single submitter","VCV000008586","16","56904031","16","56870119",8586,"23625","rs28936388","NC_000016.10:56870118:C:T"
"NM_001009944.3(PKD1):c.1396G>A (p.Val466Met)","PKD1","V466M","not provided|Autosomal dominant polycystic kidney disease|Polycystic kidney disease","Conflicting interpretations of pathogenicity(Last reviewed: Jan 1, 2019)","criteria provided, conflicting interpretations","VCV000447971","16","2167044","16","2117043",447971,"441874","rs2855341","NC_000016.10:2117042:C:T"
"NM_000558.5(HBA1):c.207C>A (p.Asn69Lys)","HBA1|LOC106804613","N69K","alpha Thalassemia","Pathogenic(Last reviewed: Dec 29, 2016)","no assertion criteria provided","VCV000375748","16","227039","16","177040",375748,"362634","rs1060339","NC_000016.10:177039:C:A"
"NM_000558.5(HBA1):c.207C>G (p.Asn69Lys)","HBA1|LOC106804613","N69K","none provided|not provided","Likely benign(Last reviewed: Jul 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000439095","16","227039","16","177040",439095,"432867","rs1060339","NC_000016.10:177039:C:G"
"NM_004608.3(TBX6):c.-49+34G>T","TBX6","","","no interpretation for the single variant","no interpretation for the single variant","VCV000427809","16","30103160","16","30091839",427809,"185945","rs3809627","NC_000016.10:30091838:C:A"
"NM_019109.5(ALG1):c.1312C>T (p.Arg438Trp)","ALG1|EEF2KMT","R327W, R438W","Congenital disorder of glycosylation","Likely pathogenic(Last reviewed: May 25, 2017)","no assertion criteria provided","VCV000690315","16","5134799","16","5084798",690315,"678020","rs16835020","NC_000016.10:5084797:C:T"
"NM_001009944.3(PKD1):c.7288C>T (p.Arg2430Ter)","PKD1","R2430*","Autosomal dominant polycystic kidney disease|not provided|Polycystic kidney disease|Polycystic kidney disease, adult type","Pathogenic(Last reviewed: Jan 1, 2019)","criteria provided, multiple submitters, no conflicts","VCV000562262","16","2156600","16","2106599",562262,"553446","rs2432403","NC_000016.10:2106598:G:A"
"NM_002474.3(MYH11):c.4401C>T (p.Tyr1467=)","MYH11|NDE1","","not specified|Familial thoracic aortic aneurysm and aortic dissection|Cardiovascular phenotype|Lissencephaly, Recessive|Aortic aneurysm, familial thoracic 4|none provided","Benign/Likely benign(Last reviewed: Dec 2, 2020)","criteria provided, multiple submitters, no conflicts","VCV000138343","16","15815456","16","15721599",138343,"142046","rs8046180","NC_000016.10:15721598:G:A"
"NM_001009944.3(PKD1):c.7642G>C (p.Glu2548Gln)","PKD1","E2548Q","not specified|not provided|Polycystic kidney disease|Polycystic kidney disease, adult type","Benign/Likely benign(Last reviewed: Jun 2, 2020)","criteria provided, multiple submitters, no conflicts","VCV000257002","16","2156153","16","2106152",257002,"255584","rs28369051","NC_000016.10:2106151:C:G"
"NM_000135.4(FANCA):c.2021C>T (p.Ser674Leu)","FANCA","S674L","not specified|Fanconi anemia","Benign/Likely benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000237038","16","89838216","16","89771808",237038,"242547","rs17232973","NC_000016.10:89771807:G:A"
"NM_002474.3(MYH11):c.4401C>G (p.Tyr1467Ter)","MYH11|NDE1","Y1467*, Y1474*","Aortic aneurysm, familial thoracic 4","Pathogenic(Last reviewed: Nov 16, 2019)","criteria provided, single submitter","VCV000201075","16","15815456","16","15721599",201075,"197866","rs8046180","NC_000016.10:15721598:G:C"
"NM_004380.3(CREBBP):c.86-1G>T","CREBBP","","Rubinstein-Taybi syndrome 1","Pathogenic(Last reviewed: Jun 3, 2014)","criteria provided, single submitter","VCV000210790","16","3901011","16","3851010",210790,"208279","rs11644721","NC_000016.10:3851009:C:A"
"NM_004448.3(ERBB2):c.2570A>G (p.Asn857Ser)","ERBB2","N857S, N827S, N842S","Ovarian Adenocarcinoma|Neoplasm of ovary","Pathogenic/Likely pathogenic(Last reviewed: May 13, 2016)","no assertion criteria provided","VCV000013880","17","37881378","17","39725125",13880,"28919","rs28933370","NC_000017.11:39725124:A:G"
"NM_000422.3(KRT17):c.296T>C (p.Leu99Pro)","KRT17","L99P","not provided|Pachyonychia congenita 2","Pathogenic(Last reviewed: Jun 9, 2015)","criteria provided, single submitter","VCV000014598","17","39780466","17","41624214",14598,"29637","rs28933089","NC_000017.11:41624213:A:G"
"NM_005557.4(KRT16):c.383T>A (p.Leu128Gln)","KRT16","L128Q","not provided|Pachyonychia congenita 1","Pathogenic(Last reviewed: Dec 1, 2001)","no assertion criteria provided","VCV000014609","17","39768558","17","41612306",14609,"29648","rs28928895","NC_000017.11:41612305:A:T"
"NM_000422.3(KRT17):c.284T>C (p.Leu95Pro)","KRT17","L95P","not provided|Pachyonychia congenita 2","Pathogenic(Last reviewed: May 14, 2015)","criteria provided, single submitter","VCV000014596","17","39780478","17","41624226",14596,"29635","rs28928899","NC_000017.11:41624225:A:G"
"NM_000422.3(KRT17):c.292T>G (p.Tyr98Asp)","KRT17","Y98D","not provided|Pachyonychia congenita 2","Pathogenic(Last reviewed: Feb 1, 1997)","no assertion criteria provided","VCV000014588","17","39780470","17","41624218",14588,"29627","rs28933088","NC_000017.11:41624217:A:C"
"NM_000422.3(KRT17):c.281G>A (p.Arg94His)","KRT17","R94H","not provided|Pachyonychia congenita 2|Steatocystoma multiplex","Pathogenic(Last reviewed: Dec 1, 2019)","criteria provided, single submitter","VCV000014590","17","39780481","17","41624229",14590,"29629","rs28928897","NC_000017.11:41624228:C:T"
"NM_000422.3(KRT17):c.281G>C (p.Arg94Pro)","KRT17","R94P","not provided|Pachyonychia congenita 2","Pathogenic(Last reviewed: May 1, 2001)","no assertion criteria provided","VCV000014594","17","39780481","17","41624229",14594,"29633","rs28928897","NC_000017.11:41624228:C:G"
"NM_000422.3(KRT17):c.284T>A (p.Leu95Gln)","KRT17","L95Q","not provided|Pachyonychia congenita 2","Pathogenic(Last reviewed: May 1, 2001)","no assertion criteria provided","VCV000014595","17","39780478","17","41624226",14595,"29634","rs28928899","NC_000017.11:41624225:A:T"
"NM_000546.6(TP53):c.215C>G (p.Pro72Arg)","TP53","P72R, P33R","not specified|not provided|Li-Fraumeni syndrome|fluorouracil response - Efficacy, Toxicity/ADR|paclitaxel response - Efficacy, Toxicity/ADR|antineoplastic agents response - Efficacy, Toxicity/ADR|cisplatin response - Efficacy, Toxicity/ADR|cyclophosphamide response - Efficacy, Toxicity/ADR|Li-Fraumeni syndrome 1|CODON 72 POLYMORPHISM|none provided|Lip and oral cavity carcinoma|Hereditary cancer-predisposing syndrome","drug response(Last reviewed: Oct 17, 2016)","reviewed by expert panel","VCV000012351","17","7579472","17","7676154",12351,"27390","rs1042522","NC_000017.11:7676153:G:C"
"NM_000546.6(TP53):c.743G>A (p.Arg248Gln)","TP53","R248Q, R116Q, R209Q, R89Q","Breast neoplasm|Neoplasm|Nasopharyngeal carcinoma|Carcinoma of colon|Li-Fraumeni syndrome 1|Carcinoma of pancreas|Choroid plexus papilloma|Osteosarcoma|Glioma susceptibility 1|Familial cancer of breast|Adrenocortical carcinoma, hereditary|Hepatocellular carcinoma|Basal cell carcinoma, susceptibility to, 7|Pancreatic adenocarcinoma|Multiple myeloma|Li-Fraumeni syndrome|Medulloblastoma|Chronic lymphocytic leukemia|Squamous cell carcinoma of the skin|Brainstem glioma|Transitional cell carcinoma of the bladder|Small cell lung carcinoma|Lung adenocarcinoma|Malignant melanoma of skin|Hepatocellular carcinoma|not provided|Neoplasm of ovary|Acute myeloid leukemia|Li-Fraumeni syndrome 1|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|Myelodysplastic syndrome|Familial cancer of breast|Malignant Colorectal Neoplasm|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Lip and oral cavity carcinoma|Lymphoma|Neoplasm of the large intestine|Hereditary cancer-predisposing syndrome|Neoplasm of brain|Ductal carcinoma in situ|Sarcoma|Rhabdomyosarcoma (disease)|Carcinoma of esophagus|Uterine Carcinosarcoma|Glioblastoma","Pathogenic(Last reviewed: Aug 28, 2019)","reviewed by expert panel","VCV000012356","17","7577538","17","7674220",12356,"27395","rs11540652","NC_000017.11:7674219:C:T"
"NM_000546.5(TP53):c.722C>T (p.Ser241Phe)","TP53","S241F, S109F, S202F, S82F","Carcinoma of gallbladder|Papillary renal cell carcinoma, sporadic|Uterine Carcinosarcoma|Lip and oral cavity carcinoma|Non-Hodgkin lymphoma|Renal cell carcinoma, papillary, 1|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Malignant melanoma of skin|Neoplasm of ovary|Hereditary cancer-predisposing syndrome|Neoplasm of brain|Squamous cell carcinoma of the head and neck|Neoplasm of the large intestine|Carcinoma of esophagus|Pancreatic adenocarcinoma|Breast neoplasm|Glioblastoma|Squamous cell carcinoma of the skin|Brainstem glioma|Transitional cell carcinoma of the bladder|Lung adenocarcinoma|Hepatoblastoma|Osteosarcoma|Li-Fraumeni syndrome","Likely pathogenic(Last reviewed: May 27, 2020)","criteria provided, multiple submitters, no conflicts","VCV000012359","17","7577559","17","7674241",12359,"27398","rs28934573","NC_000017.11:7674240:G:A"
"NM_000546.6(TP53):c.844C>T (p.Arg282Trp)","TP53","R282W, R150W, R243W, R123W","Hereditary cancer-predisposing syndrome|Malignant melanoma of skin|Hepatocellular carcinoma|Renal cell carcinoma, papillary, 1|Breast neoplasm|Neoplasm of brain|Pancreatic adenocarcinoma|Li-Fraumeni syndrome|Non-Hodgkin lymphoma|Lung adenocarcinoma|Li-Fraumeni syndrome 1|Squamous cell carcinoma of the head and neck|Squamous cell lung carcinoma|not provided|Pleomorphic xanthoastrocytoma|Astrocytoma, anaplastic|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Neoplasm of the large intestine|Glioblastoma|Li-Fraumeni-like syndrome|Neoplasm of ovary|Adenocarcinoma of stomach|Colorectal cancer|Carcinoma of esophagus","Pathogenic/Likely pathogenic(Last reviewed: Oct 29, 2020)","criteria provided, multiple submitters, no conflicts","VCV000012364","17","7577094","17","7673776",12364,"27403","rs28934574","NC_000017.11:7673775:G:A"
"NM_000546.5(TP53):c.770T>A (p.Leu257Gln)","TP53","L257Q, L125Q, L218Q, L98Q","Li-Fraumeni-like syndrome|Neoplasm of ovary|Li-Fraumeni syndrome","Uncertain significance(Last reviewed: Sep 3, 2016)","criteria provided, single submitter","VCV000012372","17","7577511","17","7674193",12372,"27411","rs28934577","NC_000017.11:7674192:A:T"
"NM_001614.5(ACTG1):c.404C>T (p.Ala135Val)","ACTG1","A135V","not provided|Baraitser-Winter Syndrome 2","Pathogenic(Last reviewed: Feb 1, 2017)","criteria provided, single submitter","VCV000029587","17","79478612","17","81511586",29587,"38541","rs11549190","NC_000017.11:81511585:G:A"
"NM_000346.4(SOX9):c.507C>T (p.His169=)","SOX9","","not specified|Camptomelic dysplasia|none provided","Benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000021164","17","70118935","17","72122794",21164,"34016","rs2229989","NC_000017.11:72122793:C:T"
"NM_007294.4(BRCA1):c.4039A>G (p.Arg1347Gly)","BRCA1","R1347G, R1300G","Hereditary cancer-predisposing syndrome|Hereditary breast and ovarian cancer syndrome|Breast-ovarian cancer, familial 1|not provided|not specified|Familial cancer of breast|none provided|Breast and/or ovarian cancer","Benign(Last reviewed: Aug 10, 2015)","reviewed by expert panel","VCV000041821","17","41243509","17","43091492",41821,"50260","rs28897689","NC_000017.11:43091491:T:C"
"NM_007294.4(BRCA1):c.5123C>T (p.Ala1708Val)","BRCA1","A1708V, A1661V, A1729V, A604V","Breast-ovarian cancer, familial 1|Craniopharyngioma|Hereditary breast and ovarian cancer syndrome|not provided|Breast and/or ovarian cancer|Hereditary cancer-predisposing syndrome|not specified|Malignant tumor of breast","Uncertain significance(Last reviewed: Apr 19, 2021)","criteria provided, multiple submitters, no conflicts","VCV000037640","17","41215920","17","43063903",37640,"46196","rs28897696","NC_000017.11:43063902:G:A"
"NM_000342.3(SLC4A1):c.268G>A (p.Glu90Lys)","SLC4A1","E90K","Spherocytosis type 4","Pathogenic(Last reviewed: Jun 1, 2001)","no assertion criteria provided","VCV000017775","17","42338084","17","44260716",17775,"32814","rs28929480","NC_000017.11:44260715:C:T"
"NM_000342.3(SLC4A1):c.2608C>T (p.Arg870Trp)","SLC4A1","R870W","Spherocytosis type 4|not provided","Likely pathogenic(Last reviewed: Jan 15, 2021)","criteria provided, multiple submitters, no conflicts","VCV000017776","17","42328574","17","44251206",17776,"32815","rs28931585","NC_000017.11:44251205:G:A"
"NM_000342.3(SLC4A1):c.1462G>A (p.Val488Met)","SLC4A1","V488M","Renal tubular acidosis, distal, with hemolytic anemia|Spherocytosis type 4","Pathogenic(Last reviewed: Feb 27, 2018)","criteria provided, multiple submitters, no conflicts","VCV000017773","17","42334882","17","44257514",17773,"32812","rs28931584","NC_000017.11:44257513:C:T"
"NM_000342.4(SLC4A1):c.166A>G (p.Lys56Glu)","SLC4A1","K56E","not provided|not specified|Hemolytic anemia|none provided|Spherocytosis type 4|Band 3 memphis|Autosomal dominant distal renal tubular acidosis","Benign/Likely benign(Last reviewed: Dec 5, 2020)","criteria provided, multiple submitters, no conflicts","VCV000017752","17","42338945","17","44261577",17752,"32791","rs5036","NC_000017.11:44261576:T:C"
"NM_000342.4(SLC4A1):c.2561C>T (p.Pro854Leu)","SLC4A1","P854L","Spherocytosis type 4|not provided|not specified|Autosomal dominant distal renal tubular acidosis|DIEGO BLOOD GROUP ANTIGEN|Hemolytic anemia","Benign(Last reviewed: Dec 31, 2019)","criteria provided, multiple submitters, no conflicts","VCV000017768","17","42328621","17","44251253",17768,"32807","rs2285644","NC_000017.11:44251252:G:A"
"NM_032043.3(BRIP1):c.139C>G (p.Pro47Ala)","BRIP1","P47A","Fanconi anemia, complementation group J|Familial cancer of breast|Hereditary cancer-predisposing syndrome|not provided|Malignant tumor of breast|Neoplasm of ovary|Familial cancer of breast|BRIP1-Related Disorders|Breast cancer, early-onset|Fanconi anemia, complementation group J|not specified","Conflicting interpretations of pathogenicity(Last reviewed: Apr 1, 2021)","criteria provided, conflicting interpretations","VCV000004736","17","59937223","17","61859862",4736,"19775","rs28903098","NC_000017.11:61859861:G:C"
"NM_005450.5(NOG):c.103C>G (p.Pro35Ala)","NOG","P35A","Brachydactyly type B2","Pathogenic(Last reviewed: Aug 1, 2007)","no assertion criteria provided","VCV000006708","17","54671687","17","56594326",6708,"21747","rs28937580","NC_000017.11:56594325:C:G"
"NM_005450.5(NOG):c.103C>T (p.Pro35Ser)","NOG","P35S","Symphalangism, proximal, 1A|Brachydactyly type B2|Stapes ankylosis with broad thumb and toes","Pathogenic(Last reviewed: Jul 1, 2008)","no assertion criteria provided","VCV000006703","17","54671687","17","56594326",6703,"21742","rs28937580","NC_000017.11:56594325:C:T"
"NM_000304.4(PMP22):c.469C>T (p.Arg157Trp)","PMP22","R157W","Charcot-Marie-Tooth disease, type I|Hereditary liability to pressure palsies|Autosomal recessive Dejerine-Sottas syndrome|Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease and deafness|PMP22-Related Disorders","Conflicting interpretations of pathogenicity(Last reviewed: Aug 4, 2020)","criteria provided, conflicting interpretations","VCV000008444","17","15134248","17","15230931",8444,"23483","rs28936682","NC_000017.11:15230930:G:A"
"NM_000286.3(PEX12):c.959C>T (p.Ser320Phe)","PEX12","S320F","not provided|Peroxisomal biogenesis disorder 3b|Peroxisome biogenesis disorder 3A","Conflicting interpretations of pathogenicity(Last reviewed: Oct 23, 2020)","criteria provided, conflicting interpretations","VCV000007775","17","33902922","17","35575903",7775,"22814","rs28936697","NC_000017.11:35575902:G:A"
"NM_001321120.2(TBX4):c.1595A>G (p.Gln532Arg)","TBX4","Q531R, Q532R","Coxopodopatellar syndrome","Pathogenic(Last reviewed: Jun 1, 2004)","no assertion criteria provided","VCV000007857","17","59560831","17","61483470",7857,"22896","rs28936696","NC_000017.11:61483469:A:G"
"NM_001614.5(ACTG1):c.611C>G (p.Ala204Gly)","ACTG1","A204G","Baraitser-Winter Syndrome 2|not provided","Likely pathogenic(Last reviewed: Jul 14, 2020)","criteria provided, multiple submitters, no conflicts","VCV000452404","17","79478405","17","81511379",452404,"445921","rs11549225","NC_000017.11:81511378:G:C"
"NM_000546.5(TP53):c.770T>C (p.Leu257Pro)","TP53","L125P, L218P, L257P, L98P","Li-Fraumeni syndrome","Uncertain significance(Last reviewed: Feb 12, 2019)","criteria provided, single submitter","VCV000458562","17","7577511","17","7674193",458562,"467516","rs28934577","NC_000017.11:7674192:A:G"
"NM_007294.4(BRCA1):c.4039A>T (p.Arg1347Ter)","BRCA1","R1347*, R1300*","Hereditary breast and ovarian cancer syndrome|Hereditary cancer-predisposing syndrome","Pathogenic(Last reviewed: May 6, 2020)","criteria provided, multiple submitters, no conflicts","VCV000531295","17","41243509","17","43091492",531295,"531245","rs28897689","NC_000017.11:43091491:T:A"
"NM_000546.5(TP53):c.329G>T (p.Arg110Leu)","TP53","R110L, R71L","Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Neoplasm of ovary","Pathogenic/Likely pathogenic(Last reviewed: Jan 14, 2021)","criteria provided, multiple submitters, no conflicts","VCV000406597","17","7579358","17","7676040",406597,"402569","rs11540654","NC_000017.11:7676039:C:A"
"NM_000546.5(TP53):c.832C>T (p.Pro278Ser)","TP53","P146S, P239S, P278S, P119S","Ovarian Serous Cystadenocarcinoma|Carcinoma of esophagus|Malignant neoplasm of body of uterus|Neoplasm of the large intestine|Breast neoplasm|Neoplasm of brain|Pancreatic adenocarcinoma|Hereditary cancer-predisposing syndrome|not provided|Neoplasm of ovary|Multiple myeloma|Malignant melanoma of skin|Lung adenocarcinoma|Squamous cell lung carcinoma|Li-Fraumeni syndrome|Squamous cell carcinoma of the head and neck|Squamous cell carcinoma of the skin","Conflicting interpretations of pathogenicity(Last reviewed: Dec 29, 2019)","criteria provided, conflicting interpretations","VCV000376642","17","7577106","17","7673788",376642,"363521","rs17849781","NC_000017.11:7673787:G:A"
"NM_000546.5(TP53):c.832C>A (p.Pro278Thr)","TP53","P146T, P239T, P278T, P119T","Squamous cell lung carcinoma|Pancreatic adenocarcinoma|Squamous cell carcinoma of the head and neck|Breast neoplasm|Multiple myeloma|Poly (ADP-Ribose) polymerase inhibitor response|Neoplasm of ovary|Lung adenocarcinoma|Malignant neoplasm of body of uterus|Neoplasm of brain|Squamous cell carcinoma of the skin|Ovarian Serous Cystadenocarcinoma|Neoplasm of the large intestine|Carcinoma of esophagus|Malignant melanoma of skin","Likely pathogenic, drug response(Last reviewed: Dec 1, 2018)","no assertion criteria provided","VCV000376643","17","7577106","17","7673788",376643,"363522","rs17849781","NC_000017.11:7673787:G:T"
"NM_000546.5(TP53):c.832C>G (p.Pro278Ala)","TP53","P146A, P239A, P278A, P119A","Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Neoplasm of the large intestine|Carcinoma of esophagus|Pancreatic adenocarcinoma|Breast neoplasm|Hereditary cancer-predisposing syndrome|Neoplasm of brain|Multiple myeloma|Neoplasm of ovary|Malignant melanoma of skin|Lung adenocarcinoma|Squamous cell lung carcinoma|Li-Fraumeni syndrome|Squamous cell carcinoma of the head and neck|Squamous cell carcinoma of the skin","Conflicting interpretations of pathogenicity(Last reviewed: Nov 11, 2019)","criteria provided, conflicting interpretations","VCV000376645","17","7577106","17","7673788",376645,"363524","rs17849781","NC_000017.11:7673787:G:C"
"NM_000546.5(TP53):c.722C>A (p.Ser241Tyr)","TP53","S109Y, S202Y, S241Y, S82Y","Squamous cell carcinoma of the head and neck|Neoplasm of the large intestine|Breast neoplasm|Renal cell carcinoma, papillary, 1|Squamous cell carcinoma of the skin|Brainstem glioma|Glioblastoma|Carcinoma of esophagus|Neoplasm of ovary|Pancreatic adenocarcinoma|Malignant melanoma of skin|Neoplasm of brain|Non-Hodgkin lymphoma|Lung adenocarcinoma|Carcinoma of gallbladder|Uterine Carcinosarcoma|Papillary renal cell carcinoma, sporadic|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Transitional cell carcinoma of the bladder|Li-Fraumeni syndrome","Pathogenic(Last reviewed: Jul 16, 2020)","criteria provided, single submitter","VCV000376663","17","7577559","17","7674241",376663,"363542","rs28934573","NC_000017.11:7674240:G:T"
"NM_001614.5(ACTG1):c.430G>A (p.Ala144Thr)","ACTG1","A144T","Baraitser-Winter Syndrome 2","Likely pathogenic(Last reviewed: May 3, 2016)","criteria provided, single submitter","VCV000434079","17","79478586","17","81511560",434079,"430029","rs11549196","NC_000017.11:81511559:C:T"
"NM_000304.4(PMP22):c.469C>G (p.Arg157Gly)","PMP22","R157G","Charcot-Marie-Tooth disease","Uncertain significance","no assertion criteria provided","VCV000637387","17","15134248","17","15230931",637387,"625362","rs28936682","NC_000017.11:15230930:G:C"
"NM_001614.5(ACTG1):c.773C>T (p.Pro258Leu)","ACTG1","P258L","not provided|Deafness, autosomal dominant 20|Baraitser-Winter Syndrome 2","Conflicting interpretations of pathogenicity(Last reviewed: Apr 1, 2021)","criteria provided, conflicting interpretations","VCV000639093","17","79478243","17","81511217",639093,"646969","rs11549191","NC_000017.11:81511216:G:A"
"NM_000088.3(COL1A1):c.4171C>T (p.Gln1391Ter)","COL1A1","Q1391*","Osteogenesis imperfecta","Pathogenic(Last reviewed: Jul 11, 2019)","criteria provided, single submitter","VCV000691323","17","48263216","17","50185855",691323,"679011","rs2586486","NC_000017.11:50185854:G:A"
"NM_000546.5(TP53):c.844C>G (p.Arg282Gly)","TP53","R150G, R243G, R282G, R123G","Li-Fraumeni syndrome|Neoplasm of ovary|Malignant melanoma of skin|Renal cell carcinoma, papillary, 1|Breast neoplasm|Squamous cell carcinoma of the head and neck|Hereditary cancer-predisposing syndrome|Hepatocellular carcinoma|Neoplasm of brain|Transitional cell carcinoma of the bladder|Squamous cell carcinoma of the skin|Adenocarcinoma of prostate|Neoplasm of the large intestine|Glioblastoma|Carcinoma of esophagus|Adenocarcinoma of stomach|Ovarian Serous Cystadenocarcinoma|Malignant neoplasm of body of uterus|Squamous cell lung carcinoma|Lung adenocarcinoma|Non-Hodgkin lymphoma|Pancreatic adenocarcinoma","Pathogenic(Last reviewed: Aug 25, 2020)","criteria provided, multiple submitters, no conflicts","VCV000140821","17","7577094","17","7673776",140821,"150535","rs28934574","NC_000017.11:7673775:G:C"
"NM_000546.6(TP53):c.329G>A (p.Arg110His)","TP53","R110H, R71H","Hereditary cancer-predisposing syndrome|Malignant tumor of breast|Li-Fraumeni syndrome|Li-Fraumeni syndrome 1|not provided|not specified","Likely benign(Last reviewed: Aug 11, 2020)","reviewed by expert panel","VCV000127808","17","7579358","17","7676040",127808,"133265","rs11540654","NC_000017.11:7676039:C:T"
"NM_000546.5(TP53):c.215= (p.Pro72=)","TP53","","not specified","Benign(Last reviewed: Aug 15, 2013)","criteria provided, single submitter","VCV000165560","17","7579472","17","7676154",165560,"176504","rs1042522","NC_000017.11:7676153:G:G"
"NM_000546.6(TP53):c.722C>G (p.Ser241Cys)","TP53","S109C, S202C, S241C, S82C","Lung adenocarcinoma|Non-Hodgkin lymphoma|Hereditary cancer-predisposing syndrome|Neoplasm of ovary|Malignant melanoma of skin|Li-Fraumeni syndrome|Neoplasm of the large intestine|Breast neoplasm|Neoplasm of brain|Transitional cell carcinoma of the bladder|Brainstem glioma|Squamous cell carcinoma of the skin|not provided|Uterine Carcinosarcoma|Carcinoma of gallbladder|Glioblastoma|Carcinoma of esophagus|Renal cell carcinoma, papillary, 1|Pancreatic adenocarcinoma|Malignant neoplasm of body of uterus|Papillary renal cell carcinoma, sporadic|Ovarian Serous Cystadenocarcinoma|Squamous cell carcinoma of the head and neck","Likely pathogenic(Last reviewed: Oct 30, 2018)","criteria provided, multiple submitters, no conflicts","VCV000177791","17","7577559","17","7674241",177791,"176503","rs28934573","NC_000017.11:7674240:G:C"
"NM_032043.2(BRIP1):c.139C>A (p.Pro47Thr)","BRIP1","P47T","not provided|Hereditary cancer-predisposing syndrome|Fanconi anemia, complementation group J|Familial cancer of breast","Uncertain significance(Last reviewed: Aug 30, 2020)","criteria provided, multiple submitters, no conflicts","VCV000182340","17","59937223","17","61859862",182340,"180961","rs28903098","NC_000017.11:61859861:G:T"
"NM_000546.5(TP53):c.770T>G (p.Leu257Arg)","TP53","L125R, L218R, L257R, L98R","Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Dec 11, 2019)","criteria provided, conflicting interpretations","VCV000142134","17","7577511","17","7674193",142134,"151848","rs28934577","NC_000017.11:7674192:A:C"
"NM_007294.4(BRCA1):c.5123C>A (p.Ala1708Glu)","BRCA1","A1708E, A1661E, A1729E, A604E","Familial cancer of breast|none provided|Breast-ovarian cancer, familial 1|not provided|Breast neoplasm|Hereditary cancer-predisposing syndrome|Hereditary breast and ovarian cancer syndrome","Pathogenic(Last reviewed: Aug 10, 2015)","reviewed by expert panel","VCV000055407","17","41215920","17","43063903",55407,"70074","rs28897696","NC_000017.11:43063902:G:T"
"NM_000180.4(GUCY2D):c.2511G>C (p.Glu837Asp)","GUCY2D","E837D","not provided","not provided","no assertion provided","VCV000098567","17","7918017","17","8014699",98567,"24393","rs28933695","NC_000017.11:8014698:G:C"
"NM_000546.5(TP53):c.743G>C (p.Arg248Pro)","TP53","R116P, R209P, R248P, R89P","Small cell lung carcinoma|Multiple myeloma|Medulloblastoma|Hepatocellular carcinoma|Neoplasm of the large intestine|Pancreatic adenocarcinoma|Myelodysplastic syndrome|Breast neoplasm|Chronic lymphocytic leukemia|Glioblastoma|Squamous cell lung carcinoma|Carcinoma of esophagus|Squamous cell carcinoma of the head and neck|Lung adenocarcinoma|Neoplasm of brain|Li-Fraumeni syndrome|Squamous cell carcinoma of the skin|Transitional cell carcinoma of the bladder|Brainstem glioma|Uterine Carcinosarcoma|Malignant neoplasm of body of uterus|Adenocarcinoma of prostate|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Malignant melanoma of skin|Acute myeloid leukemia","Pathogenic(Last reviewed: Jan 10, 2019)","criteria provided, single submitter","VCV000237954","17","7577538","17","7674220",237954,"242980","rs11540652","NC_000017.11:7674219:C:G"
"NM_000152.5(GAA):c.2238G>A (p.Trp746Ter)","GAA","W746*","not provided|Glycogen storage disease, type II","Pathogenic(Last reviewed: May 5, 2020)","reviewed by expert panel","VCV000370904","17","78090815","17","80117016",370904,"358515","rs1800312","NC_000017.11:80117015:G:A"
"NM_000152.5(GAA):c.2238G>C (p.Trp746Cys)","GAA","W746C","Glycogen storage disease, type II|not provided|Glycogen storage disease","Pathogenic/Likely pathogenic(Last reviewed: Feb 1, 2021)","criteria provided, multiple submitters, no conflicts","VCV000265160","17","78090815","17","80117016",265160,"260196","rs1800312","NC_000017.11:80117015:G:C"
"NM_005557.4(KRT16):c.383T>C (p.Leu128Pro)","KRT16","L128P","not provided","Pathogenic(Last reviewed: Aug 1, 2016)","criteria provided, single submitter","VCV000265486","17","39768558","17","41612306",265486,"260164","rs28928895","NC_000017.11:41612305:A:G"
"NM_000346.4(SOX9):c.507C>G (p.His169Gln)","SOX9","H169Q","not provided|Camptomelic dysplasia|Inborn genetic diseases","Conflicting interpretations of pathogenicity(Last reviewed: Feb 1, 2021)","criteria provided, conflicting interpretations","VCV000235914","17","70118935","17","72122794",235914,"237540","rs2229989","NC_000017.11:72122793:C:G"
"NM_000180.4(GUCY2D):c.3139-1G>C","GUCY2D","","not provided","Pathogenic(Last reviewed: Sep 29, 2016)","criteria provided, single submitter","VCV000280359","17","7919522","17","8016204",280359,"264708","rs12602083","NC_000017.11:8016203:G:C"
"NM_000546.5(TP53):c.215C>A (p.Pro72His)","TP53","P33H, P72H","Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome 1","Likely benign(Last reviewed: Apr 19, 2021)","reviewed by expert panel","VCV000185120","17","7579472","17","7676154",185120,"185405","rs1042522","NC_000017.11:7676153:G:T"
"NM_000546.5(TP53):c.743G>T (p.Arg248Leu)","TP53","R116L, R209L, R248L, R89L","Small cell lung carcinoma|Hereditary cancer-predisposing syndrome|Li-Fraumeni syndrome|Medulloblastoma|Transitional cell carcinoma of the bladder|Hepatocellular carcinoma|Multiple myeloma|Neoplasm of the large intestine|Pancreatic adenocarcinoma|Myelodysplastic syndrome|Breast neoplasm|Chronic lymphocytic leukemia|Acute myeloid leukemia|Squamous cell carcinoma of the head and neck|Glioblastoma|Squamous cell lung carcinoma|Carcinoma of esophagus|Lung adenocarcinoma|Neoplasm of brain|Brainstem glioma|Squamous cell carcinoma of the skin|Adenocarcinoma of prostate|Uterine Carcinosarcoma|Malignant neoplasm of body of uterus|Ovarian Serous Cystadenocarcinoma|Adenocarcinoma of stomach|Malignant melanoma of skin","Pathogenic(Last reviewed: Aug 28, 2019)","reviewed by expert panel","VCV000230253","17","7577538","17","7674220",230253,"236469","rs11540652","NC_000017.11:7674219:C:A"
"NM_000546.5(TP53):c.329G>C (p.Arg110Pro)","TP53","R110P, R71P","Li-Fraumeni syndrome|Hereditary cancer-predisposing syndrome","Pathogenic(Last reviewed: Sep 30, 2020)","criteria provided, multiple submitters, no conflicts","VCV000233627","17","7579358","17","7676040",233627,"236497","rs11540654","NC_000017.11:7676039:C:G"
"NM_005912.2(MC4R):c.105C>A (p.Tyr35Ter)","MC4R","Y35*","Schizophrenia|not provided|Obesity","Pathogenic(Last reviewed: Oct 23, 2020)","criteria provided, multiple submitters, no conflicts","VCV000014318","18","58039478","18","60372245",14318,"29357","rs13447324","NC_000018.10:60372244:G:T"
"NM_005912.2(MC4R):c.110A>T (p.Asp37Val)","MC4R","D37V","not specified|BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20|Obesity","Conflicting interpretations of pathogenicity(Last reviewed: Jan 1, 2019)","criteria provided, conflicting interpretations","VCV000014319","18","58039473","18","60372240",14319,"29358","rs13447325","NC_000018.10:60372239:T:A"
"NM_005912.3(MC4R):c.380C>T (p.Ser127Leu)","MC4R","S127L","not provided|BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20|Obesity","Conflicting interpretations of pathogenicity(Last reviewed: Apr 1, 2020)","criteria provided, conflicting interpretations","VCV000014336","18","58039203","18","60371970",14336,"29375","rs13447331","NC_000018.10:60371969:G:A"
"NM_000371.4(TTR):c.148G>A (p.Val50Met)","TTR","V50M","Charcot-Marie-Tooth disease|not provided|none provided|Cardiomyopathy|Amyloidogenic transthyretin amyloidosis|Amyloidogenic transthyretin amyloidosis|Dystransthyretinemic euthyroidal hyperthyroxinemia|Carpal tunnel syndrome","Pathogenic(Last reviewed: Jun 1, 2021)","criteria provided, multiple submitters, no conflicts","VCV000013417","18","29172937","18","31592974",13417,"28456","rs28933979","NC_000018.10:31592973:G:A"
"NM_000371.3(TTR):c.185A>G (p.Glu62Gly)","TTR","E42G, E62G","Amyloidogenic transthyretin amyloidosis","Pathogenic(Last reviewed: Aug 1, 1992)","no assertion criteria provided","VCV000013428","18","29172974","18","31593011",13428,"28467","rs11541796","NC_000018.10:31593010:A:G"
"NM_000371.3(TTR):c.148G>C (p.Val50Leu)","TTR","V50L","Charcot-Marie-Tooth disease|Amyloidogenic transthyretin amyloidosis","Pathogenic","criteria provided, single submitter","VCV000013440","18","29172937","18","31592974",13440,"28479","rs28933979","NC_000018.10:31592973:G:C"
"NM_000894.2(LHB):c.221A>G (p.Gln74Arg)","LHB","Q74R","Isolated lutropin deficiency","Pathogenic(Last reviewed: Jan 16, 1992)","no assertion criteria provided","VCV000014413","19","49519530","19","49016273",14413,"29452","rs5030773","NC_000019.10:49016272:T:C"
"NM_001329877.1(FUT1):c.725T>G (p.Leu242Arg)","FUT1","L242R","BOMBAY PHENOTYPE, DIGENIC|Bombay phenotype","Pathogenic, Affects(Last reviewed: Sep 8, 1997)","no assertion criteria provided","VCV000012142","19","49253814","19","48750557",12142,"27181","rs28934588","NC_000019.10:48750556:A:C"
"NM_000540.3(RYR1):c.7372C>T (p.Arg2458Cys)","RYR1","R2458C","enflurane response - Toxicity/ADR|sevoflurane response - Toxicity/ADR|succinylcholine response - Toxicity/ADR|methoxyflurane response - Toxicity/ADR|isoflurane response - Toxicity/ADR|desflurane response - Toxicity/ADR|halothane response - Toxicity/ADR|RYR1-Related Disorders|not provided|Malignant hyperthermia, susceptibility to, 1|Malignant hyperthermia susceptibility","drug response","reviewed by expert panel","VCV000012971","19","38991294","19","38500654",12971,"28010","rs28933397","NC_000019.10:38500653:C:T"
"NM_001972.4(ELANE):c.211T>C (p.Cys71Arg)","ELANE","C71R","Neutropenia, severe congenital 1, autosomal dominant","Pathogenic(Last reviewed: Nov 1, 2001)","no assertion criteria provided","VCV000016746","19","853019","19","853019",16746,"31785","rs28931611","NC_000019.10:853018:T:C"
"NM_000041.4(APOE):c.940A>C (p.Ser314Arg)","APOE","S314R, S340R","APOE4(+)","Pathogenic(Last reviewed: May 1, 1993)","no assertion criteria provided","VCV000017876","19","45412493","19","44909236",17876,"32915","rs28931579","NC_000019.10:44909235:A:C"
"NM_001285829.1(CEBPA):c.-107A>T","CEBPA","H84L, H119L, H70L","Acute myeloid leukemia","Pathogenic(Last reviewed: Mar 1, 2001)","no assertion criteria provided","VCV000017568","19","33793070","19","33302164",17568,"32607","rs28931590","NC_000019.10:33302163:T:A"
"NM_001013257.2(BCAM):c.711C>A (p.Cys237Ter)","BCAM","C237*","BLOOD GROUP--LUTHERAN NULL","Pathogenic(Last reviewed: Mar 1, 2007)","no assertion criteria provided","VCV000000442","19","45316804","19","44813547",442,"15481","rs3810141","NC_000019.10:44813546:C:A"
"NM_000483.5(APOC2):c.178G>A (p.Glu60Lys)","APOC2|APOC4-APOC2","E60K","not provided|APOLIPOPROTEIN C-II (SAN FRANCISCO)|Apolipoprotein C2 deficiency","Benign/Likely benign(Last reviewed: Jan 19, 2020)","criteria provided, multiple submitters, no conflicts","VCV000002582","19","45452080","19","44948823",2582,"17621","rs5122","NC_000019.10:44948822:G:A"
"NM_000095.3(COMP):c.1418A>G (p.Asp473Gly)","COMP","D473G","Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome","Pathogenic(Last reviewed: Dec 1, 1998)","no assertion criteria provided","VCV000009191","19","18896846","19","18786036",9191,"24230","rs28936669","NC_000019.10:18786035:T:C"
"NM_000095.3(COMP):c.2152C>T (p.Arg718Trp)","COMP","R718W","not provided|Carpal tunnel syndrome 2|Multiple epiphyseal dysplasia 1","Pathogenic(Last reviewed: Oct 23, 2020)","criteria provided, multiple submitters, no conflicts","VCV000009198","19","18893939","19","18783129",9198,"24237","rs28936368","NC_000019.10:18783128:G:A"
"NM_000435.3(NOTCH3):c.213G>T (p.Trp71Cys)","NOTCH3","W71C","Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy type 1","Pathogenic(Last reviewed: Nov 22, 1997)","no assertion criteria provided","VCV000009218","19","15303315","19","15192504",9218,"24257","rs28937321","NC_000019.10:15192503:C:A"
"NM_000435.3(NOTCH3):c.505C>T (p.Arg169Cys)","NOTCH3","R169C","Stroke|Migraine without aura|none provided|not provided|Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy type 1","Pathogenic(Last reviewed: Jun 9, 2020)","criteria provided, multiple submitters, no conflicts","VCV000009219","19","15302945","19","15192134",9219,"24258","rs28933696","NC_000019.10:15192133:G:A"
"NM_000095.3(COMP):c.2152C>A (p.Arg718=)","COMP","","Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome|not provided|Multiple epiphyseal dysplasia 1","Benign(Last reviewed: Oct 6, 2020)","criteria provided, multiple submitters, no conflicts","VCV000769450","19","18893939","19","18783129",769450,"704863","rs28936368","NC_000019.10:18783128:G:T"
"NM_000215.3(JAK3):c.394C>A (p.Pro132Thr)","JAK3","P132T","Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-negative|not specified|Lymphoblastic leukemia, acute, with lymphomatous features|Acute megakaryoblastic leukemia","Benign/Likely benign(Last reviewed: Nov 23, 2020)","criteria provided, multiple submitters, no conflicts","VCV000134580","19","17954215","19","17843406",134580,"138319","rs3212723","NC_000019.10:17843405:G:T"
"NM_000146.4(FTL):c.163T>C (p.Leu55=)","FTL|GYS1","","sporadic abdominal aortic aneurysm|Hereditary hyperferritinemia with congenital cataracts|Neuroferritinopathy|Neuroferritinopathy|Hereditary hyperferritinemia with congenital cataracts|not specified|Glycogen storage disease 0, muscle|not provided","Benign(Last reviewed: Nov 26, 2020)","criteria provided, multiple submitters, no conflicts","VCV000156440","19","49469087","19","48965830",156440,"166213","rs2230267","NC_000019.10:48965829:T:C"
"NM_000527.5(LDLR):c.2053C>A (p.Pro685Thr)","LDLR","P685T, P644T, P517T","Familial hypercholesterolemia 1","Likely pathogenic(Last reviewed: Mar 25, 2016)","criteria provided, single submitter","VCV000252193","19","11231111","19","11120435",252193,"246488","rs2569548","NC_000019.10:11120434:C:A"
"NM_000527.5(LDLR):c.2053C>T (p.Pro685Ser)","LDLR","P685S, P644S, P517S","Familial hypercholesterolemia 1","Pathogenic/Likely pathogenic(Last reviewed: Mar 25, 2016)","criteria provided, multiple submitters, no conflicts","VCV000252194","19","11231111","19","11120435",252194,"246489","rs2569548","NC_000019.10:11120434:C:T"
"NM_024407.5(NDUFS7):c.343C>T (p.Arg115Cys)","NDUFS7","R115C","not provided","Likely pathogenic(Last reviewed: Sep 25, 2014)","criteria provided, single submitter","VCV000214834","19","1390984","19","1390985",214834,"211859","rs11551664","NC_000019.10:1390984:C:T"
"NM_000523.4(HOXD13):c.964A>C (p.Ile322Leu)","HOXD13","I322L","Brachydactyly type D|Brachydactyly type E1","Pathogenic(Last reviewed: Jan 27, 2006)","no assertion criteria provided","VCV000014869","2","176959390","2","176094662",14869,"29908","rs28928891","NC_000002.12:176094661:A:C"
"NM_000523.4(HOXD13):c.947C>G (p.Ser316Cys)","HOXD13","S316C","Brachydactyly type D|Brachydactyly type E1","Pathogenic(Last reviewed: Apr 1, 2003)","no assertion criteria provided","VCV000014870","2","176959373","2","176094645",14870,"29909","rs28928892","NC_000002.12:176094644:C:G"
"NM_000821.7(GGCX):c.1502G>C (p.Trp501Ser)","GGCX","W501S, W444S","Vitamin K-dependent clotting factors, combined deficiency of, 1","Pathogenic(Last reviewed: Nov 15, 2000)","no assertion criteria provided","VCV000016195","2","85779042","2","85551919",16195,"31234","rs28928872","NC_000002.12:85551918:C:G"
"NM_000145.3(FSHR):c.1699G>A (p.Asp567Asn)","FSHR","D567N, D541N","Ovarian hyperstimulation syndrome","Pathogenic(Last reviewed: Aug 21, 2003)","no assertion criteria provided","VCV000016250","2","49190261","2","48963122",16250,"31289","rs28928871","NC_000002.12:48963121:C:T"
"NM_022437.3(ABCG8):c.55G>C (p.Asp19His)","ABCG5|ABCG8","D19H","Sitosterolemia 1|not specified|Sitosterolemia|Gallbladder disease 4","Benign/Likely benign(Last reviewed: Dec 3, 2020)","criteria provided, multiple submitters, no conflicts","VCV000004975","2","44066247","2","43839108",4975,"20014","rs11887534","NC_000002.12:43839107:G:C"
"NM_000104.4(CYP1B1):c.182G>A","CYP1B1","G61E","not provided|Glaucoma 3, primary congenital, A|Congenital glaucoma|Glaucoma 3, primary congenital, A|Glaucoma 3, primary infantile, b|Anterior segment dysgenesis 6|Anterior segment dysgenesis 6","Pathogenic(Last reviewed: May 18, 2021)","criteria provided, multiple submitters, no conflicts","VCV000007730","2","38302350","2","38075207",7730,"22769","rs28936700","NC_000002.12:38075206:C:T"
"NM_000104.3(CYP1B1):c.1405C>T (p.Arg469Trp)","CYP1B1","R469W","Glaucoma 3, primary congenital, A|not provided","Pathogenic(Last reviewed: Jan 1, 2019)","criteria provided, multiple submitters, no conflicts","VCV000007733","2","38298092","2","38070949",7733,"22772","rs28936701","NC_000002.12:38070948:G:A"
"NM_000104.3(CYP1B1):c.241T>A (p.Tyr81Asn)","CYP1B1","Y81N","not specified|not provided|Glaucoma 3, primary congenital, A|Primary open angle glaucoma|Congenital glaucoma|Congenital ocular coloboma|Irido-corneo-trabecular dysgenesis","Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)","criteria provided, conflicting interpretations","VCV000007744","2","38302291","2","38075148",7744,"22783","rs9282671","NC_000002.12:38075147:A:T"
"NM_194248.3(OTOF):c.5473C>G (p.Pro1825Ala)","OTOF","P1825A, P1135A, P1058A","Deafness, autosomal recessive 9","Pathogenic(Last reviewed: Apr 26, 2011)","no assertion criteria provided","VCV000006138","2","26684624","2","26461756",6138,"21177","rs28937591","NC_000002.12:26461755:G:C"
"NM_001079866.2(BCS1L):c.232A>G (p.Ser78Gly)","BCS1L","S78G","Mitochondrial complex III deficiency, nuclear type 1|Leigh syndrome|Pili torti-deafness syndrome|GRACILE syndrome|not provided|GRACILE syndrome|Mitochondrial complex III deficiency, nuclear type 1","Pathogenic(Last reviewed: Jan 17, 2020)","criteria provided, multiple submitters, no conflicts","VCV000006167","2","219525942","2","218661219",6167,"21206","rs28937590","NC_000002.12:218661218:A:G"
"NM_001142616.3(EHBP1):c.1185+30064G>A","EHBP1","","Prostate cancer, hereditary, 12","Pathogenic(Last reviewed: Mar 1, 2008)","no assertion criteria provided","VCV000001364","2","63131731","2","62904596",1364,"16403","rs721048","NC_000002.12:62904595:G:A"
"NM_000251.2(MSH2):c.1915C>T (p.His639Tyr)","MSH2","H639Y, H573Y","Hereditary cancer-predisposing syndrome|Lynch syndrome|not provided|Lynch syndrome I|Hereditary nonpolyposis colorectal neoplasms","Pathogenic(Last reviewed: Sep 5, 2013)","reviewed by expert panel","VCV000001756","2","47702319","2","47475180",1756,"16795","rs28929484","NC_000002.12:47475179:C:T"
"NM_032976.3(CASP10):c.*327C>T","CASP10","A414V, A347V, A371V","Non-Hodgkin lymphoma","Pathogenic(Last reviewed: Jun 1, 2002)","no assertion criteria provided","VCV000007765","2","202074111","2","201209388",7765,"22804","rs28936699","NC_000002.12:201209387:C:T"
"NM_001201543.2(FAM161A):c.1212T>A (p.Cys404Ter)","FAM161A","C404*","Retinitis pigmentosa|not provided","Pathogenic/Likely pathogenic(Last reviewed: Jan 9, 2020)","criteria provided, multiple submitters, no conflicts","VCV000425201","2","62066927","2","61839792",425201,"413535","rs4672457","NC_000002.12:61839791:A:T"
"NM_004304.5(ALK):c.4472A>G (p.Lys1491Arg)","ALK","K1491R, K423R","Hereditary cancer-predisposing syndrome|not specified|Squamous cell lung carcinoma|Neuroblastoma 3|not provided","Benign(Last reviewed: Dec 7, 2020)","criteria provided, multiple submitters, no conflicts","VCV000133474","2","29416481","2","29193615",133474,"137213","rs1881420","NC_000002.12:29193614:T:C"
"NM_004304.5(ALK):c.4587C>G (p.Asp1529Glu)","ALK","D1529E, D461E","Hereditary cancer-predisposing syndrome|not provided|Squamous cell lung carcinoma|not specified|Neuroblastoma 3","Benign(Last reviewed: Dec 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000133476","2","29416366","2","29193500",133476,"137215","rs1881421","NC_000002.12:29193499:G:C"
"NM_001201543.2(FAM161A):c.1212T>C (p.Cys404=)","FAM161A","","not provided|Retinitis pigmentosa 28|Retinitis pigmentosa|not specified","Benign(Last reviewed: Jul 10, 2021)","criteria provided, multiple submitters, no conflicts","VCV000096217","2","62066927","2","61839792",96217,"102111","rs4672457","NC_000002.12:61839791:A:G"
"NM_173076.3(ABCA12):c.859C>T (p.Arg287Ter)","ABCA12","R287*","not provided|Autosomal recessive congenital ichthyosis 4A|Autosomal recessive congenital ichthyosis 4B","Pathogenic(Last reviewed: Jul 26, 2016)","criteria provided, single submitter","VCV000264999","2","215910574","2","215045850",264999,"259726","rs11891778","NC_000002.12:215045849:G:A"
"NM_173076.3(ABCA12):c.859C>G (p.Arg287Gly)","ABCA12","R287G","Congenital ichthyosis of skin|not provided","Benign(Last reviewed: Mar 6, 2018)","criteria provided, multiple submitters, no conflicts","VCV000235771","2","215910574","2","215045850",235771,"237450","rs11891778","NC_000002.12:215045849:G:C"
"NM_000490.5(AVP):c.200T>C (p.Val67Ala)","AVP","V67A","Neurohypophyseal diabetes insipidus","Pathogenic(Last reviewed: Jan 1, 2004)","no assertion criteria provided","VCV000012218","20","3063745","20","3083099",12218,"27257","rs28934878","NC_000020.11:3083098:A:G"
"NM_000311.5(PRNP):c.598G>A (p.Glu200Lys)","PRNP","E200K","Fatal familial insomnia|Creutzfeldt-Jakob Disease, Familial|Huntington disease-like 1|none provided|not provided","Pathogenic(Last reviewed: Nov 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000013398","20","4680464","20","4699818",13398,"28437","rs28933385","NC_000020.11:4699817:G:A"
"NM_000308.3(CTSA):c.247T>C (p.Trp83Arg)","CTSA","W65R, W83R","Combined deficiency of sialidase AND beta galactosidase","Pathogenic(Last reviewed: Jun 1, 1993)","no assertion criteria provided","VCV000000378","20","44520400","20","45891761",378,"15417","rs28934603","NC_000020.11:45891760:T:C"
"NM_000557.5(GDF5):c.1322T>C (p.Leu441Pro)","GDF5|GDF5-AS1","L441P","Brachydactyly type A2|Fibular hypoplasia and complex brachydactyly","Pathogenic(Last reviewed: Mar 1, 2006)","no assertion criteria provided","VCV000008381","20","34021891","20","35434093",8381,"23420","rs28936683","NC_000020.11:35434092:A:G"
"NM_018419.3(SOX18):c.283T>A (p.Trp95Arg)","SOX18|TCEA2","W95R","Hypotrichosis-lymphedema-telangiectasia syndrome","Pathogenic(Last reviewed: Jun 1, 2003)","no assertion criteria provided","VCV000008001","20","62680587","20","64049234",8001,"23040","rs28936693","NC_000020.11:64049233:A:T"
"NM_000961.4(PTGIS):c.1358+2T>C","PTGIS","","Essential hypertension","Pathogenic(Last reviewed: Oct 11, 2002)","no assertion criteria provided","VCV000007864","20","48127563","20","49511026",7864,"22903","rs13306026","NC_000020.11:49511025:A:G"
"NM_000361.2(THBD):c.-151G>T","THBD","","Thrombophilia due to thrombomodulin defect|Atypical hemolytic-uremic syndrome 6","Benign(Last reviewed: Apr 28, 2017)","criteria provided, single submitter","VCV000139519","20","23030292","20","23049655",139519,"143163","rs16984852","NC_000020.11:23049654:C:A"
"NM_000214.3(JAG1):c.765C>T (p.Tyr255=)","JAG1","","Cardiovascular phenotype|Isolated Nonsyndromic Congenital Heart Disease|not specified|Alagille syndrome 1|not provided","Benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000143063","20","10633237","20","10652589",143063,"152781","rs1131695","NC_000020.11:10652588:G:A"
"NM_000214.3(JAG1):c.765= (p.Tyr255=)","JAG1","","not specified","Benign(Last reviewed: Mar 30, 2016)","criteria provided, single submitter","VCV000163705","20","10633237","20","10652589",163705,"176595","rs1131695","NC_000020.11:10652588:G:G"
"NM_000311.5(PRNP):c.679C>T (p.Gln227Ter)","PRNP","Q227*","Gerstmann-Straussler-Scheinker syndrome","Pathogenic(Last reviewed: Feb 1, 2010)","no assertion criteria provided","VCV000088927","20","4680545","20","4699899",88927,"94484","rs17852079","NC_000020.11:4699898:C:T"
"NM_000214.3(JAG1):c.765C>G (p.Tyr255Ter)","JAG1","Y255*","not provided","Pathogenic(Last reviewed: Oct 1, 2015)","criteria provided, single submitter","VCV000234555","20","10633237","20","10652589",234555,"232108","rs1131695","NC_000020.11:10652588:G:C"
"NM_000219.6(KCNE1):c.20C>T (p.Thr7Ile)","KCNE1","T7I","Congenital long QT syndrome|Jervell and Lange-Nielsen syndrome 2","Pathogenic(Last reviewed: Nov 1, 1997)","no assertion criteria provided","VCV000013476","21","35821913","21","34449615",13476,"28515","rs28933384","NC_000021.9:34449614:G:A"
"NM_000219.6(KCNE1):c.253G>A (p.Asp85Asn)","KCNE1","D85N","not provided|none provided|Long QT syndrome|Cardiovascular phenotype|Congenital long QT syndrome|Cardiomyopathy|Long QT syndrome 2/5|Jervell and Lange-Nielsen syndrome 2|Long QT syndrome 5|Long QT syndrome 5, acquired, susceptibility to|not specified","Conflicting interpretations of pathogenicity, other, risk factor(Last reviewed: Dec 7, 2020)","criteria provided, conflicting interpretations","VCV000013479","21","35821680","21","34449382",13479,"28518","rs1805128","NC_000021.9:34449381:C:T"
"NM_000071.3(CBS):c.833T>C (p.Ile278Thr)","CBS","I278T, I173T","Homocystinuria|Classic homocystinuria|Homocystinuria, pyridoxine-responsive|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED|none provided|Intellectual disability|Cardiovascular phenotype|not provided","Pathogenic(Last reviewed: Oct 31, 2020)","criteria provided, multiple submitters, no conflicts","VCV000000120","21","44483184","21","43063074",120,"15159","rs5742905","NC_000021.9:43063073:A:G"
"NM_000071.2(CBS):c.1330G>A (p.Asp444Asn)","CBS","D444N, D339N","not provided|Homocystinuria|Classic homocystinuria|Homocystinuria, pyridoxine-responsive|HYPERHOMOCYSTEINEMIA, THROMBOTIC, CBS-RELATED","Pathogenic/Likely pathogenic(Last reviewed: Oct 27, 2020)","criteria provided, multiple submitters, no conflicts","VCV000000126","21","44478972","21","43058862",126,"15165","rs28934891","NC_000021.9:43058861:C:T"
"NM_000211.5(ITGB2):c.1756C>T (p.Arg586Trp)","ITGB2","R586W, R517W","Leukocyte adhesion deficiency 1","Benign/Likely benign(Last reviewed: Dec 7, 2020)","criteria provided, multiple submitters, no conflicts","VCV000009463","21","46309312","21","44889397",9463,"24502","rs5030672","NC_000021.9:44889396:G:A"
"NM_020070.4(IGLL1):c.425C>T (p.Pro142Leu)","IGLL1","P142L, P143L","not specified|not provided|Agammaglobulinemia 2, autosomal recessive","Conflicting interpretations of pathogenicity(Last reviewed: Oct 7, 2020)","criteria provided, conflicting interpretations","VCV000014825","22","23915670","22","23573483",14825,"29864","rs1064422","NC_000022.11:23573482:G:A"
"NM_001953.5(TYMP):c.131G>A (p.Arg44Gln)","TYMP","R44Q","Mitochondrial DNA depletion syndrome 1 (MNGIE type)","Pathogenic(Last reviewed: Jan 14, 2016)","no assertion criteria provided","VCV000016661","22","50968008","22","50529579",16661,"31700","rs28931613","NC_000022.11:50529578:C:T"
"NM_016335.5(PRODH):c.1322T>C (p.Leu441Pro)","PRODH","L441P, L333P","not provided|Schizophrenia 4|Proline dehydrogenase deficiency","Conflicting interpretations of pathogenicity(Last reviewed: Oct 21, 2020)","criteria provided, conflicting interpretations","VCV000004008","22","18905934","22","18918421",4008,"19047","rs2904551","NC_000022.11:18918420:A:G"
"NM_016335.6(PRODH):c.1562= (p.Arg521=)","PRODH","","Proline dehydrogenase deficiency|not provided|Schizophrenia 4","Benign(Last reviewed: Dec 4, 2020)","criteria provided, single submitter","VCV000004010","22","18901004","22","18913491",4010,"19049","rs450046","NC_000022.11:18913490:C:C"
"NM_016335.5(PRODH):c.1292G>A (p.Arg431His)","PRODH","R431H, R323H","Proline dehydrogenase deficiency|Schizophrenia 4","Conflicting interpretations of pathogenicity(Last reviewed: Dec 6, 2020)","criteria provided, conflicting interpretations","VCV000004011","22","18905964","22","18918451",4011,"19050","rs2904552","NC_000022.11:18918450:C:T"
"NM_007194.4(CHEK2):c.254C>T (p.Pro85Leu)","CHEK2","P85L","not specified|not provided|Osteosarcoma|Familial cancer of breast|none provided|Hereditary cancer-predisposing syndrome|Malignant tumor of breast","Benign/Likely benign(Last reviewed: Dec 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000005594","22","29130456","22","28734468",5594,"20633","rs17883862","NC_000022.11:28734467:G:A"
"NM_001429.4(EP300):c.6662C>A (p.Pro2221Gln)","EP300","P2221Q, P2195Q","Carcinoma of colon","Pathogenic(Last reviewed: Mar 1, 2000)","no assertion criteria provided","VCV000006881","22","41574377","22","41178373",6881,"21920","rs28937578","NC_000022.11:41178372:C:A"
"NM_152299.4(NCAPH2):c.*526G>A","SCO2|NCAPH2","R171W","Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency","Pathogenic(Last reviewed: Mar 22, 2000)","no assertion criteria provided","VCV000005680","22","50962330","22","50523901",5680,"20719","rs28937598","NC_000022.11:50523900:G:A"
"NM_007194.4(CHEK2):c.254C>A (p.Pro85His)","CHEK2","P85H","Familial cancer of breast|Hereditary cancer-predisposing syndrome","Uncertain significance(Last reviewed: May 30, 2019)","criteria provided, multiple submitters, no conflicts","VCV000460819","22","29130456","22","28734468",460819,"471874","rs17883862","NC_000022.11:28734467:G:T"
"NM_213720.3(CHCHD10):c.312C>T (p.Tyr104=)","CHCHD10","","Spinal muscular atrophy, jokela type|not specified|Spinal muscular atrophy, jokela type|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|Myopathy, isolated mitochondrial, autosomal dominant","Benign(Last reviewed: Dec 3, 2020)","criteria provided, multiple submitters, no conflicts","VCV000379953","22","24108412","22","23766225",379953,"378642","rs9153","NC_000022.11:23766224:G:A"
"NM_000631.5(NCF4):c.118-1G>A","NCF4-AS1|NCF4","","not provided|Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type III","Pathogenic/Likely pathogenic(Last reviewed: Sep 9, 2020)","criteria provided, multiple submitters, no conflicts","VCV000425281","22","37260960","22","36864918",425281,"413615","rs28445840","NC_000022.11:36864917:G:A"
"NM_213720.3(CHCHD10):c.312C>G (p.Tyr104Ter)","CHCHD10","Y104*, Y111*","Spinal muscular atrophy, jokela type|Myopathy, isolated mitochondrial, autosomal dominant|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Oct 23, 2020)","criteria provided, conflicting interpretations","VCV000565755","22","24108412","22","23766225",565755,"573956","rs9153","NC_000022.11:23766224:G:C"
"NM_213720.3(CHCHD10):c.312C>A (p.Tyr104Ter)","CHCHD10","Y104*, Y111*","Spinal muscular atrophy, jokela type|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|Myopathy, isolated mitochondrial, autosomal dominant","Uncertain significance(Last reviewed: Nov 28, 2019)","criteria provided, single submitter","VCV000569761","22","24108412","22","23766225",569761,"571718","rs9153","NC_000022.11:23766224:G:T"
"NM_007194.4(CHEK2):c.349A>G (p.Arg117Gly)","CHEK2","R117G, R160G","Malignant tumor of breast|CHEK2-Related Cancer Susceptibility|Breast cancer, susceptibility to|Prostate cancer, susceptibility to|Hereditary cancer-predisposing syndrome|Familial cancer of breast|not provided|Hereditary breast and ovarian cancer syndrome|Predisposition to cancer","Pathogenic/Likely pathogenic(Last reviewed: May 13, 2021)","criteria provided, multiple submitters, no conflicts","VCV000128071","22","29121326","22","28725338",128071,"133528","rs28909982","NC_000022.11:28725337:T:C"
"NM_007194.4(CHEK2):c.254C>G (p.Pro85Arg)","CHEK2","P85R","not specified|Familial cancer of breast|not provided|Hereditary cancer-predisposing syndrome","Uncertain significance(Last reviewed: Sep 20, 2020)","criteria provided, multiple submitters, no conflicts","VCV000233261","22","29130456","22","28734468",233261,"236695","rs17883862","NC_000022.11:28734467:G:C"
"NM_000174.4(GP9):c.70T>C (p.Cys24Arg)","GP9","C24R","not provided|Bernard Soulier syndrome|Bernard-Soulier syndrome type C","Pathogenic(Last reviewed: May 11, 2020)","criteria provided, multiple submitters, no conflicts","VCV000013533","3","128780652","3","129061809",13533,"28572","rs28933378","NC_000003.12:129061808:T:C"
"NM_000174.4(GP9):c.182A>G (p.Asn61Ser)","GP9","N61S","Thrombocytopenia|Bernard Soulier syndrome|not provided|Macrothrombocytopenia|Bernard-Soulier syndrome type C","Pathogenic/Likely pathogenic(Last reviewed: Oct 28, 2020)","criteria provided, multiple submitters, no conflicts","VCV000013529","3","128780764","3","129061921",13529,"28568","rs5030764","NC_000003.12:129061920:A:G"
"NM_000174.4(GP9):c.167T>C (p.Leu56Pro)","GP9","L40P, L56P","Bernard-Soulier syndrome type C","Pathogenic(Last reviewed: Dec 1, 1998)","no assertion criteria provided","VCV000013532","3","128780749","3","129061906",13532,"28571","rs28933377","NC_000003.12:129061905:T:C"
"NM_000387.6(SLC25A20):c.713A>G (p.Gln238Arg)","SLC25A20","Q238R","Carnitine acylcarnitine translocase deficiency|not provided","Pathogenic(Last reviewed: Dec 17, 2013)","criteria provided, multiple submitters, no conflicts","VCV000012138","3","48896530","3","48859097",12138,"27177","rs28934589","NC_000003.12:48859096:T:C"
"NM_000925.4(PDHB):c.1030C>T (p.Pro344Ser)","PDHB","P344S, P326S","Pyruvate dehydrogenase E1-beta deficiency","Pathogenic(Last reviewed: Jul 1, 2004)","no assertion criteria provided","VCV000013189","3","58413811","3","58428084",13189,"28228","rs28933391","NC_000003.12:58428083:G:A"
"NM_000539.3(RHO):c.173C>G (p.Thr58Arg)","RHO","T58R","not provided|Retinal dystrophy|Retinitis pigmentosa 4","Pathogenic/Likely pathogenic(Last reviewed: Sep 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000013016","3","129247749","3","129528906",13016,"28055","rs28933394","NC_000003.12:129528905:C:G"
"NM_000539.3(RHO):c.632A>C (p.His211Pro)","RHO","H211P","Retinal dystrophy|Retinitis pigmentosa 4","Likely pathogenic(Last reviewed: Sep 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000013027","3","129251195","3","129532352",13027,"28066","rs28933993","NC_000003.12:129532351:A:C"
"NM_000539.3(RHO):c.158C>G (p.Pro53Arg)","RHO","P53R","Retinitis pigmentosa 4|Retinitis pigmentosa","Pathogenic/Likely pathogenic(Last reviewed: Jun 23, 2019)","no assertion criteria provided","VCV000013037","3","129247734","3","129528891",13037,"28076","rs28933395","NC_000003.12:129528890:C:G"
"NM_000925.4(PDHB):c.395A>G (p.Tyr132Cys)","PDHB","Y132C, Y114C","Pyruvate dehydrogenase E1-beta deficiency","Pathogenic(Last reviewed: Jul 1, 2004)","no assertion criteria provided","VCV000013188","3","58416578","3","58430851",13188,"28227","rs28935769","NC_000003.12:58430850:T:C"
"NM_003242.6(TGFBR2):c.923T>C (p.Leu308Pro)","TGFBR2","L308P, L333P","Loeys-Dietz syndrome 2","Pathogenic(Last reviewed: Apr 1, 2010)","no assertion criteria provided","VCV000012505","3","30713598","3","30672106",12505,"27544","rs28934568","NC_000003.12:30672105:T:C"
"NM_001337.4(CX3CR1):c.839C>T (p.Thr280Met)","CX3CR1","T280M, T312M","","no interpretation for the single variant","no interpretation for the single variant","VCV000025511","3","39307162","3","39265671",25511,"36774","rs3732378","NC_000003.12:39265670:G:A"
"NM_000551.4(VHL):c.463+2T>G","VHL|LOC107303340","","Von Hippel-Lindau syndrome","Likely pathogenic(Last reviewed: Nov 30, 2009)","no assertion criteria provided","VCV000043602","3","10188322","3","10146638",43602,"52771","rs5030814","NC_000003.12:10146637:T:G"
"NM_000551.4(VHL):c.464-1G>A","VHL|LOC107303340","","Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|not provided|Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Feb 19, 2019)","criteria provided, multiple submitters, no conflicts","VCV000043603","3","10191470","3","10149786",43603,"52772","rs5030817","NC_000003.12:10149785:G:A"
"NM_000340.2(SLC2A2):c.1268T>A (p.Val423Glu)","SLC2A2","V423E, V250E, V304E","Fanconi-Bickel syndrome","Pathogenic(Last reviewed: Nov 1, 2000)","no assertion criteria provided","VCV000016101","3","170716088","3","170998299",16101,"31140","rs28928874","NC_000003.12:170998298:A:T"
"NM_001904.4(CTNNB1):c.94G>T (p.Asp32Tyr)","CTNNB1","D32Y, D25Y","Transitional cell carcinoma of the bladder|Craniopharyngioma|Medulloblastoma|Malignant melanoma of skin|Hepatoblastoma|Neoplasm of uterine cervix|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Adenocarcinoma of stomach|Hepatocellular carcinoma|Pilomatrixoma","Pathogenic/Likely pathogenic, other(Last reviewed: May 31, 2016)","no assertion criteria provided","VCV000017581","3","41266097","3","41224606",17581,"32620","rs28931588","NC_000003.12:41224605:G:T"
"NM_020208.4(SLC6A20):c.596C>T (p.Thr199Met)","SLC6A20","T199M","Hyperglycinuria|Iminoglycinuria, digenic","Benign(Last reviewed: May 28, 2019)","criteria provided, multiple submitters, no conflicts","VCV000004845","3","45814094","3","45772602",4845,"19884","rs17279437","NC_000003.12:45772601:G:A"
"NM_016362.5(GHRL):c.214C>A (p.Leu72Met)","GHRLOS|GHRL","L72M, L60M, L59M, L71M","Metabolic syndrome, susceptibility to|Obesity, age at onset of","Pathogenic, risk factor(Last reviewed: Dec 1, 2005)","no assertion criteria provided","VCV000005062","3","10331457","3","10289773",5062,"20101","rs696217","NC_000003.12:10289772:G:T"
"NM_003865.3(HESX1):c.77T>C (p.Ile26Thr)","HESX1","I26T","Pituitary hormone deficiency, combined 5","Pathogenic(Last reviewed: Oct 1, 2003)","no assertion criteria provided","VCV000007695","3","57233870","3","57199842",7695,"22734","rs28936416","NC_000003.12:57199841:A:G"
"NM_003907.3(EIF2B5):c.1882T>C (p.Trp628Arg)","EIF2B5","W628R","Leukoencephalopathy with vanishing white matter","Pathogenic(Last reviewed: Dec 1, 2001)","no assertion criteria provided","VCV000005943","3","183861899","3","184144111",5943,"20982","rs28937596","NC_000003.12:184144110:T:C"
"NM_001457.4(FLNB):c.2251G>C (p.Gly751Arg)","FLNB","G751R","not specified|Atelosteogenesis type III","Likely pathogenic(Last reviewed: Jan 30, 2017)","criteria provided, single submitter","VCV000006402","3","58095354","3","58109627",6402,"21441","rs28937587","NC_000003.12:58109626:G:C"
"NM_000404.2(GLB1):c.367G>A","GLB1","G123R, G171R, G93R","Mucopolysaccharidosis, MPS-IV-B|GM1 gangliosidosis|Infantile GM1 gangliosidosis|not provided","Pathogenic/Likely pathogenic(Last reviewed: Jul 11, 2019)","criteria provided, multiple submitters, no conflicts","VCV000000928","3","33110341","3","33068849",928,"15967","rs28934274","NC_000003.12:33068848:C:T"
"NM_000551.4(VHL):c.500G>A (p.Arg167Gln)","VHL|LOC107303340","R167Q, R126Q","Hereditary cancer-predisposing syndrome|not specified|Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Oct 19, 2020)","criteria provided, conflicting interpretations","VCV000002216","3","10191507","3","10149823",2216,"17255","rs5030821","NC_000003.12:10149822:G:A"
"NM_000551.3(VHL):c.292T>C (p.Tyr98His)","VHL","Y98H","Hereditary cancer-predisposing syndrome|not provided|Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Apr 20, 2020)","criteria provided, multiple submitters, no conflicts","VCV000002223","3","10183823","3","10142139",2223,"17262","rs5030809","NC_000003.12:10142138:T:C"
"NM_000551.4(VHL):c.250G>T (p.Val84Leu)","VHL","V84L","Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Mar 2, 2012)","criteria provided, single submitter","VCV000002236","3","10183781","3","10142097",2236,"17275","rs5030827","NC_000003.12:10142096:G:T"
"NM_000388.4(CASR):c.680G>T (p.Arg227Leu)","CASR","R227L","Familial hypocalciuric hypercalcemia|Hypocalcemia, autosomal dominant 1|Neonatal severe hyperparathyroidism","Pathogenic(Last reviewed: Apr 2, 2020)","criteria provided, single submitter","VCV000008317","3","121980562","3","122261715",8317,"23356","rs28936684","NC_000003.12:122261714:G:T"
"NM_000388.4(CASR):c.680G>A (p.Arg227Gln)","CASR","R227Q","Hypocalciuric hypercalcemia, familial, type 1|Familial hypocalciuric hypercalcemia|Hypocalcemia, autosomal dominant 1|not provided","Pathogenic(Last reviewed: Oct 15, 2018)","criteria provided, multiple submitters, no conflicts","VCV000008331","3","121980562","3","122261715",8331,"23370","rs28936684","NC_000003.12:122261714:G:A"
"NM_033337.2(CAV3):c.277G>A (p.Ala93Thr)","CAV3","A93T","Rippling muscle disease 2, autosomal recessive|Long QT syndrome|Cardiovascular phenotype|not provided|Rippling muscle disease 2","Conflicting interpretations of pathogenicity(Last reviewed: Oct 15, 2020)","criteria provided, conflicting interpretations","VCV000008285","3","8787374","3","8745688",8285,"23324","rs28936686","NC_000003.12:8745687:G:A"
"NM_001330615.1(PPARG):c.735+10750G>A","PPARG","R288H, R77H, R316H","Carcinoma of colon","Pathogenic(Last reviewed: Jun 1, 1999)","no assertion criteria provided","VCV000008135","3","12458330","3","12416831",8135,"23174","rs28936407","NC_000003.12:12416830:G:A"
"NM_033337.2(CAV3):c.260T>C (p.Leu87Pro)","CAV3","L87P","not provided|Long QT syndrome|Rippling muscle disease 2","Uncertain significance(Last reviewed: Nov 15, 2017)","criteria provided, single submitter","VCV000008284","3","8787357","3","8745671",8284,"23323","rs28936685","NC_000003.12:8745670:T:C"
"NM_000335.4(SCN5A):c.3971A>G (p.Asn1324Ser)","SCN5A","N1325S, N1324S, N1271S","Brugada syndrome|Congenital long QT syndrome|Long QT syndrome 3","Pathogenic(Last reviewed: Oct 29, 2020)","criteria provided, single submitter","VCV000009370","3","38601909","3","38560418",9370,"24409","rs28937317","NC_000003.12:38560417:T:C"
"NM_000335.5(SCN5A):c.3305C>A (p.Ser1102Tyr)","SCN5A|LOC110121269","S1103Y, S1102Y","Left ventricular noncompaction|none provided|Brugada syndrome|Cardiac arrhythmia|Cardiovascular phenotype|Arrhythmia|Congenital long QT syndrome|not specified|not provided|Paroxysmal familial ventricular fibrillation 1|Progressive familial heart block, type 1A|Long qt syndrome 3, acquired, susceptibility to|SUDDEN INFANT DEATH SYNDROME|Dilated cardiomyopathy 1E|Brugada syndrome 1|Sick sinus syndrome 1, autosomal recessive|Long QT syndrome 3","Benign/Likely benign, risk factor(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000009393","3","38620907","3","38579416",9393,"24432","rs7626962","NC_000003.12:38579415:G:T"
"NM_000551.3(VHL):c.500G>T (p.Arg167Leu)","VHL|LOC107303340","R167L, R126L","Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Nov 14, 2017)","criteria provided, single submitter","VCV000526685","3","10191507","3","10149823",526685,"518692","rs5030821","NC_000003.12:10149822:G:T"
"NM_000313.3(PROS1):c.1351C>T (p.Arg451Ter)","PROS1","R451*, R483*","Thrombophilia due to protein S deficiency, autosomal recessive|not provided|Protein S deficiency disease","Pathogenic/Likely pathogenic(Last reviewed: Feb 5, 2020)","criteria provided, multiple submitters, no conflicts","VCV000503726","3","93603713","3","93884869",503726,"495151","rs5017717","NC_000003.12:93884868:G:A"
"NM_001904.4(CTNNB1):c.94G>C (p.Asp32His)","CTNNB1","D32H, D25H","Melanoma|Neoplasm of uterine cervix|Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Adenocarcinoma of stomach|Malignant melanoma of skin|Hepatocellular carcinoma|Medulloblastoma|Transitional cell carcinoma of the bladder","Likely pathogenic(Last reviewed: May 31, 2016)","no assertion criteria provided","VCV000376054","3","41266097","3","41224606",376054,"362933","rs28931588","NC_000003.12:41224605:G:C"
"NM_001904.4(CTNNB1):c.94G>A (p.Asp32Asn)","CTNNB1","D32N, D25N","Adenocarcinoma of prostate|Malignant neoplasm of body of uterus|Malignant melanoma of skin|Adenocarcinoma of stomach|Endometrial neoplasm|Esophageal Squamous Cell Carcinoma|Hepatocellular carcinoma|Neoplasm of uterine cervix|Medulloblastoma|Transitional cell carcinoma of the bladder","Likely pathogenic(Last reviewed: May 31, 2016)","no assertion criteria provided","VCV000376228","3","41266097","3","41224606",376228,"363107","rs28931588","NC_000003.12:41224605:G:A"
"NM_000551.3(VHL):c.500G>C (p.Arg167Pro)","LOC107303340|VHL","R167P, R126P","Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome","Pathogenic/Likely pathogenic(Last reviewed: Aug 28, 2018)","criteria provided, multiple submitters, no conflicts","VCV000428799","3","10191507","3","10149823",428799,"420451","rs5030821","NC_000003.12:10149822:G:C"
"NM_000551.3(VHL):c.353T>G (p.Leu118Arg)","VHL|LOC107303340","L118R","Hereditary cancer-predisposing syndrome","Pathogenic(Last reviewed: Jul 26, 2017)","criteria provided, single submitter","VCV000428802","3","10188210","3","10146526",428802,"420445","rs5030830","NC_000003.12:10146525:T:G"
"NM_000551.3(VHL):c.353T>C (p.Leu118Pro)","VHL|LOC107303340","L118P","Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Hereditary cancer-predisposing syndrome","Pathogenic(Last reviewed: Nov 30, 2018)","criteria provided, multiple submitters, no conflicts","VCV000428807","3","10188210","3","10146526",428807,"420444","rs5030830","NC_000003.12:10146525:T:C"
"NM_000551.3(VHL):c.250G>A (p.Val84Met)","VHL","V84M","Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Hereditary cancer-predisposing syndrome|Von Hippel-Lindau syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Feb 16, 2019)","criteria provided, conflicting interpretations","VCV000428813","3","10183781","3","10142097",428813,"420439","rs5030827","NC_000003.12:10142096:G:A"
"NM_001063.4(TF):c.1623-63del","TF","","Atransferrinemia","Likely pathogenic(Last reviewed: Nov 14, 2019)","no assertion criteria provided","VCV000694735","3","133489289","3","133770445",694735,"682854","rs8177291","NC_000003.12:133770444:T:"
"NM_000551.3(VHL):c.490C>G (p.Gln164Glu)","VHL|LOC107303340","Q164E, Q123E","Von Hippel-Lindau syndrome","Uncertain significance(Last reviewed: Aug 1, 2018)","criteria provided, single submitter","VCV000625253","3","10191497","3","10149813",625253,"613585","rs5030819","NC_000003.12:10149812:C:G"
"NM_000551.3(VHL):c.463+2T>C","VHL|LOC107303340","","not provided|Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2","Pathogenic(Last reviewed: Jun 5, 2018)","criteria provided, single submitter","VCV000569414","3","10188322","3","10146638",569414,"561087","rs5030814","NC_000003.12:10146637:T:C"
"NM_020949.3(SLC7A14):c.988G>A (p.Gly330Arg)","SLC7A14|SLC7A14-AS1","G330R","Retinitis pigmentosa 68|not provided","Benign(Last reviewed: Nov 14, 2020)","criteria provided, single submitter","VCV000126446","3","170201230","3","170483441",126446,"131974","rs2276717","NC_000003.12:170483440:C:T"
"NM_033337.2(CAV3):c.277G>T (p.Ala93Ser)","CAV3","A93S","Cardiovascular phenotype|Long QT syndrome|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Jan 3, 2020)","criteria provided, conflicting interpretations","VCV000180798","3","8787374","3","8745688",180798,"179088","rs28936686","NC_000003.12:8745687:G:T"
"NM_000249.3(MLH1):c.265G>T (p.Glu89Ter)","MLH1","E89*","Lynch syndrome","Pathogenic(Last reviewed: Sep 5, 2013)","reviewed by expert panel","VCV000090124","3","37042503","3","37001012",90124,"95598","rs11541859","NC_000003.12:37001011:G:T"
"NM_000313.3(PROS1):c.233C>T (p.Thr78Met)","PROS1","T78M, T110M","Protein S deficiency disease|Deep venous thrombosis|Thrombophilia due to protein S deficiency, autosomal recessive","Conflicting interpretations of pathogenicity(Last reviewed: Mar 22, 2020)","criteria provided, conflicting interpretations","VCV000215991","3","93646095","3","93927251",215991,"212340","rs6122","NC_000003.12:93927250:G:A"
"NM_000551.3(VHL):c.250G>C (p.Val84Leu)","VHL","V84L","Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome|Erythrocytosis, familial, 2|Hereditary cancer-predisposing syndrome","Pathogenic(Last reviewed: Mar 23, 2020)","criteria provided, multiple submitters, no conflicts","VCV000229860","3","10183781","3","10142097",229860,"232861","rs5030827","NC_000003.12:10142096:G:C"
"NM_000551.3(VHL):c.464-1G>C","VHL|LOC107303340","","Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Jul 31, 2019)","criteria provided, single submitter","VCV000223220","3","10191470","3","10149786",223220,"224951","rs5030817","NC_000003.12:10149785:G:C"
"NM_000551.3(VHL):c.464-1G>T","VHL|LOC107303340","","Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Feb 26, 2016)","no assertion criteria provided","VCV000223221","3","10191470","3","10149786",223221,"224952","rs5030817","NC_000003.12:10149785:G:T"
"NM_000551.4(VHL):c.464-2A>G","VHL|LOC107303340","","not provided|Von Hippel-Lindau syndrome|Hereditary cancer-predisposing syndrome|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|Pheochromocytoma|Erythrocytosis, familial, 2|Renal cell carcinoma, nonpapillary|Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Jun 30, 2021)","criteria provided, multiple submitters, no conflicts","VCV000223222","3","10191469","3","10149785",223222,"224950","rs5030816","NC_000003.12:10149784:A:G"
"NM_000551.3(VHL):c.490C>T (p.Gln164Ter)","VHL|LOC107303340","Q164*, Q123*","not provided|Erythrocytosis, familial, 2|Von Hippel-Lindau syndrome|Von Hippel-Lindau syndrome","Pathogenic(Last reviewed: Oct 4, 2018)","criteria provided, multiple submitters, no conflicts","VCV000223228","3","10191497","3","10149813",223228,"224958","rs5030819","NC_000003.12:10149812:C:T"
"NM_002448.3(MSX1):c.251A>T (p.Glu84Val)","MSX1","E84V","Orofacial cleft 5","Pathogenic(Last reviewed: Jun 1, 2003)","no assertion criteria provided","VCV000014883","4","4861877","4","4860150",14883,"29922","rs28928890","NC_000004.12:4860149:A:T"
"NM_000128.3(F11):c.976C>T (p.Arg326Cys)","F11","R326C","Hereditary factor XI deficiency disease","Likely pathogenic(Last reviewed: Feb 1, 2019)","criteria provided, single submitter","VCV000011898","4","187201487","4","186280333",11898,"26937","rs28934608","NC_000004.12:186280332:C:T"
"NM_000142.5(FGFR3):c.749C>G (p.Pro250Arg)","FGFR3","P250R","Craniosynostosis syndrome|not specified|not provided|Saethre-Chotzen syndrome|Muenke syndrome|Hypochondroplasia|Camptodactyly-tall stature-scoliosis-hearing loss syndrome|Cancer of cervix|Achondroplasia|Severe achondroplasia with developmental delay and acanthosis nigricans|Malignant tumor of testis|Muenke syndrome|Carcinoma of colon|Hypochondroplasia|Thanatophoric dysplasia type 1|Levy-Hollister syndrome|Crouzon syndrome with acanthosis nigricans|Epidermal nevus|Urinary bladder cancer|Thanatophoric dysplasia, type 2|Inborn genetic diseases|Achondroplasia|Coronal craniosynostosis|Crouzon syndrome|Facial asymmetry|Infantile axial hypotonia|Absence seizures|Unilateral renal agenesis|Seizures","Pathogenic/Likely pathogenic(Last reviewed: Apr 1, 2021)","criteria provided, multiple submitters, no conflicts","VCV000016340","4","1803571","4","1801844",16340,"31379","rs4647924","NC_000004.12:1801843:C:G"
"NM_021870.3(FGG):c.571G>A (p.Gly191Arg)","FGG","G191R","not specified|not provided|Hypofibrinogenemia|Afibrinogenemia, congenital|Fibrinogen Milano XII, digenic","Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)","criteria provided, conflicting interpretations","VCV000016378","4","155530877","4","154609725",16378,"31417","rs6063","NC_000004.12:154609724:C:T"
"NM_000406.3(GNRHR):c.851A>G (p.Tyr284Cys)","GNRHR","Y284C","Hypogonadotropic hypogonadism 7 with or without anosmia","Pathogenic(Last reviewed: Jan 1, 1998)","no assertion criteria provided","VCV000016025","4","68606334","4","67740616",16025,"31064","rs28933074","NC_000004.12:67740615:T:C"
"NM_006005.3(WFS1):c.461-9A>G","WFS1","","WFS1-Related Spectrum Disorders|not specified|none provided|not provided|Type 2 diabetes mellitus|Autosomal dominant nonsyndromic deafness 6","Benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000004527","4","6292915","4","6291188",4527,"19566","rs10010131","NC_000004.12:6291187:A:G"
"NM_006005.3(WFS1):c.713-1075C>G","WFS1","","not provided|Diabetes mellitus, noninsulin-dependent, association with|Type 2 diabetes mellitus|Wolfram syndrome 1","Benign(Last reviewed: May 28, 2019)","criteria provided, multiple submitters, no conflicts","VCV000004528","4","6295693","4","6293966",4528,"19567","rs6446482","NC_000004.12:6293965:C:G"
"NM_000142.5(FGFR3):c.749C>T (p.Pro250Leu)","FGFR3","P250L","Craniosynostosis syndrome","Uncertain significance(Last reviewed: Oct 2, 2017)","criteria provided, single submitter","VCV000533893","4","1803571","4","1801844",533893,"519844","rs4647924","NC_000004.12:1801843:C:T"
"NM_000203.5(IDUA):c.1403-1G>T","IDUA","","Mucopolysaccharidosis type 1","Likely pathogenic(Last reviewed: Dec 21, 2018)","criteria provided, single submitter","VCV000652306","4","996823","4","1003035",652306,"651143","rs4690223","NC_000004.12:1003034:G:T"
"NM_000203.5(IDUA):c.1225G>C (p.Gly409Arg)","IDUA","G409R, G277R","not provided|not specified|Mucopolysaccharidosis type 1|Hurler syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Dec 8, 2020)","criteria provided, conflicting interpretations","VCV000092627","4","996555","4","1002767",92627,"26950","rs11934801","NC_000004.12:1002766:G:C"
"NM_003060.4(SLC22A5):c.51C>G (p.Phe17Leu)","SLC22A5","F17L","Renal carnitine transport defect|not provided","Pathogenic(Last reviewed: Oct 12, 2020)","criteria provided, multiple submitters, no conflicts","VCV000025350","5","131705715","5","132370023",25350,"36684","rs11568520","NC_000005.10:132370022:C:G"
"NM_213647.3(FGFR4):c.1162G>A (p.Gly388Arg)","FGFR4","G388R","Cancer progression and tumor cell motility|See cases","Uncertain significance(Last reviewed: Oct 17, 2019)","criteria provided, single submitter","VCV000016326","5","176520243","5","177093242",16326,"31365","rs351855","NC_000005.10:177093241:G:A"
"NM_000521.3(HEXB):c.185C>T (p.Ser62Leu)","HEXB","","Sandhoff disease, infantile type|Sandhoff disease","Benign(Last reviewed: Dec 8, 2020)","criteria provided, single submitter","VCV000003882","5","73981270","5","74685445",3882,"18921","rs820878","NC_000005.10:74685444:T:T"
"NM_007255.3(B4GALT7):c.808C>T (p.Arg270Cys)","B4GALT7","R270C","Lethal skeletal dysplasia|not provided|Multiple joint dislocations, short stature, craniofacial dysmorphism, and congenital heart defects|Ehlers-Danlos syndrome, spondylodysplastic type, 1","Pathogenic(Last reviewed: Aug 1, 2020)","criteria provided, multiple submitters, no conflicts","VCV000005613","5","177035995","5","177608994",5613,"20652","rs28937869","NC_000005.10:177608993:C:T"
"NM_006790.2(MYOT):c.170C>T (p.Thr57Ile)","MYOT|PKD2L2-DT","T57I","not provided|Myofibrillar myopathy 3","Pathogenic(Last reviewed: Aug 25, 2020)","criteria provided, multiple submitters, no conflicts","VCV000005834","5","137206510","5","137870821",5834,"20873","rs28937597","NC_000005.10:137870820:C:T"
"NM_004387.4(NKX2-5):c.73C>T (p.Arg25Cys)","NKX2-5","R25C","not specified|Atrial septal defect 7 with or without atrioventricular conduction defects|Hypothyroidism, congenital, nongoitrous, 5|Truncus arteriosus|Congenital heart disease|Cardiovascular phenotype|Interrupted aortic arch|Tetralogy of Fallot|Hypoplastic left heart syndrome 2","Conflicting interpretations of pathogenicity(Last reviewed: Dec 6, 2020)","criteria provided, conflicting interpretations","VCV000009008","5","172662014","5","173235011",9008,"24047","rs28936670","NC_000005.10:173235010:G:A"
"NM_002109.6(HARS1):c.616G>T (p.Asp206Tyr)","HARS1","D132Y, D146Y, D166Y, D177Y, D186Y, D206Y, D92Y","Choreoathetosis|Cerebellar atrophy|Tremor|Peripheral neuropathy|Oculomotor apraxia|Intellectual disability|Nystagmus|Dysmetria|Dysarthria|Spastic ataxia","Pathogenic(Last reviewed: Jan 1, 2019)","criteria provided, single submitter","VCV000804285","5","140057507","5","140677922",804285,"792643","rs1131040","NC_000005.10:140677921:C:A"
"NM_000521.4(HEXB):c.185T>C (p.Leu62Ser)","HEXB","L62S","not specified|Sandhoff disease","Benign(Last reviewed: Jul 10, 2021)","criteria provided, multiple submitters, no conflicts","VCV000167173","5","73981270","5","74685445",167173,"177767","rs820878","NC_000005.10:74685444:T:C"
"NM_000176.3(NR3C1):c.66G>A (p.Glu22=)","NR3C1","","Glucocorticoid resistance, generalized|Glucocorticoid resistance, relative","Benign/Likely benign(Last reviewed: May 28, 2019)","criteria provided, multiple submitters, no conflicts","VCV000155925","5","142780339","5","143400774",155925,"31193","rs6189","NC_000005.10:143400773:C:T"
"NM_000500.9(CYP21A2):c.1069C>T (p.Arg357Trp)","CYP21A2|TNXB|LOC106780800","R357W, R327W, R222W","not provided|Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency","Pathogenic(Last reviewed: Aug 20, 2020)","criteria provided, multiple submitters, no conflicts","VCV000012152","6","32008312","6","32040535",12152,"27191","rs7769409","NC_000006.12:32040534:C:T"
"NM_000500.9(CYP21A2):c.92C>T (p.Pro31Leu)","CYP21A2|LOC106780800","P31L","not provided|Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency","Pathogenic(Last reviewed: Dec 17, 2019)","criteria provided, multiple submitters, no conflicts","VCV000012153","6","32006291","6","32038514",12153,"27192","rs9378251","NC_000006.12:32038513:C:T"
"NM_000500.9(CYP21A2):c.293-13C>G","CYP21A2|LOC106780800","","not provided|Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency|Inborn genetic diseases|Adrenal hyperplasia","Pathogenic(Last reviewed: Aug 5, 2020)","criteria provided, multiple submitters, no conflicts","VCV000012155","6","32006858","6","32039081",12155,"27194","rs6467","NC_000006.12:32039080:C:G"
"NM_001710.6(CFB):c.26T>A (p.Leu9His)","CFB|C2","L9H","Age-related macular degeneration 14|not provided|Atypical hemolytic uremic syndrome|Atypical hemolytic-uremic syndrome 4|not specified|Macular degeneration|Complement component 2 deficiency","Benign/Likely benign(Last reviewed: Jun 10, 2021)","criteria provided, multiple submitters, no conflicts","VCV000016077","6","31914024","6","31946247",16077,"31116","rs4151667","NC_000006.12:31946246:T:A"
"NM_000165.5(GJA1):c.1085G>A (p.Arg362Gln)","GJA1","R362Q","not provided|Oculodentodigital dysplasia, autosomal recessive|Atrioventricular septal defect 3|Hypoplastic left heart syndrome 1","Conflicting interpretations of pathogenicity(Last reviewed: Dec 31, 2019)","criteria provided, conflicting interpretations","VCV000016990","6","121769078","6","121447932",16990,"32029","rs2227885","NC_000006.12:121447931:G:A"
"NM_000500.9(CYP21A2):c.293-13C>T","CYP21A2|LOC106780800","","Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency","not provided","no assertion provided","VCV000430830","6","32006858","6","32039081",430830,"424373","rs6467","NC_000006.12:32039080:C:T"
"NM_138272.2(MPIG6B):c.523C>T (p.Arg175Ter)","MPIG6B","R175*","not provided","Pathogenic(Last reviewed: Dec 27, 2018)","criteria provided, single submitter","VCV000660958","6","31692386","6","31724609",660958,"634804","rs11575845","NC_000006.12:31724608:C:T"
"NM_000500.9(CYP21A2):c.40G>T (p.Ala14Ser)","CYP21A2|LOC106780800","A14S","Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency","Uncertain significance","no assertion criteria provided","VCV000998097","6","32006239","6","32038462",998097,"985825","rs6445","NC_000006.12:32038461:G:T"
"NM_148919.4(PSMB8):c.145C>A (p.Gln49Lys)","PSMB8","Q49K","not specified|Proteasome-associated autoinflammatory syndrome 1","Benign(Last reviewed: Dec 3, 2020)","criteria provided, multiple submitters, no conflicts","VCV000356368","6","32811629","6","32843852",356368,"302501","rs2071543","NC_000006.12:32843851:G:T"
"NM_000500.9(CYP21A2):c.293-13C>A","CYP21A2|LOC106780800","","not specified|Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency","Conflicting interpretations of pathogenicity(Last reviewed: May 12, 2021)","criteria provided, conflicting interpretations","VCV000196278","6","32006858","6","32039081",196278,"193439","rs6467","NC_000006.12:32039080:C:A"
"NM_000255.4(MMUT):c.828G>C (p.Glu276Asp)","MMUT","E276D","Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency","Pathogenic","criteria provided, single submitter","VCV000222921","6","49423876","6","49456163",222921,"224640","rs12175488","NC_000006.12:49456162:C:G"
"NM_000603.5(NOS3):c.894T>G (p.Asp298Glu)","NOS3","D298E","Ischemic stroke, susceptibility to|Alzheimer disease, late-onset, susceptibility to|not specified|Hypertension resistant to conventional therapy|Ischemic heart disease, susceptibility to|Coronary artery spasm 1, susceptibility to|Hypertension, pregnancy-induced, susceptibility to","Benign(Last reviewed: Mar 28, 2016)","criteria provided, single submitter","VCV000014015","7","150696111","7","150999023",14015,"29054","rs1799983","NC_000007.14:150999022:T:G"
"NM_001348946.2(ABCB1):c.554G>T (p.Gly185Val)","ABCB1","G185V, G255V","Colchicine resistance","Pathogenic(Last reviewed: Sep 1, 1990)","no assertion criteria provided","VCV000013698","7","87195534","7","87566218",13698,"28737","rs1128501","NC_000007.14:87566217:C:A"
"NM_000168.6(GLI3):c.2800G>C (p.Ala934Pro)","GLI3","A934P","Greig cephalopolysyndactyly syndrome, severe","Pathogenic(Last reviewed: Jun 1, 2006)","no assertion criteria provided","VCV000013825","7","42005871","7","41966273",13825,"28864","rs28933372","NC_000007.14:41966272:C:G"
"NM_172056.2(KCNH2):c.1778T>G (p.Ile593Arg)","KCNH2","I593R, I253R","Congenital long QT syndrome|not provided|Long QT syndrome 2","Pathogenic(Last reviewed: May 24, 2019)","criteria provided, single submitter","VCV000014423","7","150648703","7","150951615",14423,"29462","rs28928904","NC_000007.14:150951614:A:C"
"NM_172056.2(KCNH2):c.1714G>C (p.Gly572Arg)","KCNH2","G572R, G232R","Long QT syndrome 2|Congenital long QT syndrome","Pathogenic(Last reviewed: Feb 1, 2000)","no assertion criteria provided","VCV000014429","7","150648767","7","150951679",14429,"29468","rs9333649","NC_000007.14:150951678:C:G"
"NM_172056.2(KCNH2):c.2350C>T (p.Arg784Trp)","KCNH2","R784W, R444W","Brugada syndrome|Arrhythmia|Long QT syndrome 2, acquired, susceptibility to|Long QT syndrome 2|Congenital long QT syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Feb 22, 2021)","criteria provided, conflicting interpretations","VCV000014433","7","150647304","7","150950216",14433,"29472","rs12720441","NC_000007.14:150950215:G:A"
"NM_000492.4(CFTR):c.2002C>T (p.Arg668Cys)","CFTR","R668C","Cystic fibrosis|not specified|CFTR-related disorders|not provided|Bronchiectasis with or without elevated sweat chloride 1|Congenital bilateral aplasia of vas deferens from CFTR mutation|Hereditary pancreatitis|Cystic fibrosis|Lung disease, non-specific|Chronic sinusitis|Inborn genetic diseases|none provided","Conflicting interpretations of pathogenicity(Last reviewed: May 18, 2021)","criteria provided, conflicting interpretations","VCV000035835","7","117232223","7","117592169",35835,"44499","rs1800100","NC_000007.14:117592168:C:T"
"NM_000492.4(CFTR):c.224G>A (p.Arg75Gln)","CFTR","R75Q","Hereditary pancreatitis|Cystic fibrosis|not specified|not provided|Abnormality of the pancreas|CFTR-related disorders|Inborn genetic diseases|Lung disease, non-specific|none provided","Conflicting interpretations of pathogenicity(Last reviewed: May 18, 2021)","criteria provided, conflicting interpretations","VCV000035839","7","117149147","7","117509093",35839,"44503","rs1800076","NC_000007.14:117509092:G:A"
"NM_000941.3(POR):c.1370G>A (p.Arg457His)","POR","R457H","Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis|Disordered steroidogenesis due to cytochrome p450 oxidoreductase deficiency","Pathogenic/Likely pathogenic(Last reviewed: Apr 2, 2018)","criteria provided, multiple submitters, no conflicts","VCV000016907","7","75614497","7","75985179",16907,"31946","rs28931608","NC_000007.14:75985178:G:A"
"NM_000823.4(GHRHR):c.57+1G>A","GHRHR","","Isolated growth hormone deficiency, type 4","Pathogenic(Last reviewed: Dec 1, 2007)","no assertion criteria provided","VCV000015990","7","31003741","7","30964126",15990,"31029","rs2302022","NC_000007.14:30964125:G:A"
"NM_001540.5(HSPB1):c.545C>T (p.Pro182Leu)","HSPB1","P182L","Distal hereditary motor neuronopathy type 2B","Pathogenic(Last reviewed: Jan 15, 2006)","no assertion criteria provided","VCV000007481","7","75933417","7","76304100",7481,"22520","rs28937569","NC_000007.14:76304099:C:T"
"NM_000492.4(CFTR):c.3808G>A (p.Asp1270Asn)","CFTR","D1270N","CFTR-related disorders|Cystic fibrosis|ivacaftor response - Efficacy|Inborn genetic diseases|Congenital bilateral aplasia of vas deferens from CFTR mutation|not provided|Hereditary pancreatitis|not specified","drug response(Last reviewed: Mar 23, 2018)","reviewed by expert panel","VCV000007164","7","117282582","7","117642528",7164,"22203","rs11971167","NC_000007.14:117642527:G:A"
"NM_000492.4(CFTR):c.1727G>C (p.Gly576Ala)","CFTR","G576A","Inborn genetic diseases|Congenital bilateral aplasia of vas deferens from CFTR mutation|not provided|Lung disease, non-specific|Chronic sinusitis|none provided|Cystic fibrosis|CFTR-related disorders|not specified","Conflicting interpretations of pathogenicity(Last reviewed: May 18, 2021)","criteria provided, conflicting interpretations","VCV000007165","7","117230454","7","117590400",7165,"22204","rs1800098","NC_000007.14:117590399:G:C"
"NM_001540.5(HSPB1):c.452C>T (p.Thr151Ile)","HSPB1","T151I","Charcot-Marie-Tooth disease|Distal hereditary motor neuronopathy type 2B|Charcot-Marie-Tooth disease axonal type 2F","Conflicting interpretations of pathogenicity(Last reviewed: Sep 10, 2018)","criteria provided, conflicting interpretations","VCV000007480","7","75933324","7","76304007",7480,"22519","rs28937568","NC_000007.14:76304006:C:T"
"NM_000193.4(SHH):c.91G>A (p.Gly31Arg)","SHH","G31R","Holoprosencephaly 3","Pathogenic(Last reviewed: Aug 29, 2013)","no assertion criteria provided","VCV000008877","7","155604726","7","155812032",8877,"23916","rs28936675","NC_000007.14:155812031:C:T"
"NM_000492.3(CFTR):c.3485G>A (p.Arg1162Gln)","CFTR","R1162Q","not provided|Cystic fibrosis","Uncertain significance(Last reviewed: Jan 14, 2020)","criteria provided, multiple submitters, no conflicts","VCV000555228","7","117267592","7","117627538",555228,"544211","rs1800120","NC_000007.14:117627537:G:A"
"NM_172056.2(KCNH2):c.1714G>A (p.Gly572Ser)","KCNH2","G232S, G572S","not provided|Cardiovascular phenotype|Long QT syndrome 2|Long QT syndrome|Congenital long QT syndrome","Pathogenic(Last reviewed: Nov 8, 2019)","criteria provided, multiple submitters, no conflicts","VCV000067248","7","150648767","7","150951679",67248,"78144","rs9333649","NC_000007.14:150951678:C:T"
"NM_172056.2(KCNH2):c.1714G>T (p.Gly572Cys)","KCNH2","G232C, G572C","Congenital long QT syndrome","not provided","no assertion provided","VCV000067249","7","150648767","7","150951679",67249,"78145","rs9333649","NC_000007.14:150951678:C:A"
"NM_172056.2(KCNH2):c.1778T>A (p.Ile593Lys)","KCNH2","I253K, I593K","Long QT syndrome|Congenital long QT syndrome","Pathogenic(Last reviewed: Jul 25, 2017)","criteria provided, single submitter","VCV000067269","7","150648703","7","150951615",67269,"78165","rs28928904","NC_000007.14:150951614:A:T"
"NM_172056.2(KCNH2):c.1778T>C (p.Ile593Thr)","KCNH2","I253T, I593T","Congenital long QT syndrome|not provided","Pathogenic(Last reviewed: Feb 2, 2014)","criteria provided, single submitter","VCV000067270","7","150648703","7","150951615",67270,"78166","rs28928904","NC_000007.14:150951614:A:G"
"NM_000492.3(CFTR):c.224G>T (p.Arg75Leu)","CFTR","R75L","Cystic fibrosis|not specified","Uncertain significance(Last reviewed: Apr 10, 2019)","criteria provided, single submitter","VCV000053461","7","117149147","7","117509093",53461,"68129","rs1800076","NC_000007.14:117509092:G:T"
"NM_000492.4(CFTR):c.509G>A (p.Arg170His)","CFTR","R170H","Cystic fibrosis|Inborn genetic diseases|not provided|not specified|CFTR-related disorders|none provided","Conflicting interpretations of pathogenicity(Last reviewed: Mar 26, 2021)","criteria provided, conflicting interpretations","VCV000053983","7","117174349","7","117534295",53983,"68650","rs1800079","NC_000007.14:117534294:G:A"
"NM_000492.3(CFTR):c.3485G>T (p.Arg1162Leu)","CFTR","R1162L","Cystic fibrosis|Inborn genetic diseases|not provided|CFTR-related disorders|none provided|not specified","Conflicting interpretations of pathogenicity(Last reviewed: Feb 5, 2021)","criteria provided, conflicting interpretations","VCV000256253","7","117267592","7","117627538",256253,"252571","rs1800120","NC_000007.14:117627537:G:T"
"NM_000823.4(GHRHR):c.57+1G>T","GHRHR","","Isolated growth hormone deficiency type IB","Uncertain significance(Last reviewed: Sep 28, 2016)","criteria provided, single submitter","VCV000360028","7","31003741","7","30964126",360028,"310914","rs2302022","NC_000007.14:30964125:G:T"
"NM_006158.5(NEFL):c.64C>T (p.Pro22Ser)","NEFL","P22S","Charcot-Marie-Tooth disease, demyelinating, type 1f|Charcot-Marie-Tooth disease type 2E|Peripheral demyelination|Hand muscle atrophy|Distal muscle weakness|Peripheral neuropathy|Decreased nerve conduction velocity|not provided|Peripheral neuropathy|Distal lower limb muscle weakness|Pes cavus|Charcot-Marie-Tooth disease, type 1C","Pathogenic/Likely pathogenic(Last reviewed: Sep 20, 2019)","criteria provided, multiple submitters, no conflicts","VCV000014029","8","24813966","8","24956452",14029,"29068","rs28928910","NC_000008.11:24956451:G:A"
"NM_006158.4(NEFL):c.64C>A (p.Pro22Thr)","NEFL","P22T","Charcot-Marie-Tooth disease, demyelinating, type 1f|not provided","Pathogenic(Last reviewed: Oct 18, 2012)","no assertion criteria provided","VCV000041238","8","24813966","8","24956452",41238,"49662","rs28928910","NC_000008.11:24956451:G:T"
"NM_000756.3(CRH):c.-669C>A","CRH","","Autosomal dominant nocturnal frontal lobe epilepsy","Pathogenic(Last reviewed: Feb 19, 2015)","no assertion criteria provided","VCV000038800","8","67091182","8","66178947",38800,"47403","rs12721510","NC_000008.11:66178946:G:T"
"NM_006096.3(NDRG1):c.538-1G>A","NDRG1","","Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease, type 4D","Conflicting interpretations of pathogenicity(Last reviewed: Aug 1, 2003)","no assertion criteria provided","VCV000005121","8","134266839","8","133254596",5121,"20160","rs11575976","NC_000008.11:133254595:C:T"
"NM_020427.3(SLURP1):c.256G>A (p.Gly86Arg)","SLURP1","G86R","Acroerythrokeratoderma","Pathogenic(Last reviewed: Jan 1, 2003)","no assertion criteria provided","VCV000004602","8","143822617","8","142741199",4602,"19641","rs28937888","NC_000008.11:142741198:C:T"
"NM_020427.3(SLURP1):c.256G>C (p.Gly86Arg)","SLURP1","G86R","Acroerythrokeratoderma","Pathogenic(Last reviewed: Jan 1, 2003)","no assertion criteria provided","VCV000004603","8","143822617","8","142741199",4603,"19642","rs28937888","NC_000008.11:142741198:C:G"
"NM_020427.3(SLURP1):c.1A>C (p.Met1Leu)","SLURP1","M1L","Acroerythrokeratoderma","Pathogenic(Last reviewed: Jan 1, 2003)","no assertion criteria provided","VCV000004604","8","143823803","8","142742385",4604,"19643","rs28937889","NC_000008.11:142742384:T:G"
"NM_012082.4(ZFPM2):c.1969A>G (p.Ser657Gly)","ZFPM2|ZFPM2-AS1","S657G, S525G, S604G","Tetralogy of Fallot|46,XY sex reversal 9","Benign(Last reviewed: Dec 3, 2020)","criteria provided, multiple submitters, no conflicts","VCV000006127","8","106814279","8","105802051",6127,"21166","rs28374544","NC_000008.11:105802050:A:G"
"NM_000067.3(CA2):c.754A>G (p.Asn252Asp)","CA2","N252D, N151D","not provided|CARBONIC ANHYDRASE II VARIANT|Osteopetrosis with renal tubular acidosis","Benign/Likely benign(Last reviewed: Dec 31, 2019)","criteria provided, multiple submitters, no conflicts","VCV000000913","8","86392989","8","85480760",913,"15952","rs2228063","NC_000008.11:85480759:A:G"
"NM_006269.2(RP1):c.5008G>A (p.Ala1670Thr)","RP1","A1670T","Autosomal recessive retinitis pigmentosa|not specified|not provided|Retinitis pigmentosa","Benign(Last reviewed: Dec 2, 2020)","criteria provided, multiple submitters, no conflicts","VCV000095352","8","55541450","8","54628890",95352,"101251","rs446227","NC_000008.11:54628889:G:A"
"NM_000498.3(CYP11B2):c.541C>T (p.Arg181Trp)","CYP11B2|LOC106799834","R181W","Corticosterone methyl oxidase type II deficiency|not provided","Uncertain significance(Last reviewed: Oct 25, 2020)","criteria provided, single submitter","VCV000242773","8","143996516","8","142915100",242773,"31915","rs28931609","NC_000008.11:142915099:G:A"
"NM_003235.5(TG):c.2443G>A (p.Gly815Arg)","TG","G815R","Iodotyrosyl coupling defect","Likely benign(Last reviewed: Jan 12, 2018)","criteria provided, single submitter","VCV000361924","8","133900495","8","132888250",361924,"304296","rs16904774","NC_000008.11:132888249:G:A"
"NM_000497.3(CYP11B1):c.825T>C (p.Tyr275=)","CYP11B1|LOC106799833","","Hyperaldosteronism, familial, type I|Deficiency of steroid 11-beta-monooxygenase|not specified|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Dec 4, 2020)","criteria provided, conflicting interpretations","VCV000362158","8","143957786","8","142876370",362158,"313384","rs5290","NC_000008.11:142876369:A:G"
"NM_003235.5(TG):c.2443G>T (p.Gly815Ter)","TG","G815*","not provided","Pathogenic(Last reviewed: Oct 20, 2016)","criteria provided, single submitter","VCV000372918","8","133900495","8","132888250",372918,"359830","rs16904774","NC_000008.11:132888249:G:T"
"NM_000031.6(ALAD):c.177G>C (p.Lys59Asn)","ALAD","K59N, K51N, K88N","not provided|Porphobilinogen synthase deficiency|AMINOLEVULINATE DEHYDRATASE, ALAD*1/ALAD*2 POLYMORPHISM","Benign(Last reviewed: Dec 5, 2020)","criteria provided, multiple submitters, no conflicts","VCV000016864","9","116153891","9","113391611",16864,"31903","rs1800435","NC_000009.12:113391610:C:G"
"NM_003995.3(NPR2):c.343T>G (p.Trp115Gly)","NPR2","W115G","Acromesomelic dysplasia, Maroteaux type","Pathogenic(Last reviewed: Jul 1, 2004)","no assertion criteria provided","VCV000017785","9","35792748","9","35792751",17785,"32824","rs28931582","NC_000009.12:35792750:T:G"
"NM_001701.4(BAAT):c.226A>G (p.Met76Val)","BAAT","M76V","Bile acid conjugation defect 1","Pathogenic(Last reviewed: May 1, 2003)","no assertion criteria provided","VCV000006720","9","104133461","9","101371179",6720,"21759","rs28937579","NC_000009.12:101371178:T:C"
"NM_004473.4(FOXE1):c.170G>A (p.Ser57Asn)","FOXE1","S57N","Bamforth-Lazarus syndrome","Pathogenic(Last reviewed: Mar 1, 2011)","no assertion criteria provided","VCV000006987","9","100616366","9","97854084",6987,"22026","rs28937575","NC_000009.12:97854083:G:A"
"NM_005476.7(GNE):c.2135T>C (p.Met712Thr)","GNE","M712T, M743T, M602T, M638T, M653T, M661T","not provided|GNE myopathy|Sialuria|GNE myopathy","Pathogenic(Last reviewed: Oct 8, 2020)","criteria provided, multiple submitters, no conflicts","VCV000006025","9","36217396","9","36217399",6025,"21064","rs28937594","NC_000009.12:36217398:A:G"
"NM_019892.6(INPP5E):c.1543C>T (p.Arg515Trp)","INPP5E","R515W, R514W","Joubert syndrome 1","Pathogenic(Last reviewed: Sep 1, 2009)","no assertion criteria provided","VCV000000397","9","139326282","9","136431830",397,"15436","rs13297509","NC_000009.12:136431829:G:A"
"NM_000155.4(GALT):c.940A>G (p.Asn314Asp)","GALT","N314D, N205D","not provided|Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase|GALT POLYMORPHISM (DUARTE, D2)|Galactosemia|not specified","Conflicting interpretations of pathogenicity, other(Last reviewed: Jun 10, 2021)","criteria provided, conflicting interpretations","VCV000003613","9","34649442","9","34649445",3613,"18652","rs2070074","NC_000009.12:34649444:A:G"
"NM_005502.4(ABCA1):c.3295G>T (p.Asp1099Tyr)","ABCA1","D1099Y","Familial hypoalphalipoproteinemia","Pathogenic(Last reviewed: May 21, 2002)","no assertion criteria provided","VCV000009501","9","107581111","9","104818830",9501,"24540","rs28933692","NC_000009.12:104818829:C:A"
"NM_005502.4(ABCA1):c.1790A>G (p.Gln597Arg)","ABCA1","Q597R","Tangier disease","Pathogenic(Last reviewed: Aug 1, 1999)","no assertion criteria provided","VCV000009485","9","107593308","9","104831027",9485,"24524","rs2853578","NC_000009.12:104831026:T:C"
"NM_005502.4(ABCA1):c.2804A>G (p.Asn935Ser)","ABCA1","N935S","Tangier disease","Pathogenic(Last reviewed: Aug 1, 1999)","no assertion criteria provided","VCV000009488","9","107584801","9","104822520",9488,"24527","rs28937313","NC_000009.12:104822519:T:C"
"NM_005502.4(ABCA1):c.2803A>C (p.Asn935His)","ABCA1","N935H","Tangier disease","Pathogenic(Last reviewed: Jan 1, 2002)","no assertion criteria provided","VCV000009498","9","107584802","9","104822521",9498,"24537","rs28937314","NC_000009.12:104822520:T:G"
"NM_012144.4(DNAI1):c.1003G>T (p.Val335Phe)","DNAI1","V335F, V339F","Kartagener syndrome|Primary ciliary dyskinesia","Uncertain significance(Last reviewed: Dec 1, 2017)","criteria provided, single submitter","VCV000525451","9","34500821","9","34500823",525451,"525082","rs11793196","NC_000009.12:34500822:G:T"
"NM_000077.4(CDKN2A):c.-34G>A","CDKN2A","","Melanoma-pancreatic cancer syndrome|Hereditary melanoma|not specified","Likely benign(Last reviewed: Nov 25, 2020)","criteria provided, multiple submitters, no conflicts","VCV000379882","9","21974860","9","21974861",379882,"371197","rs1800586","NC_000009.12:21974860:C:T"
"NM_032888.4(COL27A1):c.3075del (p.Lys1026fs)","COL27A1","K1026fs","Steel syndrome","Pathogenic(Last reviewed: Jan 16, 2020)","no assertion criteria provided","VCV000807557","9","117014912","9","114252632",807557,"798607","rs5900078","NC_000009.12:114252631:CCC:CC"
"NM_005502.4(ABCA1):c.1759C>T (p.Arg587Trp)","ABCA1","R587W","ABCA1-Related Disorders","Pathogenic(Last reviewed: Jan 11, 2019)","criteria provided, single submitter","VCV000632033","9","107593339","9","104831058",632033,"620315","rs2853574","NC_000009.12:104831057:G:A"
"NM_005502.4(ABCA1):c.2803A>G (p.Asn935Asp)","ABCA1","N935D","Tangier disease","Likely pathogenic(Last reviewed: May 1, 2016)","no assertion criteria provided","VCV000374312","9","107584802","9","104822521",374312,"361192","rs28937314","NC_000009.12:104822520:T:C"
"NM_004629.1(FANCG):c.1538G>A (p.Arg513Gln)","FANCG|VCP","R513Q","not provided|not specified|Fanconi anemia, complementation group G|Amyotrophic Lateral Sclerosis, Dominant|Fanconi anemia|Inclusion Body Myopathy, Dominant","Conflicting interpretations of pathogenicity(Last reviewed: May 18, 2021)","criteria provided, conflicting interpretations","VCV000134361","9","35075022","9","35075025",134361,"138100","rs17885240","NC_000009.12:35075024:C:T"
"NM_000077.4(CDKN2A):c.-34G>T","CDKN2A","","Cutaneous malignant melanoma 2|Melanoma and neural system tumor syndrome|Melanoma-pancreatic cancer syndrome|Melanoma-pancreatic cancer syndrome|Hereditary cancer-predisposing syndrome|not provided|Hereditary melanoma","Pathogenic(Last reviewed: Oct 21, 2020)","criteria provided, multiple submitters, no conflicts","VCV000182414","9","21974860","9","21974861",182414,"180325","rs1800586","NC_000009.12:21974860:C:A"
"NM_012144.4(DNAI1):c.1003G>A (p.Val335Ile)","DNAI1","V335I, V339I","not specified|Primary ciliary dyskinesia|Kartagener syndrome","Benign/Likely benign(Last reviewed: Jul 1, 2021)","criteria provided, multiple submitters, no conflicts","VCV000163164","9","34500821","9","34500823",163164,"175107","rs11793196","NC_000009.12:34500822:G:A"
"NM_019892.6(INPP5E):c.1543C>A (p.Arg515=)","INPP5E","","not specified","Likely benign","criteria provided, single submitter","VCV000261196","9","139326282","9","136431830",261196,"253469","rs13297509","NC_000009.12:136431829:G:T"
"NM_000077.4(CDKN2A):c.-34G>C","CDKN2A","","Hereditary melanoma|Melanoma-pancreatic cancer syndrome|not specified|Hereditary cancer-predisposing syndrome","Conflicting interpretations of pathogenicity(Last reviewed: Dec 7, 2020)","criteria provided, conflicting interpretations","VCV000245907","9","21974860","9","21974861",245907,"244550","rs1800586","NC_000009.12:21974860:C:G"
"NM_000402.4(G6PD):c.292G>A (p.Val98Met)","G6PD","V68M, V98M","Glucose 6 phosphate dehydrogenase deficiency|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD ASAHI|Inborn genetic diseases|not specified|chlorproguanil and dapsone response - Toxicity/ADR|not provided|Parkinsonism with spasticity, X-linked|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|Glucose 6 phosphate dehydrogenase deficiency","drug response(Last reviewed: Oct 14, 2015)","reviewed by expert panel","VCV000037123","X","153764217","X","154536002",37123,"25400","rs1050828","NC_000023.11:154536001:C:T"
"NM_000402.4(G6PD):c.632A>T (p.Asp211Val)","G6PD","D181V, D211V","not provided|Anemia, nonspherocytic hemolytic, due to G6PD deficiency|G6PD MALAGA","Pathogenic(Last reviewed: Sep 24, 2020)","criteria provided, multiple submitters, no conflicts","VCV000037203","X","153762655","X","154534440",37203,"25421","rs5030872","NC_000023.11:154534439:T:A"
"NM_001363.5(DKC1):c.961C>G (p.Leu321Val)","DKC1","L321V","Dyskeratosis congenita, X-linked","Pathogenic(Last reviewed: May 10, 2012)","no assertion criteria provided","VCV000038958","X","153999079","X","154770804",38958,"47561","rs2728726","NC_000023.11:154770803:C:G"
"NM_000132.3(F8):c.5558C>T (p.Ala1853Val)","F8","A1853V","Hereditary factor VIII deficiency disease","Pathogenic(Last reviewed: Dec 1, 1993)","no assertion criteria provided","VCV000010284","X","154133114","X","154904839",10284,"25323","rs28933677","NC_000023.11:154904838:G:A"
"NM_000132.3(F8):c.5600A>G (p.His1867Arg)","F8","H1867R","Hereditary factor VIII deficiency disease","Pathogenic(Last reviewed: Oct 1, 1991)","no assertion criteria provided","VCV000010288","X","154132786","X","154904511",10288,"25327","rs28933679","NC_000023.11:154904510:T:C"
"NM_000132.3(F8):c.5618C>G (p.Pro1873Arg)","F8","P1873R","Hereditary factor VIII deficiency disease","Pathogenic(Last reviewed: Jan 1, 1995)","no assertion criteria provided","VCV000010289","X","154132768","X","154904493",10289,"25328","rs28933680","NC_000023.11:154904492:G:C"
"NM_000132.3(F8):c.5822A>G (p.Asn1941Ser)","F8","N1941S","Hereditary factor VIII deficiency disease","Pathogenic(Last reviewed: Apr 9, 2020)","criteria provided, single submitter","VCV000010294","X","154132357","X","154904082",10294,"25333","rs28933682","NC_000023.11:154904081:T:C"
"NM_000132.3(F8):c.5879G>T (p.Arg1960Leu)","F8","R1960L","Hereditary factor VIII deficiency disease","Pathogenic(Last reviewed: Jan 1, 1992)","no assertion criteria provided","VCV000010295","X","154132300","X","154904025",10295,"25334","rs28937294","NC_000023.11:154904024:C:A"
"NM_000169.2(GLA):c.484T>C (p.Trp162Arg)","GLA|RPL36A-HNRNPH2","W162R","Fabry disease","Likely pathogenic(Last reviewed: Jul 2, 2018)","criteria provided, single submitter","VCV000010728","X","100656683","X","101401695",10728,"25767","rs28935196","NC_000023.11:101401694:A:G"
"NM_000169.2(GLA):c.806T>C (p.Val269Ala)","GLA|RPL36A-HNRNPH2","V269A","Fabry disease","Pathogenic(Last reviewed: Jul 1, 1993)","no assertion criteria provided","VCV000010731","X","100653551","X","101398563",10731,"25770","rs28935488","NC_000023.11:101398562:A:G"
"NM_000132.3(F8):c.5879G>A (p.Arg1960Gln)","F8","R1960Q","Hereditary factor VIII deficiency disease|not provided","Pathogenic(Last reviewed: Dec 6, 2017)","criteria provided, single submitter","VCV000010110","X","154132300","X","154904025",10110,"25149","rs28937294","NC_000023.11:154904024:C:T"
"NM_000132.3(F8):c.5096A>T (p.Tyr1699Phe)","F8","Y1699F","Hereditary factor VIII deficiency disease","Pathogenic(Last reviewed: Dec 31, 2020)","criteria provided, multiple submitters, no conflicts","VCV000010115","X","154156969","X","154928694",10115,"25154","rs28935203","NC_000023.11:154928693:T:A"
"NM_000132.3(F8):c.1226A>G (p.Glu409Gly)","F8","E409G","Hereditary factor VIII deficiency disease","Pathogenic(Last reviewed: Jan 1, 1995)","no assertion criteria provided","VCV000010209","X","154194746","X","154966471",10209,"25248","rs28933671","NC_000023.11:154966470:T:C"
"NM_000132.3(F8):c.1293G>T (p.Leu431Phe)","F8","L431F","Hereditary factor VIII deficiency disease","Pathogenic(Last reviewed: Oct 1, 1991)","no assertion criteria provided","VCV000010210","X","154194395","X","154966120",10210,"25249","rs28933672","NC_000023.11:154966119:C:A"
"NM_000132.3(F8):c.2215G>A (p.Glu739Lys)","F8","E739K","Hereditary factor VIII deficiency disease","Pathogenic(Last reviewed: Jan 1, 1995)","no assertion criteria provided","VCV000010247","X","154159850","X","154931575",10247,"25286","rs28937285","NC_000023.11:154931574:C:T"
"NM_000132.3(F8):c.5323T>G (p.Leu1775Val)","F8","L1775V","Hereditary factor VIII deficiency disease","Pathogenic(Last reviewed: Jan 1, 1995)","no assertion criteria provided","VCV000010271","X","154134745","X","154906470",10271,"25310","rs28937287","NC_000023.11:154906469:A:C"
"NM_004429.4(EFNB1):c.472A>G (p.Met158Val)","EFNB1","M158V","Craniofrontonasal syndrome","Pathogenic(Last reviewed: Jun 8, 2004)","no assertion criteria provided","VCV000011711","X","68059572","X","68839729",11711,"26750","rs28936071","NC_000023.11:68839728:A:G"
"NM_001109878.2(TBX22):c.790A>T (p.Asn264Tyr)","TBX22","N264Y, N144Y","Cleft palate with ankyloglossia","Pathogenic(Last reviewed: Jan 1, 2004)","no assertion criteria provided","VCV000011336","X","79282359","X","80026860",11336,"26375","rs28935177","NC_000023.11:80026859:A:T"
"NM_014009.3(FOXP3):c.1189C>T (p.Arg397Trp)","FOXP3","R397W, R362W","Insulin-dependent diabetes mellitus secretory diarrhea syndrome|Hydrops fetalis","Pathogenic(Last reviewed: Mar 2, 2020)","criteria provided, single submitter","VCV000011407","X","49107902","X","49251441",11407,"26446","rs28935477","NC_000023.11:49251440:G:A"
"NM_001037811.2(HSD17B10):c.388C>T (p.Arg130Cys)","HSD17B10","R130C","not provided|HSD10 disease","Pathogenic(Last reviewed: Jun 27, 2019)","criteria provided, multiple submitters, no conflicts","VCV000011442","X","53459034","X","53432086",11442,"26481","rs28935475","NC_000023.11:53432085:G:A"
"NM_001037811.2(HSD17B10):c.364C>G (p.Leu122Val)","HSD17B10","L122V","HSD10 disease","Pathogenic(Last reviewed: May 1, 2003)","no assertion criteria provided","VCV000011443","X","53459058","X","53432110",11443,"26482","rs28935476","NC_000023.11:53432109:G:C"
"NM_006579.3(EBP):c.440G>A (p.Arg147His)","EBP","R147H","Chondrodysplasia punctata 2 X-linked dominant","Pathogenic(Last reviewed: Feb 8, 2013)","criteria provided, single submitter","VCV000011492","X","48385644","X","48527256",11492,"26531","rs28935174","NC_000023.11:48527255:G:A"
"NM_004586.3(RPS6KA3):c.2186G>A (p.Arg729Gln)","RPS6KA3","R729Q","Inborn genetic diseases|not provided|Coffin-Lowry syndrome|Intellectual disability","Likely pathogenic(Last reviewed: Apr 20, 2020)","criteria provided, multiple submitters, no conflicts","VCV000011658","X","20173553","X","20155435",11658,"26697","rs28935171","NC_000023.11:20155434:C:T"
"NM_004085.4(TIMM8A):c.238C>T (p.Arg80Ter)","TIMM8A","R80*","Deafness dystonia syndrome","Pathogenic(Last reviewed: Jun 1, 2001)","no assertion criteria provided","VCV000011324","X","100601543","X","101346555",11324,"26363","rs1054894","NC_000023.11:101346554:G:A"
"NM_004429.4(EFNB1):c.474G>T (p.Met158Ile)","EFNB1","M158I","Craniofrontonasal syndrome","Pathogenic(Last reviewed: Jun 8, 2004)","no assertion criteria provided","VCV000011712","X","68059574","X","68839731",11712,"26751","rs28935170","NC_000023.11:68839730:G:T"
"NM_001110556.2(FLNA):c.245A>T (p.Glu82Val)","FLNA","E82V","Periventricular nodular heterotopia 1","Pathogenic(Last reviewed: Mar 26, 2002)","no assertion criteria provided","VCV000011754","X","153599369","X","154371001",11754,"26793","rs28935169","NC_000023.11:154371000:T:A"
"NM_001110556.2(FLNA):c.620C>T (p.Pro207Leu)","FLNA","P207L","not specified|Oto-palato-digital syndrome, type I|Cleft palate|Conductive hearing impairment|Short stature","Pathogenic(Last reviewed: Nov 20, 2018)","criteria provided, multiple submitters, no conflicts","VCV000011755","X","153596212","X","154367844",11755,"26794","rs28935469","NC_000023.11:154367843:G:A"
"NM_001110556.2(FLNA):c.3562G>A (p.Ala1188Thr)","FLNA","A1188T","not provided|Melnick-Needles syndrome","Pathogenic(Last reviewed: Oct 12, 2017)","criteria provided, single submitter","VCV000011758","X","153588601","X","154360233",11758,"26797","rs28935472","NC_000023.11:154360232:C:T"
"NM_001110556.2(FLNA):c.3596C>T (p.Ser1199Leu)","FLNA","S1199L","Oto-palato-digital syndrome, type II|Melnick-Needles syndrome|Melnick-Needles syndrome|Frontometaphyseal dysplasia|Periventricular nodular heterotopia 1|Oto-palato-digital syndrome, type II","Pathogenic(Last reviewed: Dec 23, 2016)","criteria provided, multiple submitters, no conflicts","VCV000011759","X","153588567","X","154360199",11759,"26798","rs28935473","NC_000023.11:154360198:G:A"
"NM_001110792.2(MECP2):c.509C>T (p.Thr170Met)","MECP2","T158M, T170M, T65M","History of neurodevelopmental disorder|Angelman syndrome|Inborn genetic diseases|Severe neonatal-onset encephalopathy with microcephaly|Syndromic X-linked intellectual disability Lubs type|Autism, susceptibility to, X-linked 3|Rett syndrome|Mental retardation, X-linked, syndromic 13|Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome|not provided|not specified|Autism, susceptibility to, X-linked 3","Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)","criteria provided, multiple submitters, no conflicts","VCV000011811","X","153296806","X","154031355",11811,"26850","rs28934906","NC_000023.11:154031354:G:A"
"NM_001110792.2(MECP2):c.352C>T (p.Arg118Trp)","MECP2","R106W, R118W, R13W","not provided|Autism, susceptibility to, X-linked 3|Rett syndrome|Severe neonatal-onset encephalopathy with microcephaly|History of neurodevelopmental disorder|not specified","Pathogenic/Likely pathogenic(Last reviewed: Jul 14, 2020)","criteria provided, multiple submitters, no conflicts","VCV000011814","X","153297719","X","154032268",11814,"26853","rs28934907","NC_000023.11:154032267:G:A"
"NM_000054.6(AVPR2):c.337C>T (p.Arg113Trp)","AVPR2","R113W","Nephrogenic diabetes insipidus, X-linked","Pathogenic(Last reviewed: May 27, 1993)","no assertion criteria provided","VCV000010840","X","153171297","X","153905843",10840,"25879","rs28935496","NC_000023.11:153905842:C:T"
"NM_000169.2(GLA):c.797A>T (p.Asp266Val)","GLA|RPL36A-HNRNPH2","D266V","not provided|Fabry disease","Pathogenic(Last reviewed: Jan 12, 2021)","criteria provided, multiple submitters, no conflicts","VCV000010735","X","100653777","X","101398789",10735,"25774","rs28935487","NC_000023.11:101398788:T:A"
"NM_001199973.2(RPL36A-HNRNPH2):c.300+2933G>T","GLA|RPL36A-HNRNPH2","Q327K","Fabry disease","Pathogenic(Last reviewed: Jul 1, 1993)","no assertion criteria provided","VCV000010739","X","100653378","X","101398390",10739,"25778","rs28935491","NC_000023.11:101398389:G:T"
"NM_000169.2(GLA):c.815A>G (p.Asn272Ser)","GLA|RPL36A-HNRNPH2","N272S","Fabry disease","Pathogenic(Last reviewed: Jul 1, 2019)","criteria provided, single submitter","VCV000010774","X","100653542","X","101398554",10774,"25813","rs28935495","NC_000023.11:101398553:T:C"
"NM_004463.3(FGD1):c.935C>T (p.Pro312Leu)","FGD1","P312L","not provided|Aarskog syndrome|Syndromic X-linked mental retardation 16|Intellectual disability|History of neurodevelopmental disorder","Conflicting interpretations of pathogenicity(Last reviewed: May 1, 2018)","criteria provided, conflicting interpretations","VCV000010828","X","54496615","X","54470182",10828,"25867","rs28935498","NC_000023.11:54470181:G:A"
"NM_000533.5(PLP1):c.44C>T (p.Pro15Leu)","PLP1|RAB9B","P15L","Pelizaeus-Merzbacher disease","Pathogenic(Last reviewed: Dec 1, 1989)","no assertion criteria provided","VCV000011075","X","103040550","X","103785621",11075,"26114","rs11543022","NC_000023.11:103785620:C:T"
"NM_139058.3(ARX):c.98T>C (p.Leu33Pro)","ARX","L33P","Mental retardation, with or without seizures, ARX-related, X-linked","Pathogenic(Last reviewed: Apr 15, 2002)","no assertion criteria provided","VCV000011198","X","25033757","X","25015640",11198,"26237","rs28936077","NC_000023.11:25015639:A:G"
"NM_139058.3(ARX):c.856G>A (p.Gly286Ser)","ARX","G286S","Mental retardation, with or without seizures, ARX-related, X-linked|Epileptic encephalopathy, early infantile, 1|Mental retardation, with or without seizures, ARX-related, X-linked|not provided","Conflicting interpretations of pathogenicity(Last reviewed: Oct 8, 2020)","criteria provided, conflicting interpretations","VCV000011199","X","25031256","X","25013139",11199,"26238","rs28935479","NC_000023.11:25013138:C:T"
"NM_000033.4(ABCD1):c.1850G>A (p.Arg617His)","ABCD1","R617H","not provided|none provided|Adrenoleukodystrophy","Pathogenic(Last reviewed: Oct 9, 2020)","criteria provided, multiple submitters, no conflicts","VCV000011312","X","153008510","X","153743056",11312,"26351","rs11146842","NC_000023.11:153743055:G:A"
"NM_000033.4(ABCD1):c.1849C>T (p.Arg617Cys)","ABCD1","R617C","Adrenoleukodystrophy|none provided|not provided","Pathogenic/Likely pathogenic(Last reviewed: Jan 22, 2021)","criteria provided, multiple submitters, no conflicts","VCV000011313","X","153008509","X","153743055",11313,"26352","rs4010613","NC_000023.11:153743054:C:T"
"NM_000061.2(BTK):c.370T>C (p.Trp124Arg)","BTK","W124R, W158R","not provided","Likely pathogenic(Last reviewed: Nov 11, 2015)","criteria provided, single submitter","VCV000381633","X","100625007","X","101370019",381633,"378793","rs7474275","NC_000023.11:101370018:A:G"
"NM_014009.4(FOXP3):c.155G>T (p.Gly52Val)","FOXP3","G52V","Non-obstructive azoospermia|Insulin-dependent diabetes mellitus secretory diarrhea syndrome","Benign(Last reviewed: Nov 23, 2020)","criteria provided, single submitter","VCV000712945","X","49114808","X","49258351",712945,"729636","rs17847095","NC_000023.11:49258350:C:A"
"NM_001110792.2(MECP2):c.352C>G (p.Arg118Gly)","MECP2","R106G, R118G, R13G","Rett syndrome","Uncertain significance(Last reviewed: Jan 21, 2008)","no assertion criteria provided","VCV000143533","X","153297719","X","154032268",143533,"153265","rs28934907","NC_000023.11:154032267:G:C"
"NM_004006.3(DMD):c.5530C>T","DMD","R1844*, R1721*, R1840*, R503*, R1836*, R500*","Duchenne muscular dystrophy|not provided","Pathogenic(Last reviewed: Apr 23, 2020)","criteria provided, multiple submitters, no conflicts","VCV000094669","X","32364116","X","32345999",94669,"100569","rs1064325","NC_000023.11:32345998:G:A"
"NM_000330.3(RS1):c.330T>A (p.Cys110Ter)","RS1|CDKL5","C110*","not provided","Pathogenic(Last reviewed: Aug 15, 2019)","criteria provided, single submitter","VCV000098939","X","18662742","X","18644622",98939,"104829","rs1801161","NC_000023.11:18644621:A:T"
"NM_000330.3(RS1):c.330T>C (p.Cys110=)","RS1|CDKL5","","not provided|not specified","Benign(Last reviewed: Dec 4, 2020)","criteria provided, multiple submitters, no conflicts","VCV000098940","X","18662742","X","18644622",98940,"104830","rs1801161","NC_000023.11:18644621:A:G"
"NM_004006.2(DMD):c.5530C>A (p.Arg1844=)","DMD","","not specified|not provided|Duchenne muscular dystrophy","Conflicting interpretations of pathogenicity(Last reviewed: Nov 25, 2020)","criteria provided, conflicting interpretations","VCV000289167","X","32364116","X","32345999",289167,"273404","rs1064325","NC_000023.11:32345998:G:T"
"NM_001199973.2(RPL36A-HNRNPH2):c.300+2933G>A","GLA|RPL36A-HNRNPH2","Q327*","not provided","Pathogenic(Last reviewed: Aug 19, 2015)","criteria provided, single submitter","VCV000281030","X","100653378","X","101398390",281030,"265267","rs28935491","NC_000023.11:101398389:G:A"
"NM_001199973.2(RPL36A-HNRNPH2):c.300+3106A>T","GLA|RPL36A-HNRNPH2","V269E","not provided","Uncertain significance(Last reviewed: Jun 30, 2015)","criteria provided, single submitter","VCV000281865","X","100653551","X","101398563",281865,"266102","rs28935488","NC_000023.11:101398562:A:T"
"NM_000169.2(GLA):c.806T>G (p.Val269Gly)","GLA|RPL36A-HNRNPH2","V269G","Migalastat response|Fabry disease","Pathogenic, drug response(Last reviewed: Jan 1, 2014)","no assertion criteria provided","VCV000217399","X","100653551","X","101398563",217399,"214027","rs28935488","NC_000023.11:101398562:A:C"
"NM_001323289.2(CDKL5):c.2494C>T (p.Gln832Ter)","CDKL5","Q832*","Early infantile epileptic encephalopathy 2","Pathogenic(Last reviewed: Mar 13, 2014)","no assertion criteria provided","VCV000189573","X","18643365","X","18625245",189573,"187625","rs17857094","NC_000023.11:18625244:C:T"
"NM_000169.3(GLA):c.797A>C (p.Asp266Ala)","GLA|RPL36A-HNRNPH2","D266A","not specified","Uncertain significance(Last reviewed: Mar 11, 2015)","criteria provided, single submitter","VCV000228701","X","100653777","X","101398789",228701,"231408","rs28935487","NC_000023.11:101398788:T:G"
